id	sid	tid	token	lemma	pos
aiua-8110	1	1	stesura	stesura	PROPN
aiua-8110	1	2	seveso	seveso	PROPN
aiua-8110	1	3	97archivio	97archivio	NUM
aiua-8110	1	4	italiano	italiano	PROPN
aiua-8110	1	5	di	di	PROPN
aiua-8110	1	6	urologia	urologia	PROPN
aiua-8110	1	7	e	e	PROPN
aiua-8110	1	8	andrologia	andrologia	NOUN
aiua-8110	1	9	2019	2019	NUM
aiua-8110	1	10	;	;	PUNCT
aiua-8110	1	11	91	91	NUM
aiua-8110	1	12	,	,	PUNCT
aiua-8110	1	13	2	2	NUM
aiua-8110	1	14	original	original	ADJ
aiua-8110	1	15	paper	paper	NOUN
aiua-8110	1	16	increased	increase	VERB
aiua-8110	1	17	neutrophil	neutrophil	ADJ
aiua-8110	1	18	/	/	SYM
aiua-8110	1	19	lymphocyte	lymphocyte	ADJ
aiua-8110	1	20	ratio	ratio	NOUN
aiua-8110	1	21	in	in	ADP
aiua-8110	1	22	testicular	testicular	ADJ
aiua-8110	1	23	cancer	cancer	NOUN
aiua-8110	1	24	aytaç	aytaç	PROPN
aiua-8110	1	25	şahin	şahin	PROPN
aiua-8110	1	26	,	,	PUNCT
aiua-8110	1	27	tuncay	tuncay	NOUN
aiua-8110	1	28	toprak	toprak	NOUN
aiua-8110	1	29	,	,	PUNCT
aiua-8110	1	30	musab	musab	PROPN
aiua-8110	1	31	ali	ali	PROPN
aiua-8110	1	32	kutluhan	kutluhan	PROPN
aiua-8110	1	33	,	,	PUNCT
aiua-8110	1	34	yasin	yasin	PROPN
aiua-8110	1	35	vural	vural	PROPN
aiua-8110	1	36	,	,	PUNCT
aiua-8110	1	37	ahmet	ahmet	PROPN
aiua-8110	1	38	ürkmez	ürkmez	NOUN
aiua-8110	1	39	,	,	PUNCT
aiua-8110	1	40	ayhan	ayhan	PROPN
aiua-8110	1	41	verit	verit	PROPN
aiua-8110	1	42	sbu	sbu	PROPN
aiua-8110	1	43	fatih	fatih	PROPN
aiua-8110	1	44	sultan	sultan	PROPN
aiua-8110	1	45	mehmet	mehmet	PROPN
aiua-8110	1	46	training	training	PROPN
aiua-8110	1	47	and	and	CCONJ
aiua-8110	1	48	research	research	NOUN
aiua-8110	1	49	hospital	hospital	NOUN
aiua-8110	1	50	,	,	PUNCT
aiua-8110	1	51	istanbul	istanbul	PROPN
aiua-8110	1	52	.	.	PUNCT
aiua-8110	2	1	objective	objective	ADJ
aiua-8110	2	2	:	:	PUNCT
aiua-8110	2	3	testicular	testicular	ADJ
aiua-8110	2	4	cancers	cancer	NOUN
aiua-8110	2	5	,	,	PUNCT
aiua-8110	2	6	which	which	PRON
aiua-8110	2	7	are	be	AUX
aiua-8110	2	8	less	less	ADV
aiua-8110	2	9	common	common	ADJ
aiua-8110	2	10	than	than	ADP
aiua-8110	2	11	other	other	ADJ
aiua-8110	2	12	cancers	cancer	NOUN
aiua-8110	2	13	,	,	PUNCT
aiua-8110	2	14	are	be	AUX
aiua-8110	2	15	important	important	ADJ
aiua-8110	2	16	in	in	ADP
aiua-8110	2	17	terms	term	NOUN
aiua-8110	2	18	of	of	ADP
aiua-8110	2	19	being	be	AUX
aiua-8110	2	20	seen	see	VERB
aiua-8110	2	21	in	in	ADP
aiua-8110	2	22	young	young	ADJ
aiua-8110	2	23	people	people	NOUN
aiua-8110	2	24	.	.	PUNCT
aiua-8110	3	1	physical	physical	ADJ
aiua-8110	3	2	examination	examination	NOUN
aiua-8110	3	3	,	,	PUNCT
aiua-8110	3	4	imaging	imaging	NOUN
aiua-8110	3	5	,	,	PUNCT
aiua-8110	3	6	laboratory	laboratory	NOUN
aiua-8110	3	7	and	and	CCONJ
aiua-8110	3	8	tumor	tumor	NOUN
aiua-8110	3	9	markers	marker	NOUN
aiua-8110	3	10	are	be	AUX
aiua-8110	3	11	used	use	VERB
aiua-8110	3	12	for	for	ADP
aiua-8110	3	13	diagnosis	diagnosis	NOUN
aiua-8110	3	14	.	.	PUNCT
aiua-8110	4	1	there	there	PRON
aiua-8110	4	2	are	be	VERB
aiua-8110	4	3	some	some	DET
aiua-8110	4	4	studies	study	NOUN
aiua-8110	4	5	of	of	ADP
aiua-8110	4	6	some	some	DET
aiua-8110	4	7	blood	blood	NOUN
aiua-8110	4	8	parameters	parameter	NOUN
aiua-8110	4	9	that	that	PRON
aiua-8110	4	10	can	can	AUX
aiua-8110	4	11	be	be	AUX
aiua-8110	4	12	involved	involve	VERB
aiua-8110	4	13	in	in	ADP
aiua-8110	4	14	inflammation	inflammation	NOUN
aiua-8110	4	15	and	and	CCONJ
aiua-8110	4	16	tumorogenesis	tumorogenesis	NOUN
aiua-8110	4	17	.	.	PUNCT
aiua-8110	5	1	we	we	PRON
aiua-8110	5	2	retrospectively	retrospectively	ADV
aiua-8110	5	3	compared	compare	VERB
aiua-8110	5	4	hematological	hematological	ADJ
aiua-8110	5	5	values	value	NOUN
aiua-8110	5	6	measured	measure	VERB
aiua-8110	5	7	in	in	ADP
aiua-8110	5	8	our	our	PRON
aiua-8110	5	9	patients	patient	NOUN
aiua-8110	5	10	who	who	PRON
aiua-8110	5	11	were	be	AUX
aiua-8110	5	12	diagnosed	diagnose	VERB
aiua-8110	5	13	with	with	ADP
aiua-8110	5	14	testicular	testicular	ADJ
aiua-8110	5	15	tumor	tumor	NOUN
aiua-8110	5	16	in	in	ADP
aiua-8110	5	17	comparison	comparison	NOUN
aiua-8110	5	18	with	with	ADP
aiua-8110	5	19	patients	patient	NOUN
aiua-8110	5	20	with	with	ADP
aiua-8110	5	21	similar	similar	ADJ
aiua-8110	5	22	age	age	NOUN
aiua-8110	5	23	group	group	NOUN
aiua-8110	5	24	who	who	PRON
aiua-8110	5	25	underwent	undergo	VERB
aiua-8110	5	26	varicocelectomy	varicocelectomy	ADJ
aiua-8110	5	27	repair	repair	NOUN
aiua-8110	5	28	.	.	PUNCT
aiua-8110	6	1	materials	material	NOUN
aiua-8110	6	2	and	and	CCONJ
aiua-8110	6	3	methods	method	NOUN
aiua-8110	6	4	:	:	PUNCT
aiua-8110	6	5	this	this	DET
aiua-8110	6	6	cross	cross	ADJ
aiua-8110	6	7	-	-	ADJ
aiua-8110	6	8	sectional	sectional	ADJ
aiua-8110	6	9	retrospective	retrospective	ADJ
aiua-8110	6	10	study	study	NOUN
aiua-8110	6	11	included	include	VERB
aiua-8110	6	12	120	120	NUM
aiua-8110	6	13	patients	patient	NOUN
aiua-8110	6	14	who	who	PRON
aiua-8110	6	15	underwent	undergo	VERB
aiua-8110	6	16	radical	radical	ADJ
aiua-8110	6	17	inguinal	inguinal	ADJ
aiua-8110	6	18	orchiectomy	orchiectomy	NOUN
aiua-8110	6	19	for	for	ADP
aiua-8110	6	20	testicular	testicular	ADJ
aiua-8110	6	21	tumor	tumor	NOUN
aiua-8110	6	22	between	between	ADP
aiua-8110	6	23	january	january	PROPN
aiua-8110	6	24	2010	2010	NUM
aiua-8110	6	25	and	and	CCONJ
aiua-8110	6	26	december	december	PROPN
aiua-8110	6	27	2018	2018	NUM
aiua-8110	6	28	,	,	PUNCT
aiua-8110	6	29	and	and	CCONJ
aiua-8110	6	30	171	171	NUM
aiua-8110	6	31	patients	patient	NOUN
aiua-8110	6	32	who	who	PRON
aiua-8110	6	33	underwent	undergo	VERB
aiua-8110	6	34	varicocelectomy	varicocelectomy	NOUN
aiua-8110	6	35	as	as	ADP
aiua-8110	6	36	a	a	DET
aiua-8110	6	37	control	control	NOUN
aiua-8110	6	38	group	group	NOUN
aiua-8110	6	39	.	.	PUNCT
aiua-8110	7	1	patients	patient	NOUN
aiua-8110	7	2	with	with	ADP
aiua-8110	7	3	an	an	DET
aiua-8110	7	4	active	active	ADJ
aiua-8110	7	5	infection	infection	NOUN
aiua-8110	7	6	and	and	CCONJ
aiua-8110	7	7	hematological	hematological	ADJ
aiua-8110	7	8	disorders	disorder	NOUN
aiua-8110	7	9	were	be	AUX
aiua-8110	7	10	excluded	exclude	VERB
aiua-8110	7	11	from	from	ADP
aiua-8110	7	12	the	the	DET
aiua-8110	7	13	study	study	NOUN
aiua-8110	7	14	.	.	PUNCT
aiua-8110	8	1	we	we	PRON
aiua-8110	8	2	evaulated	evaulate	VERB
aiua-8110	8	3	hematological	hematological	ADJ
aiua-8110	8	4	parameters	parameter	NOUN
aiua-8110	8	5	including	include	VERB
aiua-8110	8	6	neutrophil	neutrophil	ADJ
aiua-8110	8	7	(	(	PUNCT
aiua-8110	8	8	neu	neu	NOUN
aiua-8110	8	9	)	)	PUNCT
aiua-8110	8	10	,	,	PUNCT
aiua-8110	8	11	lymphocyte	lymphocyte	NOUN
aiua-8110	8	12	(	(	PUNCT
aiua-8110	8	13	lym	lym	PROPN
aiua-8110	8	14	)	)	PUNCT
aiua-8110	8	15	,	,	PUNCT
aiua-8110	8	16	platelet	platelet	NOUN
aiua-8110	8	17	(	(	PUNCT
aiua-8110	8	18	plt	plt	NOUN
aiua-8110	8	19	)	)	PUNCT
aiua-8110	8	20	count	count	NOUN
aiua-8110	8	21	,	,	PUNCT
aiua-8110	8	22	and	and	CCONJ
aiua-8110	8	23	mean	mean	VERB
aiua-8110	8	24	platelet	platelet	NOUN
aiua-8110	8	25	volume	volume	NOUN
aiua-8110	8	26	.	.	PUNCT
aiua-8110	9	1	the	the	DET
aiua-8110	9	2	study	study	NOUN
aiua-8110	9	3	was	be	AUX
aiua-8110	9	4	conducted	conduct	VERB
aiua-8110	9	5	on	on	ADP
aiua-8110	9	6	291	291	NUM
aiua-8110	9	7	patients	patient	NOUN
aiua-8110	9	8	.	.	PUNCT
aiua-8110	10	1	divided	divide	VERB
aiua-8110	10	2	in	in	ADP
aiua-8110	10	3	two	two	NUM
aiua-8110	10	4	groups	group	NOUN
aiua-8110	10	5	:	:	PUNCT
aiua-8110	10	6	tumor	tumor	NOUN
aiua-8110	10	7	(	(	PUNCT
aiua-8110	10	8	n	n	NOUN
aiua-8110	10	9	=	=	SYM
aiua-8110	10	10	120	120	NUM
aiua-8110	10	11	)	)	PUNCT
aiua-8110	10	12	and	and	CCONJ
aiua-8110	10	13	varicocele	varicocele	NOUN
aiua-8110	10	14	(	(	PUNCT
aiua-8110	10	15	n	n	NOUN
aiua-8110	10	16	=	=	NOUN
aiua-8110	10	17	171	171	NUM
aiua-8110	10	18	)	)	PUNCT
aiua-8110	10	19	.	.	PUNCT
aiua-8110	11	1	results	result	NOUN
aiua-8110	11	2	:	:	PUNCT
aiua-8110	11	3	there	there	PRON
aiua-8110	11	4	was	be	VERB
aiua-8110	11	5	no	no	DET
aiua-8110	11	6	statistically	statistically	ADV
aiua-8110	11	7	significant	significant	ADJ
aiua-8110	11	8	difference	difference	NOUN
aiua-8110	11	9	between	between	ADP
aiua-8110	11	10	the	the	DET
aiua-8110	11	11	groups	group	NOUN
aiua-8110	11	12	in	in	ADP
aiua-8110	11	13	terms	term	NOUN
aiua-8110	11	14	of	of	ADP
aiua-8110	11	15	plt	plt	NOUN
aiua-8110	11	16	/	/	PUNCT
aiua-8110	11	17	lymphocyte	lymphocyte	NOUN
aiua-8110	11	18	ratio	ratio	NOUN
aiua-8110	11	19	and	and	CCONJ
aiua-8110	11	20	mean	mean	VERB
aiua-8110	11	21	platelet	platelet	NOUN
aiua-8110	11	22	volume	volume	NOUN
aiua-8110	11	23	(	(	PUNCT
aiua-8110	11	24	mpv	mpv	PROPN
aiua-8110	11	25	)	)	PUNCT
aiua-8110	11	26	levels	level	NOUN
aiua-8110	11	27	(	(	PUNCT
aiua-8110	11	28	p	p	X
aiua-8110	11	29	>	>	X
aiua-8110	11	30	0.05	0.05	NUM
aiua-8110	11	31	)	)	PUNCT
aiua-8110	11	32	.	.	PUNCT
aiua-8110	12	1	the	the	DET
aiua-8110	12	2	neutrophil	neutrophil	ADJ
aiua-8110	12	3	/lymphocyte	/lymphocyte	CCONJ
aiua-8110	12	4	ratio	ratio	NOUN
aiua-8110	12	5	(	(	PUNCT
aiua-8110	12	6	nlr	nlr	PROPN
aiua-8110	12	7	)	)	PUNCT
aiua-8110	12	8	of	of	ADP
aiua-8110	12	9	the	the	DET
aiua-8110	12	10	tumor	tumor	NOUN
aiua-8110	12	11	group	group	NOUN
aiua-8110	12	12	was	be	AUX
aiua-8110	12	13	significantly	significantly	ADV
aiua-8110	12	14	higher	high	ADJ
aiua-8110	12	15	than	than	ADP
aiua-8110	12	16	the	the	DET
aiua-8110	12	17	varicocele	varicocele	NOUN
aiua-8110	12	18	group	group	NOUN
aiua-8110	12	19	(	(	PUNCT
aiua-8110	12	20	p	p	X
aiua-8110	12	21	=	=	NOUN
aiua-8110	12	22	0.001	0.001	NUM
aiua-8110	12	23	;	;	PUNCT
aiua-8110	12	24	p	p	X
aiua-8110	12	25	<	<	X
aiua-8110	12	26	0.05	0.05	NUM
aiua-8110	12	27	)	)	PUNCT
aiua-8110	12	28	.	.	PUNCT
aiua-8110	13	1	there	there	PRON
aiua-8110	13	2	was	be	VERB
aiua-8110	13	3	a	a	DET
aiua-8110	13	4	statistically	statistically	ADV
aiua-8110	13	5	significant	significant	ADJ
aiua-8110	13	6	difference	difference	NOUN
aiua-8110	13	7	between	between	ADP
aiua-8110	13	8	the	the	DET
aiua-8110	13	9	tumor	tumor	NOUN
aiua-8110	13	10	stages	stage	NOUN
aiua-8110	13	11	in	in	ADP
aiua-8110	13	12	terms	term	NOUN
aiua-8110	13	13	of	of	ADP
aiua-8110	13	14	plt	plt	NOUN
aiua-8110	13	15	/	/	PUNCT
aiua-8110	13	16	lymphocyte	lymphocyte	ADJ
aiua-8110	13	17	ratios	ratio	NOUN
aiua-8110	13	18	(	(	PUNCT
aiua-8110	13	19	p	p	X
aiua-8110	13	20	=	=	NOUN
aiua-8110	13	21	0.006	0.006	NUM
aiua-8110	13	22	;	;	PUNCT
aiua-8110	13	23	p	p	X
aiua-8110	13	24	<	<	X
aiua-8110	13	25	0.05	0.05	NUM
aiua-8110	13	26	)	)	PUNCT
aiua-8110	13	27	.	.	PUNCT
aiua-8110	14	1	conclusions	conclusion	NOUN
aiua-8110	14	2	:	:	PUNCT
aiua-8110	14	3	there	there	PRON
aiua-8110	14	4	was	be	VERB
aiua-8110	14	5	only	only	ADV
aiua-8110	14	6	a	a	DET
aiua-8110	14	7	statistically	statistically	ADV
aiua-8110	14	8	significant	significant	ADJ
aiua-8110	14	9	increase	increase	NOUN
aiua-8110	14	10	in	in	ADP
aiua-8110	14	11	nlr	nlr	PROPN
aiua-8110	14	12	values	value	NOUN
aiua-8110	14	13	in	in	ADP
aiua-8110	14	14	the	the	DET
aiua-8110	14	15	testicular	testicular	ADJ
aiua-8110	14	16	tumor	tumor	NOUN
aiua-8110	14	17	group	group	NOUN
aiua-8110	14	18	compared	compare	VERB
aiua-8110	14	19	to	to	ADP
aiua-8110	14	20	the	the	DET
aiua-8110	14	21	varicocele	varicocele	PROPN
aiua-8110	14	22	group	group	NOUN
aiua-8110	14	23	.	.	PUNCT
aiua-8110	15	1	larger	large	ADJ
aiua-8110	15	2	,	,	PUNCT
aiua-8110	15	3	randomized	randomize	VERB
aiua-8110	15	4	controlled	control	VERB
aiua-8110	15	5	studies	study	NOUN
aiua-8110	15	6	are	be	AUX
aiua-8110	15	7	needed	need	VERB
aiua-8110	15	8	at	at	ADP
aiua-8110	15	9	this	this	DET
aiua-8110	15	10	field	field	NOUN
aiua-8110	15	11	.	.	PUNCT
aiua-8110	16	1	key	key	ADJ
aiua-8110	16	2	words	word	NOUN
aiua-8110	16	3	:	:	PUNCT
aiua-8110	16	4	testis	testis	NOUN
aiua-8110	16	5	;	;	PUNCT
aiua-8110	16	6	cancer	cancer	NOUN
aiua-8110	16	7	;	;	PUNCT
aiua-8110	16	8	mean	mean	VERB
aiua-8110	16	9	platelet	platelet	NOUN
aiua-8110	16	10	volume	volume	NOUN
aiua-8110	16	11	(	(	PUNCT
aiua-8110	16	12	mpv	mpv	PROPN
aiua-8110	16	13	)	)	PUNCT
aiua-8110	16	14	;	;	PUNCT
aiua-8110	16	15	neutrophil	neutrophil	ADJ
aiua-8110	16	16	/	/	SYM
aiua-8110	16	17	lymphocyte	lymphocyte	ADJ
aiua-8110	16	18	ratio	ratio	NOUN
aiua-8110	16	19	(	(	PUNCT
aiua-8110	16	20	nlr	nlr	PROPN
aiua-8110	16	21	)	)	PUNCT
aiua-8110	16	22	.	.	PUNCT
aiua-8110	16	23	submitted	submit	VERB
aiua-8110	16	24	13	13	NUM
aiua-8110	16	25	january	january	PROPN
aiua-8110	16	26	2019	2019	NUM
aiua-8110	16	27	;	;	PUNCT
aiua-8110	16	28	accepted	accept	VERB
aiua-8110	16	29	2	2	NUM
aiua-8110	16	30	april	april	PROPN
aiua-8110	16	31	2019	2019	NUM
aiua-8110	16	32	summary	summary	NOUN
aiua-8110	16	33	no	no	DET
aiua-8110	16	34	conflict	conflict	NOUN
aiua-8110	16	35	of	of	ADP
aiua-8110	16	36	interest	interest	NOUN
aiua-8110	16	37	declared	declare	VERB
aiua-8110	16	38	.	.	PUNCT
aiua-8110	17	1	diagnosis	diagnosis	NOUN
aiua-8110	17	2	more	more	ADV
aiua-8110	17	3	effective	effective	ADJ
aiua-8110	17	4	treatment	treatment	NOUN
aiua-8110	17	5	schedules	schedule	NOUN
aiua-8110	17	6	can	can	AUX
aiua-8110	17	7	be	be	AUX
aiua-8110	17	8	applied	apply	VERB
aiua-8110	17	9	contributing	contribute	VERB
aiua-8110	17	10	to	to	ADP
aiua-8110	17	11	better	well	ADJ
aiua-8110	17	12	survival	survival	NOUN
aiua-8110	17	13	.	.	PUNCT
aiua-8110	18	1	at	at	ADP
aiua-8110	18	2	this	this	DET
aiua-8110	18	3	point	point	NOUN
aiua-8110	18	4	,	,	PUNCT
aiua-8110	18	5	simple	simple	ADJ
aiua-8110	18	6	,	,	PUNCT
aiua-8110	18	7	inexpensive	inexpensive	ADJ
aiua-8110	18	8	and	and	CCONJ
aiua-8110	18	9	easily	easily	ADV
aiua-8110	18	10	applicable	applicable	ADJ
aiua-8110	18	11	markers	marker	NOUN
aiua-8110	18	12	can	can	AUX
aiua-8110	18	13	be	be	AUX
aiua-8110	18	14	useful	useful	ADJ
aiua-8110	18	15	in	in	ADP
aiua-8110	18	16	the	the	DET
aiua-8110	18	17	clinical	clinical	ADJ
aiua-8110	18	18	approach	approach	NOUN
aiua-8110	18	19	.	.	PUNCT
aiua-8110	19	1	there	there	PRON
aiua-8110	19	2	are	be	VERB
aiua-8110	19	3	some	some	DET
aiua-8110	19	4	studies	study	NOUN
aiua-8110	19	5	that	that	SCONJ
aiua-8110	19	6	some	some	DET
aiua-8110	19	7	blood	blood	NOUN
aiua-8110	19	8	parameters	parameter	NOUN
aiua-8110	19	9	can	can	AUX
aiua-8110	19	10	be	be	AUX
aiua-8110	19	11	associated	associate	VERB
aiua-8110	19	12	to	to	ADP
aiua-8110	19	13	inflammation	inflammation	NOUN
aiua-8110	19	14	and	and	CCONJ
aiua-8110	19	15	tumorogenesis	tumorogenesis	NOUN
aiua-8110	19	16	.	.	PUNCT
aiua-8110	20	1	studies	study	NOUN
aiua-8110	20	2	have	have	AUX
aiua-8110	20	3	shown	show	VERB
aiua-8110	20	4	that	that	SCONJ
aiua-8110	20	5	inflammatory	inflammatory	ADJ
aiua-8110	20	6	response	response	NOUN
aiua-8110	20	7	is	be	AUX
aiua-8110	20	8	closely	closely	ADV
aiua-8110	20	9	related	relate	VERB
aiua-8110	20	10	to	to	ADP
aiua-8110	20	11	tumorigenesis	tumorigenesis	NOUN
aiua-8110	20	12	and	and	CCONJ
aiua-8110	20	13	tumor	tumor	NOUN
aiua-8110	20	14	invasion	invasion	NOUN
aiua-8110	20	15	(	(	PUNCT
aiua-8110	20	16	2	2	NUM
aiua-8110	20	17	)	)	PUNCT
aiua-8110	20	18	.	.	PUNCT
aiua-8110	21	1	interactions	interaction	NOUN
aiua-8110	21	2	occur	occur	VERB
aiua-8110	21	3	between	between	ADP
aiua-8110	21	4	the	the	DET
aiua-8110	21	5	tumor	tumor	NOUN
aiua-8110	21	6	and	and	CCONJ
aiua-8110	21	7	inflammation	inflammation	NOUN
aiua-8110	21	8	according	accord	VERB
aiua-8110	21	9	to	to	ADP
aiua-8110	21	10	complex	complex	ADJ
aiua-8110	21	11	and	and	CCONJ
aiua-8110	21	12	various	various	ADJ
aiua-8110	21	13	mechanisms	mechanism	NOUN
aiua-8110	21	14	.	.	PUNCT
aiua-8110	22	1	at	at	ADP
aiua-8110	22	2	each	each	DET
aiua-8110	22	3	stage	stage	NOUN
aiua-8110	22	4	of	of	ADP
aiua-8110	22	5	carcinogenesis	carcinogenesis	NOUN
aiua-8110	22	6	;	;	PUNCT
aiua-8110	22	7	inflammation	inflammation	NOUN
aiua-8110	22	8	has	have	VERB
aiua-8110	22	9	an	an	DET
aiua-8110	22	10	important	important	ADJ
aiua-8110	22	11	role	role	NOUN
aiua-8110	22	12	(	(	PUNCT
aiua-8110	22	13	3	3	NUM
aiua-8110	22	14	)	)	PUNCT
aiua-8110	22	15	.	.	PUNCT
aiua-8110	23	1	changes	change	NOUN
aiua-8110	23	2	in	in	ADP
aiua-8110	23	3	systemic	systemic	ADJ
aiua-8110	23	4	inflammatory	inflammatory	ADJ
aiua-8110	23	5	response	response	NOUN
aiua-8110	23	6	can	can	AUX
aiua-8110	23	7	be	be	AUX
aiua-8110	23	8	assessed	assess	VERB
aiua-8110	23	9	by	by	ADP
aiua-8110	23	10	hematological	hematological	ADJ
aiua-8110	23	11	parameters	parameter	NOUN
aiua-8110	23	12	.	.	PUNCT
aiua-8110	24	1	for	for	ADP
aiua-8110	24	2	example	example	NOUN
aiua-8110	24	3	,	,	PUNCT
aiua-8110	24	4	changes	change	NOUN
aiua-8110	24	5	in	in	ADP
aiua-8110	24	6	c	c	NOUN
aiua-8110	24	7	-	-	PUNCT
aiua-8110	24	8	reactive	reactive	ADJ
aiua-8110	24	9	protein	protein	NOUN
aiua-8110	24	10	(	(	PUNCT
aiua-8110	24	11	crp	crp	PROPN
aiua-8110	24	12	)	)	PUNCT
aiua-8110	24	13	and	and	CCONJ
aiua-8110	24	14	neutrophil	neutrophil	ADJ
aiua-8110	24	15	to	to	ADP
aiua-8110	24	16	lymphocyte	lymphocyte	ADJ
aiua-8110	24	17	ratio	ratio	NOUN
aiua-8110	24	18	(	(	PUNCT
aiua-8110	24	19	nlr	nlr	PROPN
aiua-8110	24	20	)	)	PUNCT
aiua-8110	24	21	show	show	VERB
aiua-8110	24	22	signs	sign	NOUN
aiua-8110	24	23	of	of	ADP
aiua-8110	24	24	systemic	systemic	ADJ
aiua-8110	24	25	inflammatory	inflammatory	ADJ
aiua-8110	24	26	response	response	NOUN
aiua-8110	24	27	in	in	ADP
aiua-8110	24	28	various	various	ADJ
aiua-8110	24	29	malignancies	malignancy	NOUN
aiua-8110	24	30	(	(	PUNCT
aiua-8110	24	31	4	4	NUM
aiua-8110	24	32	)	)	PUNCT
aiua-8110	24	33	.	.	PUNCT
aiua-8110	25	1	there	there	PRON
aiua-8110	25	2	are	be	VERB
aiua-8110	25	3	also	also	ADV
aiua-8110	25	4	reports	report	NOUN
aiua-8110	25	5	that	that	SCONJ
aiua-8110	25	6	elevated	elevated	ADJ
aiua-8110	25	7	nlr	nlr	PROPN
aiua-8110	25	8	is	be	AUX
aiua-8110	25	9	associated	associate	VERB
aiua-8110	25	10	with	with	ADP
aiua-8110	25	11	poor	poor	ADJ
aiua-8110	25	12	prognosis	prognosis	NOUN
aiua-8110	25	13	in	in	ADP
aiua-8110	25	14	some	some	DET
aiua-8110	25	15	urothelial	urothelial	ADJ
aiua-8110	25	16	cancers	cancer	NOUN
aiua-8110	25	17	(	(	PUNCT
aiua-8110	25	18	5	5	NUM
aiua-8110	25	19	)	)	PUNCT
aiua-8110	25	20	.	.	PUNCT
aiua-8110	26	1	the	the	DET
aiua-8110	26	2	vast	vast	ADJ
aiua-8110	26	3	majority	majority	NOUN
aiua-8110	26	4	of	of	ADP
aiua-8110	26	5	studies	study	NOUN
aiua-8110	26	6	have	have	AUX
aiua-8110	26	7	reported	report	VERB
aiua-8110	26	8	that	that	SCONJ
aiua-8110	26	9	the	the	DET
aiua-8110	26	10	increase	increase	NOUN
aiua-8110	26	11	in	in	ADP
aiua-8110	26	12	nlr	nlr	PROPN
aiua-8110	26	13	is	be	AUX
aiua-8110	26	14	associated	associate	VERB
aiua-8110	26	15	with	with	ADP
aiua-8110	26	16	poor	poor	ADJ
aiua-8110	26	17	prognosis	prognosis	NOUN
aiua-8110	26	18	in	in	ADP
aiua-8110	26	19	many	many	ADJ
aiua-8110	26	20	malignant	malignant	ADJ
aiua-8110	26	21	tumors	tumor	NOUN
aiua-8110	26	22	.	.	PUNCT
aiua-8110	27	1	for	for	ADP
aiua-8110	27	2	this	this	DET
aiua-8110	27	3	reason	reason	NOUN
aiua-8110	27	4	,	,	PUNCT
aiua-8110	27	5	nlr	nlr	PROPN
aiua-8110	27	6	can	can	AUX
aiua-8110	27	7	be	be	AUX
aiua-8110	27	8	used	use	VERB
aiua-8110	27	9	not	not	PART
aiua-8110	27	10	only	only	ADV
aiua-8110	27	11	as	as	ADP
aiua-8110	27	12	a	a	DET
aiua-8110	27	13	marker	marker	NOUN
aiua-8110	27	14	of	of	ADP
aiua-8110	27	15	systemic	systemic	ADJ
aiua-8110	27	16	inflammatory	inflammatory	ADJ
aiua-8110	27	17	response	response	NOUN
aiua-8110	27	18	,	,	PUNCT
aiua-8110	27	19	but	but	CCONJ
aiua-8110	27	20	also	also	ADV
aiua-8110	27	21	in	in	ADP
aiua-8110	27	22	various	various	ADJ
aiua-8110	27	23	tumor	tumor	NOUN
aiua-8110	27	24	types	type	NOUN
aiua-8110	27	25	and	and	CCONJ
aiua-8110	27	26	inflammatory	inflammatory	ADJ
aiua-8110	27	27	conditions	condition	NOUN
aiua-8110	27	28	(	(	PUNCT
aiua-8110	27	29	6	6	NUM
aiua-8110	27	30	)	)	PUNCT
aiua-8110	27	31	.	.	PUNCT
aiua-8110	28	1	in	in	ADP
aiua-8110	28	2	order	order	NOUN
aiua-8110	28	3	to	to	PART
aiua-8110	28	4	predict	predict	VERB
aiua-8110	28	5	cancer	cancer	NOUN
aiua-8110	28	6	prognosis	prognosis	NOUN
aiua-8110	28	7	and	and	CCONJ
aiua-8110	28	8	inflammatory	inflammatory	ADJ
aiua-8110	28	9	conditions	condition	NOUN
aiua-8110	28	10	,	,	PUNCT
aiua-8110	28	11	there	there	PRON
aiua-8110	28	12	is	be	VERB
aiua-8110	28	13	a	a	DET
aiua-8110	28	14	growing	grow	VERB
aiua-8110	28	15	interest	interest	NOUN
aiua-8110	28	16	in	in	ADP
aiua-8110	28	17	simple	simple	ADJ
aiua-8110	28	18	blood	blood	NOUN
aiua-8110	28	19	methods	method	NOUN
aiua-8110	28	20	such	such	ADJ
aiua-8110	28	21	as	as	ADP
aiua-8110	28	22	nlr	nlr	PROPN
aiua-8110	28	23	.	.	PROPN
aiua-8110	28	24	nlr	nlr	PROPN
aiua-8110	28	25	,	,	PUNCT
aiua-8110	28	26	lymphocytemonocyte	lymphocytemonocyte	PROPN
aiua-8110	28	27	ratio	ratio	PROPN
aiua-8110	28	28	(	(	PUNCT
aiua-8110	28	29	lmr	lmr	PROPN
aiua-8110	28	30	)	)	PUNCT
aiua-8110	28	31	,	,	PUNCT
aiua-8110	28	32	platelet	platelet	ADJ
aiua-8110	28	33	-	-	PUNCT
aiua-8110	28	34	lymphocyte	lymphocyte	ADJ
aiua-8110	28	35	ratio	ratio	NOUN
aiua-8110	28	36	(	(	PUNCT
aiua-8110	28	37	plr	plr	NOUN
aiua-8110	28	38	)	)	PUNCT
aiua-8110	28	39	and	and	CCONJ
aiua-8110	28	40	mean	mean	VERB
aiua-8110	28	41	platelet	platelet	NOUN
aiua-8110	28	42	volume	volume	NOUN
aiua-8110	28	43	(	(	PUNCT
aiua-8110	28	44	mpv	mpv	PROPN
aiua-8110	28	45	)	)	PUNCT
aiua-8110	28	46	can	can	AUX
aiua-8110	28	47	be	be	AUX
aiua-8110	28	48	used	use	VERB
aiua-8110	28	49	as	as	ADP
aiua-8110	28	50	factors	factor	NOUN
aiua-8110	28	51	to	to	PART
aiua-8110	28	52	determine	determine	VERB
aiua-8110	28	53	the	the	DET
aiua-8110	28	54	prognosis	prognosis	NOUN
aiua-8110	28	55	of	of	ADP
aiua-8110	28	56	patients	patient	NOUN
aiua-8110	28	57	in	in	ADP
aiua-8110	28	58	various	various	ADJ
aiua-8110	28	59	clinical	clinical	ADJ
aiua-8110	28	60	situations	situation	NOUN
aiua-8110	28	61	(	(	PUNCT
aiua-8110	28	62	7	7	NUM
aiua-8110	28	63	)	)	PUNCT
aiua-8110	28	64	.	.	PUNCT
aiua-8110	29	1	platelets	platelet	NOUN
aiua-8110	29	2	are	be	AUX
aiua-8110	29	3	seedless	seedless	ADJ
aiua-8110	29	4	cells	cell	NOUN
aiua-8110	29	5	derived	derive	VERB
aiua-8110	29	6	from	from	ADP
aiua-8110	29	7	megakaryocytes	megakaryocyte	NOUN
aiua-8110	29	8	in	in	ADP
aiua-8110	29	9	the	the	DET
aiua-8110	29	10	bone	bone	NOUN
aiua-8110	29	11	marrow	marrow	NOUN
aiua-8110	29	12	.	.	PUNCT
aiua-8110	30	1	platelets	platelet	NOUN
aiua-8110	30	2	,	,	PUNCT
aiua-8110	30	3	an	an	DET
aiua-8110	30	4	element	element	NOUN
aiua-8110	30	5	of	of	ADP
aiua-8110	30	6	the	the	DET
aiua-8110	30	7	immune	immune	ADJ
aiua-8110	30	8	system	system	NOUN
aiua-8110	30	9	,	,	PUNCT
aiua-8110	30	10	also	also	ADV
aiua-8110	30	11	play	play	VERB
aiua-8110	30	12	a	a	DET
aiua-8110	30	13	role	role	NOUN
aiua-8110	30	14	in	in	ADP
aiua-8110	30	15	cancer	cancer	NOUN
aiua-8110	30	16	formation	formation	NOUN
aiua-8110	30	17	,	,	PUNCT
aiua-8110	30	18	progression	progression	NOUN
aiua-8110	30	19	and	and	CCONJ
aiua-8110	30	20	metastatization	metastatization	NOUN
aiua-8110	30	21	.	.	PUNCT
aiua-8110	31	1	it	it	PRON
aiua-8110	31	2	is	be	AUX
aiua-8110	31	3	known	know	VERB
aiua-8110	31	4	that	that	SCONJ
aiua-8110	31	5	activated	activate	VERB
aiua-8110	31	6	platelets	platelet	NOUN
aiua-8110	31	7	have	have	VERB
aiua-8110	31	8	critical	critical	ADJ
aiua-8110	31	9	roles	role	NOUN
aiua-8110	31	10	in	in	ADP
aiua-8110	31	11	tumor	tumor	NOUN
aiua-8110	31	12	proliferation	proliferation	NOUN
aiua-8110	31	13	,	,	PUNCT
aiua-8110	31	14	neoangiogenesis	neoangiogenesis	NOUN
aiua-8110	31	15	and	and	CCONJ
aiua-8110	31	16	release	release	NOUN
aiua-8110	31	17	of	of	ADP
aiua-8110	31	18	mitogenic	mitogenic	ADJ
aiua-8110	31	19	mediators	mediator	NOUN
aiua-8110	31	20	in	in	ADP
aiua-8110	31	21	the	the	DET
aiua-8110	31	22	microenvironment	microenvironment	NOUN
aiua-8110	31	23	of	of	ADP
aiua-8110	31	24	cells	cell	NOUN
aiua-8110	31	25	that	that	PRON
aiua-8110	31	26	exhibit	exhibit	VERB
aiua-8110	31	27	tumoral	tumoral	ADJ
aiua-8110	31	28	behavior	behavior	NOUN
aiua-8110	31	29	,	,	PUNCT
aiua-8110	31	30	although	although	SCONJ
aiua-8110	31	31	their	their	PRON
aiua-8110	31	32	production	production	NOUN
aiua-8110	31	33	,	,	PUNCT
aiua-8110	31	34	maturation	maturation	NOUN
aiua-8110	31	35	and	and	CCONJ
aiua-8110	31	36	clearance	clearance	NOUN
aiua-8110	31	37	from	from	ADP
aiua-8110	31	38	circulation	circulation	NOUN
aiua-8110	31	39	are	be	AUX
aiua-8110	31	40	still	still	ADV
aiua-8110	31	41	not	not	PART
aiua-8110	31	42	fully	fully	ADV
aiua-8110	31	43	elucidated	elucidated	ADJ
aiua-8110	31	44	(	(	PUNCT
aiua-8110	31	45	8)	8)	NUM
aiua-8110	31	46	.	.	PUNCT
aiua-8110	32	1	yun	yun	PROPN
aiua-8110	32	2	zy	zy	PROPN
aiua-8110	32	3	et	et	PROPN
aiua-8110	32	4	al	al	PROPN
aiua-8110	32	5	.	.	PROPN
aiua-8110	32	6	reported	report	VERB
aiua-8110	32	7	that	that	PRON
aiua-8110	32	8	decreased	decrease	VERB
aiua-8110	32	9	mpv	mpv	PROPN
aiua-8110	32	10	may	may	AUX
aiua-8110	32	11	be	be	AUX
aiua-8110	32	12	a	a	DET
aiua-8110	32	13	marker	marker	NOUN
aiua-8110	32	14	of	of	ADP
aiua-8110	32	15	poor	poor	ADJ
aiua-8110	32	16	prognosis	prognosis	NOUN
aiua-8110	32	17	in	in	ADP
aiua-8110	32	18	renal	renal	ADJ
aiua-8110	32	19	cell	cell	NOUN
aiua-8110	32	20	cancer	cancer	NOUN
aiua-8110	32	21	(	(	PUNCT
aiua-8110	32	22	9	9	NUM
aiua-8110	32	23	)	)	PUNCT
aiua-8110	32	24	.	.	PUNCT
aiua-8110	33	1	because	because	SCONJ
aiua-8110	33	2	it	it	PRON
aiua-8110	33	3	is	be	AUX
aiua-8110	33	4	known	know	VERB
aiua-8110	33	5	that	that	SCONJ
aiua-8110	33	6	mpv	mpv	PROPN
aiua-8110	33	7	is	be	AUX
aiua-8110	33	8	an	an	DET
aiua-8110	33	9	index	index	NOUN
aiua-8110	33	10	of	of	ADP
aiua-8110	33	11	bioactive	bioactive	ADJ
aiua-8110	33	12	platelets	platelet	NOUN
aiua-8110	33	13	activated	activate	VERB
aiua-8110	33	14	for	for	ADP
aiua-8110	33	15	any	any	DET
aiua-8110	33	16	reason	reason	NOUN
aiua-8110	33	17	and	and	CCONJ
aiua-8110	33	18	incorporated	incorporate	VERB
aiua-8110	33	19	into	into	ADP
aiua-8110	33	20	the	the	DET
aiua-8110	33	21	inflammation	inflammation	NOUN
aiua-8110	33	22	process	process	NOUN
aiua-8110	33	23	,	,	PUNCT
aiua-8110	33	24	rather	rather	ADV
aiua-8110	33	25	than	than	ADP
aiua-8110	33	26	platelet	platelet	NOUN
aiua-8110	33	27	count	count	NOUN
aiua-8110	33	28	(	(	PUNCT
aiua-8110	33	29	10	10	NUM
aiua-8110	33	30	)	)	PUNCT
aiua-8110	33	31	.	.	PUNCT
aiua-8110	34	1	these	these	DET
aiua-8110	34	2	markers	marker	NOUN
aiua-8110	34	3	,	,	PUNCT
aiua-8110	34	4	which	which	PRON
aiua-8110	34	5	are	be	AUX
aiua-8110	34	6	easily	easily	ADV
aiua-8110	34	7	applicable	applicable	ADJ
aiua-8110	34	8	in	in	ADP
aiua-8110	34	9	practice	practice	NOUN
aiua-8110	34	10	,	,	PUNCT
aiua-8110	34	11	were	be	AUX
aiua-8110	34	12	retrospectively	retrospectively	ADV
aiua-8110	34	13	analyzed	analyze	VERB
aiua-8110	34	14	in	in	ADP
aiua-8110	34	15	our	our	PRON
aiua-8110	34	16	patients	patient	NOUN
aiua-8110	34	17	who	who	PRON
aiua-8110	34	18	were	be	AUX
aiua-8110	34	19	diagnosed	diagnose	VERB
aiua-8110	34	20	with	with	ADP
aiua-8110	34	21	testicular	testicular	ADJ
aiua-8110	34	22	tumor	tumor	NOUN
aiua-8110	34	23	and	and	CCONJ
aiua-8110	34	24	compared	compare	VERB
aiua-8110	34	25	with	with	ADP
aiua-8110	34	26	the	the	DET
aiua-8110	34	27	values	value	NOUN
aiua-8110	34	28	of	of	ADP
aiua-8110	34	29	patients	patient	NOUN
aiua-8110	34	30	with	with	ADP
aiua-8110	34	31	similar	similar	ADJ
aiua-8110	34	32	age	age	NOUN
aiua-8110	34	33	group	group	NOUN
aiua-8110	34	34	of	of	ADP
aiua-8110	34	35	patients	patient	NOUN
aiua-8110	34	36	who	who	PRON
aiua-8110	34	37	underwent	undergo	VERB
aiua-8110	34	38	varicocelectomy	varicocelectomy	ADJ
aiua-8110	34	39	repair	repair	NOUN
aiua-8110	34	40	.	.	PUNCT
aiua-8110	35	1	doi	doi	NOUN
aiua-8110	35	2	:	:	PUNCT
aiua-8110	35	3	10.4081	10.4081	NUM
aiua-8110	35	4	/	/	SYM
aiua-8110	35	5	aiua.2019.2.97	aiua.2019.2.97	NOUN
aiua-8110	35	6	introduction	introduction	NOUN
aiua-8110	35	7	testicular	testicular	ADJ
aiua-8110	35	8	cancers	cancer	NOUN
aiua-8110	35	9	,	,	PUNCT
aiua-8110	35	10	which	which	PRON
aiua-8110	35	11	are	be	AUX
aiua-8110	35	12	less	less	ADV
aiua-8110	35	13	common	common	ADJ
aiua-8110	35	14	than	than	ADP
aiua-8110	35	15	other	other	ADJ
aiua-8110	35	16	cancers	cancer	NOUN
aiua-8110	35	17	,	,	PUNCT
aiua-8110	35	18	are	be	AUX
aiua-8110	35	19	important	important	ADJ
aiua-8110	35	20	because	because	SCONJ
aiua-8110	35	21	they	they	PRON
aiua-8110	35	22	are	be	AUX
aiua-8110	35	23	often	often	ADV
aiua-8110	35	24	seen	see	VERB
aiua-8110	35	25	in	in	ADP
aiua-8110	35	26	young	young	ADJ
aiua-8110	35	27	people	people	NOUN
aiua-8110	35	28	.	.	PUNCT
aiua-8110	36	1	it	it	PRON
aiua-8110	36	2	is	be	AUX
aiua-8110	36	3	the	the	DET
aiua-8110	36	4	most	most	ADV
aiua-8110	36	5	common	common	ADJ
aiua-8110	36	6	solid	solid	ADJ
aiua-8110	36	7	organ	organ	NOUN
aiua-8110	36	8	cancer	cancer	NOUN
aiua-8110	36	9	in	in	ADP
aiua-8110	36	10	men	man	NOUN
aiua-8110	36	11	between	between	ADP
aiua-8110	36	12	the	the	DET
aiua-8110	36	13	ages	age	NOUN
aiua-8110	36	14	of	of	ADP
aiua-8110	36	15	15	15	NUM
aiua-8110	36	16	-	-	SYM
aiua-8110	36	17	35	35	NUM
aiua-8110	36	18	while	while	SCONJ
aiua-8110	36	19	it	it	PRON
aiua-8110	36	20	contitutes	contitute	VERB
aiua-8110	36	21	11.5	11.5	NUM
aiua-8110	36	22	%	%	NOUN
aiua-8110	36	23	of	of	ADP
aiua-8110	36	24	all	all	DET
aiua-8110	36	25	male	male	ADJ
aiua-8110	36	26	cancers	cancer	NOUN
aiua-8110	36	27	.	.	PUNCT
aiua-8110	37	1	in	in	ADP
aiua-8110	37	2	developed	develop	VERB
aiua-8110	37	3	countries	country	NOUN
aiua-8110	37	4	there	there	PRON
aiua-8110	37	5	is	be	VERB
aiua-8110	37	6	an	an	DET
aiua-8110	37	7	increase	increase	NOUN
aiua-8110	37	8	incidence	incidence	NOUN
aiua-8110	37	9	for	for	ADP
aiua-8110	37	10	testicular	testicular	ADJ
aiua-8110	37	11	cancer	cancer	NOUN
aiua-8110	37	12	(	(	PUNCT
aiua-8110	37	13	1	1	NUM
aiua-8110	37	14	)	)	PUNCT
aiua-8110	37	15	.	.	PUNCT
aiua-8110	38	1	both	both	DET
aiua-8110	38	2	testes	testis	NOUN
aiua-8110	38	3	can	can	AUX
aiua-8110	38	4	be	be	AUX
aiua-8110	38	5	easily	easily	ADV
aiua-8110	38	6	examined	examine	VERB
aiua-8110	38	7	and	and	CCONJ
aiua-8110	38	8	results	result	NOUN
aiua-8110	38	9	of	of	ADP
aiua-8110	38	10	early	early	ADJ
aiua-8110	38	11	diagnosis	diagnosis	NOUN
aiua-8110	38	12	of	of	ADP
aiua-8110	38	13	testicle	testicle	NOUN
aiua-8110	38	14	tumours	tumour	NOUN
aiua-8110	38	15	are	be	AUX
aiua-8110	38	16	very	very	ADV
aiua-8110	38	17	favorable	favorable	ADJ
aiua-8110	38	18	enhancing	enhance	VERB
aiua-8110	38	19	the	the	DET
aiua-8110	38	20	importance	importance	NOUN
aiua-8110	38	21	of	of	ADP
aiua-8110	38	22	early	early	ADJ
aiua-8110	38	23	diagnosis	diagnosis	NOUN
aiua-8110	38	24	and	and	CCONJ
aiua-8110	38	25	treatment	treatment	NOUN
aiua-8110	38	26	of	of	ADP
aiua-8110	38	27	testicular	testicular	ADJ
aiua-8110	38	28	tumors	tumor	NOUN
aiua-8110	38	29	.	.	PUNCT
aiua-8110	39	1	physical	physical	ADJ
aiua-8110	39	2	examination	examination	NOUN
aiua-8110	39	3	,	,	PUNCT
aiua-8110	39	4	imaging	imaging	NOUN
aiua-8110	39	5	,	,	PUNCT
aiua-8110	39	6	laboratory	laboratory	NOUN
aiua-8110	39	7	and	and	CCONJ
aiua-8110	39	8	tumor	tumor	NOUN
aiua-8110	39	9	markers	marker	NOUN
aiua-8110	39	10	are	be	AUX
aiua-8110	39	11	used	use	VERB
aiua-8110	39	12	for	for	ADP
aiua-8110	39	13	diagnosis	diagnosis	NOUN
aiua-8110	39	14	.	.	PUNCT
aiua-8110	40	1	with	with	ADP
aiua-8110	40	2	early	early	ADJ
aiua-8110	40	3	archivio	archivio	NOUN
aiua-8110	40	4	italiano	italiano	X
aiua-8110	40	5	di	di	X
aiua-8110	40	6	urologia	urologia	PROPN
aiua-8110	40	7	e	e	PROPN
aiua-8110	40	8	andrologia	andrologia	NOUN
aiua-8110	40	9	2019	2019	NUM
aiua-8110	40	10	;	;	PUNCT
aiua-8110	40	11	91	91	NUM
aiua-8110	40	12	,	,	PUNCT
aiua-8110	40	13	2	2	NUM
aiua-8110	40	14	a.	a.	NOUN
aiua-8110	40	15	şahin	şahin	PROPN
aiua-8110	40	16	,	,	PUNCT
aiua-8110	40	17	t.	t.	PROPN
aiua-8110	40	18	toprak	toprak	PROPN
aiua-8110	40	19	,	,	PUNCT
aiua-8110	40	20	m.	m.	PROPN
aiua-8110	40	21	ali	ali	PROPN
aiua-8110	40	22	kutluhan	kutluhan	PROPN
aiua-8110	40	23	,	,	PUNCT
aiua-8110	40	24	yasin	yasin	PROPN
aiua-8110	40	25	vural	vural	PROPN
aiua-8110	40	26	,	,	PUNCT
aiua-8110	40	27	a.	a.	NOUN
aiua-8110	40	28	ürkmez	ürkmez	NOUN
aiua-8110	40	29	,	,	PUNCT
aiua-8110	40	30	a.	a.	PROPN
aiua-8110	40	31	verit	verit	PROPN
aiua-8110	40	32	98	98	NUM
aiua-8110	40	33	materials	material	NOUN
aiua-8110	40	34	and	and	CCONJ
aiua-8110	40	35	methods	method	NOUN
aiua-8110	40	36	this	this	DET
aiua-8110	40	37	cross	cross	ADJ
aiua-8110	40	38	-	-	ADJ
aiua-8110	40	39	sectional	sectional	ADJ
aiua-8110	40	40	retrospective	retrospective	ADJ
aiua-8110	40	41	study	study	NOUN
aiua-8110	40	42	included	include	VERB
aiua-8110	40	43	120	120	NUM
aiua-8110	40	44	patients	patient	NOUN
aiua-8110	40	45	who	who	PRON
aiua-8110	40	46	underwent	undergo	VERB
aiua-8110	40	47	radical	radical	ADJ
aiua-8110	40	48	inguinal	inguinal	ADJ
aiua-8110	40	49	orchiectomy	orchiectomy	NOUN
aiua-8110	40	50	for	for	ADP
aiua-8110	40	51	testicular	testicular	ADJ
aiua-8110	40	52	tumor	tumor	NOUN
aiua-8110	40	53	between	between	ADP
aiua-8110	40	54	january	january	PROPN
aiua-8110	40	55	2010	2010	NUM
aiua-8110	40	56	and	and	CCONJ
aiua-8110	40	57	december	december	PROPN
aiua-8110	40	58	2018	2018	NUM
aiua-8110	40	59	,	,	PUNCT
aiua-8110	40	60	and	and	CCONJ
aiua-8110	40	61	171	171	NUM
aiua-8110	40	62	patients	patient	NOUN
aiua-8110	40	63	who	who	PRON
aiua-8110	40	64	underwent	undergo	VERB
aiua-8110	40	65	varicocelectomy	varicocelectomy	NOUN
aiua-8110	40	66	as	as	ADP
aiua-8110	40	67	a	a	DET
aiua-8110	40	68	control	control	NOUN
aiua-8110	40	69	group	group	NOUN
aiua-8110	40	70	.	.	PUNCT
aiua-8110	41	1	patients	patient	NOUN
aiua-8110	41	2	with	with	ADP
aiua-8110	41	3	acute	acute	ADJ
aiua-8110	41	4	infections	infection	NOUN
aiua-8110	41	5	,	,	PUNCT
aiua-8110	41	6	chronic	chronic	ADJ
aiua-8110	41	7	inflammatory	inflammatory	ADJ
aiua-8110	41	8	disease	disease	NOUN
aiua-8110	41	9	,	,	PUNCT
aiua-8110	41	10	malignancies	malignancy	NOUN
aiua-8110	41	11	or	or	CCONJ
aiua-8110	41	12	hematological	hematological	ADJ
aiua-8110	41	13	disorders	disorder	NOUN
aiua-8110	41	14	,	,	PUNCT
aiua-8110	41	15	those	those	PRON
aiua-8110	41	16	using	use	VERB
aiua-8110	41	17	anticoagulant	anticoagulant	ADJ
aiua-8110	41	18	treatment	treatment	NOUN
aiua-8110	41	19	,	,	PUNCT
aiua-8110	41	20	and	and	CCONJ
aiua-8110	41	21	subjects	subject	NOUN
aiua-8110	41	22	with	with	ADP
aiua-8110	41	23	a	a	DET
aiua-8110	41	24	history	history	NOUN
aiua-8110	41	25	of	of	ADP
aiua-8110	41	26	hormonal	hormonal	ADJ
aiua-8110	41	27	treatment	treatment	NOUN
aiua-8110	41	28	in	in	ADP
aiua-8110	41	29	the	the	DET
aiua-8110	41	30	last	last	ADJ
aiua-8110	41	31	12	12	NUM
aiua-8110	41	32	months	month	NOUN
aiua-8110	41	33	or	or	CCONJ
aiua-8110	41	34	blood	blood	NOUN
aiua-8110	41	35	product	product	NOUN
aiua-8110	41	36	administration	administration	NOUN
aiua-8110	41	37	in	in	ADP
aiua-8110	41	38	the	the	DET
aiua-8110	41	39	last	last	ADJ
aiua-8110	41	40	month	month	NOUN
aiua-8110	41	41	were	be	AUX
aiua-8110	41	42	excluded	exclude	VERB
aiua-8110	41	43	.	.	PUNCT
aiua-8110	42	1	hematological	hematological	ADJ
aiua-8110	42	2	parameters	parameter	NOUN
aiua-8110	42	3	were	be	AUX
aiua-8110	42	4	evaluated	evaluate	VERB
aiua-8110	42	5	with	with	ADP
aiua-8110	42	6	peripheral	peripheral	ADJ
aiua-8110	42	7	blood	blood	NOUN
aiua-8110	42	8	samples	sample	NOUN
aiua-8110	42	9	taken	take	VERB
aiua-8110	42	10	preoperatively	preoperatively	ADV
aiua-8110	42	11	.	.	PUNCT
aiua-8110	43	1	these	these	DET
aiua-8110	43	2	hematological	hematological	ADJ
aiua-8110	43	3	parameters	parameter	NOUN
aiua-8110	43	4	include	include	VERB
aiua-8110	43	5	neutrophil	neutrophil	NOUN
aiua-8110	43	6	(	(	PUNCT
aiua-8110	43	7	neu	neu	NOUN
aiua-8110	43	8	)	)	PUNCT
aiua-8110	43	9	,	,	PUNCT
aiua-8110	43	10	lymphocyte	lymphocyte	NOUN
aiua-8110	43	11	(	(	PUNCT
aiua-8110	43	12	lym	lym	PROPN
aiua-8110	43	13	)	)	PUNCT
aiua-8110	43	14	,	,	PUNCT
aiua-8110	43	15	platelet	platelet	NOUN
aiua-8110	43	16	count	count	NOUN
aiua-8110	43	17	,	,	PUNCT
aiua-8110	43	18	and	and	CCONJ
aiua-8110	43	19	mean	mean	VERB
aiua-8110	43	20	platelet	platelet	NOUN
aiua-8110	43	21	volume	volume	NOUN
aiua-8110	43	22	(	(	PUNCT
aiua-8110	43	23	mpv	mpv	PROPN
aiua-8110	43	24	)	)	PUNCT
aiua-8110	43	25	.	.	PUNCT
aiua-8110	44	1	the	the	DET
aiua-8110	44	2	staging	staging	NOUN
aiua-8110	44	3	of	of	ADP
aiua-8110	44	4	patients	patient	NOUN
aiua-8110	44	5	with	with	ADP
aiua-8110	44	6	testicular	testicular	ADJ
aiua-8110	44	7	tumors	tumor	NOUN
aiua-8110	44	8	was	be	AUX
aiua-8110	44	9	performed	perform	VERB
aiua-8110	44	10	by	by	ADP
aiua-8110	44	11	examining	examine	VERB
aiua-8110	44	12	the	the	DET
aiua-8110	44	13	computed	computed	ADJ
aiua-8110	44	14	tomography	tomography	NOUN
aiua-8110	44	15	and	and	CCONJ
aiua-8110	44	16	by	by	ADP
aiua-8110	44	17	measurement	measurement	NOUN
aiua-8110	44	18	of	of	ADP
aiua-8110	44	19	beta	beta	ADJ
aiua-8110	44	20	human	human	ADJ
aiua-8110	44	21	chorionic	chorionic	ADJ
aiua-8110	44	22	gonadotropin	gonadotropin	NOUN
aiua-8110	44	23	,	,	PUNCT
aiua-8110	44	24	alpha	alpha	NOUN
aiua-8110	44	25	fetoprotein	fetoprotein	NOUN
aiua-8110	44	26	and	and	CCONJ
aiua-8110	44	27	lactate	lactate	PROPN
aiua-8110	44	28	dehydrogenase	dehydrogenase	NOUN
aiua-8110	44	29	(	(	PUNCT
aiua-8110	44	30	ldh	ldh	PROPN
aiua-8110	44	31	)	)	PUNCT
aiua-8110	44	32	as	as	ADP
aiua-8110	44	33	tumor	tumor	NOUN
aiua-8110	44	34	markers	marker	NOUN
aiua-8110	44	35	.	.	PUNCT
aiua-8110	45	1	statistical	statistical	ADJ
aiua-8110	45	2	analysis	analysis	NOUN
aiua-8110	45	3	to	to	PART
aiua-8110	45	4	evaluate	evaluate	VERB
aiua-8110	45	5	the	the	DET
aiua-8110	45	6	findings	finding	NOUN
aiua-8110	45	7	obtained	obtain	VERB
aiua-8110	45	8	in	in	ADP
aiua-8110	45	9	this	this	DET
aiua-8110	45	10	study	study	NOUN
aiua-8110	45	11	,	,	PUNCT
aiua-8110	45	12	ibm	ibm	PROPN
aiua-8110	45	13	spss	spss	PROPN
aiua-8110	45	14	statistics	statistic	NOUN
aiua-8110	45	15	22	22	NUM
aiua-8110	45	16	for	for	ADP
aiua-8110	45	17	statistical	statistical	ADJ
aiua-8110	45	18	analysis	analysis	NOUN
aiua-8110	45	19	(	(	PUNCT
aiua-8110	45	20	spss	spss	PROPN
aiua-8110	45	21	ibm	ibm	PROPN
aiua-8110	45	22	,	,	PUNCT
aiua-8110	45	23	turkey	turkey	PROPN
aiua-8110	45	24	)	)	PUNCT
aiua-8110	45	25	program	program	NOUN
aiua-8110	45	26	was	be	AUX
aiua-8110	45	27	used	use	VERB
aiua-8110	45	28	.	.	PUNCT
aiua-8110	46	1	conformity	conformity	NOUN
aiua-8110	46	2	of	of	ADP
aiua-8110	46	3	the	the	DET
aiua-8110	46	4	parameters	parameter	NOUN
aiua-8110	46	5	to	to	ADP
aiua-8110	46	6	the	the	DET
aiua-8110	46	7	normal	normal	ADJ
aiua-8110	46	8	distribution	distribution	NOUN
aiua-8110	46	9	was	be	AUX
aiua-8110	46	10	evaluated	evaluate	VERB
aiua-8110	46	11	by	by	ADP
aiua-8110	46	12	the	the	DET
aiua-8110	46	13	shapiro	shapiro	PROPN
aiua-8110	46	14	wilks	wilks	PROPN
aiua-8110	46	15	test	test	NOUN
aiua-8110	46	16	.	.	PUNCT
aiua-8110	47	1	descriptive	descriptive	ADJ
aiua-8110	47	2	statistical	statistical	ADJ
aiua-8110	47	3	values	value	NOUN
aiua-8110	47	4	were	be	AUX
aiua-8110	47	5	computed	compute	VERB
aiua-8110	47	6	(	(	PUNCT
aiua-8110	47	7	mean	mean	ADJ
aiua-8110	47	8	,	,	PUNCT
aiua-8110	47	9	standard	standard	ADJ
aiua-8110	47	10	deviation	deviation	NOUN
aiua-8110	47	11	,	,	PUNCT
aiua-8110	47	12	frequency	frequency	NOUN
aiua-8110	47	13	)	)	PUNCT
aiua-8110	47	14	and	and	CCONJ
aiua-8110	47	15	the	the	DET
aiua-8110	47	16	comparison	comparison	NOUN
aiua-8110	47	17	of	of	ADP
aiua-8110	47	18	quantitative	quantitative	ADJ
aiua-8110	47	19	data	datum	NOUN
aiua-8110	47	20	were	be	AUX
aiua-8110	47	21	done	do	VERB
aiua-8110	47	22	by	by	ADP
aiua-8110	47	23	kruskal	kruskal	PROPN
aiua-8110	47	24	wallis	wallis	PROPN
aiua-8110	47	25	test	test	PROPN
aiua-8110	47	26	and	and	CCONJ
aiua-8110	47	27	the	the	DET
aiua-8110	47	28	mann	mann	PROPN
aiua-8110	47	29	whitney	whitney	PROPN
aiua-8110	47	30	u	u	PROPN
aiua-8110	47	31	test	test	NOUN
aiua-8110	47	32	was	be	AUX
aiua-8110	47	33	used	use	VERB
aiua-8110	47	34	for	for	ADP
aiua-8110	47	35	the	the	DET
aiua-8110	47	36	determination	determination	NOUN
aiua-8110	47	37	of	of	ADP
aiua-8110	47	38	the	the	DET
aiua-8110	47	39	group	group	NOUN
aiua-8110	47	40	causing	cause	VERB
aiua-8110	47	41	the	the	DET
aiua-8110	47	42	difference	difference	NOUN
aiua-8110	47	43	.	.	PUNCT
aiua-8110	48	1	mann	mann	PROPN
aiua-8110	48	2	-	-	PUNCT
aiua-8110	48	3	whitney	whitney	PROPN
aiua-8110	48	4	u	u	PROPN
aiua-8110	48	5	test	test	NOUN
aiua-8110	48	6	was	be	AUX
aiua-8110	48	7	used	use	VERB
aiua-8110	48	8	for	for	ADP
aiua-8110	48	9	the	the	DET
aiua-8110	48	10	two	two	NUM
aiua-8110	48	11	-	-	PUNCT
aiua-8110	48	12	group	group	NOUN
aiua-8110	48	13	comparisons	comparison	NOUN
aiua-8110	48	14	of	of	ADP
aiua-8110	48	15	the	the	DET
aiua-8110	48	16	parameters	parameter	NOUN
aiua-8110	48	17	that	that	PRON
aiua-8110	48	18	did	do	AUX
aiua-8110	48	19	not	not	PART
aiua-8110	48	20	show	show	VERB
aiua-8110	48	21	normal	normal	ADJ
aiua-8110	48	22	distribution	distribution	NOUN
aiua-8110	48	23	,	,	PUNCT
aiua-8110	48	24	and	and	CCONJ
aiua-8110	48	25	student	student	NOUN
aiua-8110	48	26	's	's	PART
aiua-8110	48	27	t	t	PROPN
aiua-8110	48	28	test	test	NOUN
aiua-8110	48	29	was	be	AUX
aiua-8110	48	30	used	use	VERB
aiua-8110	48	31	for	for	ADP
aiua-8110	48	32	the	the	DET
aiua-8110	48	33	parameters	parameter	NOUN
aiua-8110	48	34	with	with	ADP
aiua-8110	48	35	normal	normal	ADJ
aiua-8110	48	36	distribution	distribution	NOUN
aiua-8110	48	37	.	.	PUNCT
aiua-8110	49	1	the	the	DET
aiua-8110	49	2	cut	cut	VERB
aiua-8110	49	3	-	-	PUNCT
aiua-8110	49	4	off	off	ADP
aiua-8110	49	5	point	point	NOUN
aiua-8110	49	6	was	be	AUX
aiua-8110	49	7	chosen	choose	VERB
aiua-8110	49	8	based	base	VERB
aiua-8110	49	9	on	on	ADP
aiua-8110	49	10	the	the	DET
aiua-8110	49	11	roc	roc	PROPN
aiua-8110	49	12	curve	curve	NOUN
aiua-8110	49	13	analysis	analysis	NOUN
aiua-8110	49	14	.	.	PUNCT
aiua-8110	50	1	a	a	DET
aiua-8110	50	2	p	p	X
aiua-8110	50	3	<	<	X
aiua-8110	50	4	0.05	0.05	NUM
aiua-8110	50	5	was	be	AUX
aiua-8110	50	6	considered	consider	VERB
aiua-8110	50	7	significant	significant	ADJ
aiua-8110	50	8	.	.	PUNCT
aiua-8110	51	1	results	result	VERB
aiua-8110	51	2	the	the	DET
aiua-8110	51	3	study	study	NOUN
aiua-8110	51	4	was	be	AUX
aiua-8110	51	5	conducted	conduct	VERB
aiua-8110	51	6	on	on	ADP
aiua-8110	51	7	291	291	NUM
aiua-8110	51	8	patients	patient	NOUN
aiua-8110	51	9	with	with	ADP
aiua-8110	51	10	ages	age	NOUN
aiua-8110	51	11	ranging	range	VERB
aiua-8110	51	12	from	from	ADP
aiua-8110	51	13	1	1	NUM
aiua-8110	51	14	to	to	PART
aiua-8110	51	15	85	85	NUM
aiua-8110	51	16	years	year	NOUN
aiua-8110	51	17	.	.	PUNCT
aiua-8110	52	1	the	the	DET
aiua-8110	52	2	mean	mean	ADJ
aiua-8110	52	3	age	age	NOUN
aiua-8110	52	4	was	be	AUX
aiua-8110	52	5	34.25	34.25	NUM
aiua-8110	52	6	±	±	NUM
aiua-8110	52	7	16.56	16.56	NUM
aiua-8110	52	8	years	year	NOUN
aiua-8110	52	9	.	.	PUNCT
aiua-8110	53	1	the	the	DET
aiua-8110	53	2	cases	case	NOUN
aiua-8110	53	3	were	be	AUX
aiua-8110	53	4	divided	divide	VERB
aiua-8110	53	5	into	into	ADP
aiua-8110	53	6	two	two	NUM
aiua-8110	53	7	groups	group	NOUN
aiua-8110	53	8	:	:	PUNCT
aiua-8110	53	9	tumor	tumor	NOUN
aiua-8110	53	10	(	(	PUNCT
aiua-8110	53	11	n	n	NOUN
aiua-8110	53	12	=	=	SYM
aiua-8110	53	13	120	120	NUM
aiua-8110	53	14	)	)	PUNCT
aiua-8110	53	15	and	and	CCONJ
aiua-8110	53	16	varicocele	varicocele	NOUN
aiua-8110	53	17	(	(	PUNCT
aiua-8110	53	18	n	n	NOUN
aiua-8110	53	19	=	=	NOUN
aiua-8110	53	20	171	171	NUM
aiua-8110	53	21	)	)	PUNCT
aiua-8110	53	22	.	.	PUNCT
aiua-8110	54	1	there	there	PRON
aiua-8110	54	2	was	be	VERB
aiua-8110	54	3	no	no	DET
aiua-8110	54	4	statistically	statistically	ADV
aiua-8110	54	5	significant	significant	ADJ
aiua-8110	54	6	difference	difference	NOUN
aiua-8110	54	7	between	between	ADP
aiua-8110	54	8	the	the	DET
aiua-8110	54	9	groups	group	NOUN
aiua-8110	54	10	in	in	ADP
aiua-8110	54	11	terms	term	NOUN
aiua-8110	54	12	of	of	ADP
aiua-8110	54	13	plt	plt	NOUN
aiua-8110	54	14	/	/	SYM
aiua-8110	54	15	lymphocyte	lymphocyte	NOUN
aiua-8110	54	16	ratio	ratio	NOUN
aiua-8110	54	17	and	and	CCONJ
aiua-8110	54	18	mpv	mpv	PROPN
aiua-8110	54	19	levels	level	NOUN
aiua-8110	54	20	(	(	PUNCT
aiua-8110	54	21	p	p	X
aiua-8110	54	22	>	>	X
aiua-8110	54	23	0.05	0.05	NUM
aiua-8110	54	24	)	)	PUNCT
aiua-8110	54	25	.	.	PUNCT
aiua-8110	55	1	the	the	DET
aiua-8110	55	2	neutrophil	neutrophil	ADJ
aiua-8110	55	3	/	/	SYM
aiua-8110	55	4	lymphocyte	lymphocyte	ADJ
aiua-8110	55	5	ratio	ratio	NOUN
aiua-8110	55	6	of	of	ADP
aiua-8110	55	7	the	the	DET
aiua-8110	55	8	tumor	tumor	NOUN
aiua-8110	55	9	group	group	NOUN
aiua-8110	55	10	was	be	AUX
aiua-8110	55	11	significantly	significantly	ADV
aiua-8110	55	12	higher	high	ADJ
aiua-8110	55	13	than	than	ADP
aiua-8110	55	14	the	the	DET
aiua-8110	55	15	varicocele	varicocele	NOUN
aiua-8110	55	16	group	group	NOUN
aiua-8110	55	17	(	(	PUNCT
aiua-8110	55	18	p	p	X
aiua-8110	55	19	=	=	NOUN
aiua-8110	55	20	0.001	0.001	NUM
aiua-8110	55	21	;	;	PUNCT
aiua-8110	55	22	p	p	X
aiua-8110	55	23	<	<	X
aiua-8110	55	24	0.05	0.05	NUM
aiua-8110	55	25	)	)	PUNCT
aiua-8110	55	26	(	(	PUNCT
aiua-8110	55	27	table	table	NOUN
aiua-8110	55	28	1	1	NUM
aiua-8110	55	29	,	,	PUNCT
aiua-8110	55	30	figure	figure	NOUN
aiua-8110	55	31	1	1	NUM
aiua-8110	55	32	)	)	PUNCT
aiua-8110	55	33	.	.	PUNCT
aiua-8110	56	1	there	there	PRON
aiua-8110	56	2	was	be	VERB
aiua-8110	56	3	a	a	DET
aiua-8110	56	4	statistically	statistically	ADV
aiua-8110	56	5	significant	significant	ADJ
aiua-8110	56	6	difference	difference	NOUN
aiua-8110	56	7	between	between	ADP
aiua-8110	56	8	the	the	DET
aiua-8110	56	9	tumor	tumor	NOUN
aiua-8110	56	10	stages	stage	NOUN
aiua-8110	56	11	in	in	ADP
aiua-8110	56	12	terms	term	NOUN
aiua-8110	56	13	of	of	ADP
aiua-8110	56	14	plt	plt	NOUN
aiua-8110	56	15	/	/	SYM
aiua-8110	56	16	lymphocyte	lymphocyte	ADJ
aiua-8110	56	17	ratios	ratio	NOUN
aiua-8110	56	18	(	(	PUNCT
aiua-8110	56	19	p	p	X
aiua-8110	56	20	=	=	NOUN
aiua-8110	56	21	0.006	0.006	NUM
aiua-8110	56	22	;	;	PUNCT
aiua-8110	56	23	p	p	X
aiua-8110	56	24	<	<	X
aiua-8110	56	25	0.05	0.05	NUM
aiua-8110	56	26	)	)	PUNCT
aiua-8110	56	27	.	.	PUNCT
aiua-8110	57	1	paired	pair	VERB
aiua-8110	57	2	comparisons	comparison	NOUN
aiua-8110	57	3	demonstrated	demonstrate	VERB
aiua-8110	57	4	that	that	SCONJ
aiua-8110	57	5	plt	plt	NOUN
aiua-8110	57	6	/	/	SYM
aiua-8110	57	7	lymphocyte	lymphocyte	NOUN
aiua-8110	57	8	ratio	ratio	NOUN
aiua-8110	57	9	of	of	ADP
aiua-8110	57	10	pt3	pt3	NOUN
aiua-8110	57	11	group	group	NOUN
aiua-8110	57	12	was	be	AUX
aiua-8110	57	13	significantly	significantly	ADV
aiua-8110	57	14	higher	high	ADJ
aiua-8110	57	15	than	than	ADP
aiua-8110	57	16	pt1	pt1	PROPN
aiua-8110	57	17	and	and	CCONJ
aiua-8110	57	18	pt2	pt2	PROPN
aiua-8110	57	19	(	(	PUNCT
aiua-8110	57	20	p1	p1	PROPN
aiua-8110	57	21	=	=	PUNCT
aiua-8110	57	22	0.002	0.002	NUM
aiua-8110	57	23	;	;	PUNCT
aiua-8110	57	24	p2	p2	PROPN
aiua-8110	57	25	=	=	SYM
aiua-8110	57	26	0.003	0.003	NUM
aiua-8110	57	27	;	;	PUNCT
aiua-8110	57	28	p	p	X
aiua-8110	57	29	<	<	X
aiua-8110	57	30	0.05	0.05	NUM
aiua-8110	57	31	)	)	PUNCT
aiua-8110	57	32	.	.	PUNCT
aiua-8110	58	1	there	there	PRON
aiua-8110	58	2	was	be	VERB
aiua-8110	58	3	no	no	DET
aiua-8110	58	4	significant	significant	ADJ
aiua-8110	58	5	difference	difference	NOUN
aiua-8110	58	6	between	between	ADP
aiua-8110	58	7	pt1	pt1	PROPN
aiua-8110	58	8	and	and	CCONJ
aiua-8110	58	9	pt2	pt2	NOUN
aiua-8110	58	10	stages	stage	NOUN
aiua-8110	58	11	(	(	PUNCT
aiua-8110	58	12	p	p	X
aiua-8110	58	13	>	>	X
aiua-8110	58	14	0.05	0.05	NUM
aiua-8110	58	15	)	)	PUNCT
aiua-8110	58	16	.	.	PUNCT
aiua-8110	59	1	there	there	PRON
aiua-8110	59	2	was	be	VERB
aiua-8110	59	3	no	no	DET
aiua-8110	59	4	statistically	statistically	ADV
aiua-8110	59	5	significant	significant	ADJ
aiua-8110	59	6	difference	difference	NOUN
aiua-8110	59	7	in	in	ADP
aiua-8110	59	8	neutrophil	neutrophil	ADJ
aiua-8110	59	9	/	/	SYM
aiua-8110	59	10	lymphocyte	lymphocyte	ADJ
aiua-8110	59	11	ratio	ratio	NOUN
aiua-8110	59	12	and	and	CCONJ
aiua-8110	59	13	mpv	mpv	PROPN
aiua-8110	59	14	levels	level	NOUN
aiua-8110	59	15	between	between	ADP
aiua-8110	59	16	tumor	tumor	NOUN
aiua-8110	59	17	stages	stage	NOUN
aiua-8110	59	18	(	(	PUNCT
aiua-8110	59	19	p	p	X
aiua-8110	59	20	>	>	X
aiua-8110	59	21	0.05	0.05	NUM
aiua-8110	59	22	)	)	PUNCT
aiua-8110	59	23	(	(	PUNCT
aiua-8110	59	24	table	table	NOUN
aiua-8110	59	25	2	2	NUM
aiua-8110	59	26	)	)	PUNCT
aiua-8110	59	27	.	.	PUNCT
aiua-8110	60	1	the	the	DET
aiua-8110	60	2	roc	roc	PROPN
aiua-8110	60	3	curve	curve	NOUN
aiua-8110	60	4	for	for	ADP
aiua-8110	60	5	neutrophil	neutrophil	ADJ
aiua-8110	60	6	/	/	SYM
aiua-8110	60	7	lymphocyte	lymphocyte	ADJ
aiua-8110	60	8	ratio	ratio	NOUN
aiua-8110	60	9	(	(	PUNCT
aiua-8110	60	10	nlr	nlr	PROPN
aiua-8110	60	11	)	)	PUNCT
aiua-8110	60	12	was	be	AUX
aiua-8110	60	13	plotted	plot	VERB
aiua-8110	60	14	in	in	ADP
aiua-8110	60	15	the	the	DET
aiua-8110	60	16	diagnosis	diagnosis	NOUN
aiua-8110	60	17	of	of	ADP
aiua-8110	60	18	testicular	testicular	ADJ
aiua-8110	60	19	tumor	tumor	NOUN
aiua-8110	60	20	.	.	PUNCT
aiua-8110	61	1	the	the	DET
aiua-8110	61	2	area	area	NOUN
aiua-8110	61	3	table	table	NOUN
aiua-8110	61	4	1	1	NUM
aiua-8110	61	5	.	.	PUNCT
aiua-8110	61	6	evaluation	evaluation	NOUN
aiua-8110	61	7	of	of	ADP
aiua-8110	61	8	groups	group	NOUN
aiua-8110	61	9	in	in	ADP
aiua-8110	61	10	terms	term	NOUN
aiua-8110	61	11	of	of	ADP
aiua-8110	61	12	plt	plt	NOUN
aiua-8110	61	13	/	/	SYM
aiua-8110	61	14	lymphocyte	lymphocyte	ADJ
aiua-8110	61	15	,	,	PUNCT
aiua-8110	61	16	neutrophil	neutrophil	ADJ
aiua-8110	61	17	/	/	SYM
aiua-8110	61	18	lymphocyte	lymphocyte	ADJ
aiua-8110	61	19	ratio	ratio	NOUN
aiua-8110	61	20	and	and	CCONJ
aiua-8110	61	21	mpv	mpv	PROPN
aiua-8110	61	22	.	.	PROPN
aiua-8110	62	1	tumor	tumor	PROPN
aiua-8110	62	2	varicocele	varicocele	NOUN
aiua-8110	62	3	p	p	X
aiua-8110	62	4	mean	mean	VERB
aiua-8110	62	5	±	±	NUM
aiua-8110	62	6	sd	sd	NOUN
aiua-8110	62	7	(	(	PUNCT
aiua-8110	62	8	median	median	PROPN
aiua-8110	62	9	)	)	PUNCT
aiua-8110	62	10	mean	mean	NOUN
aiua-8110	62	11	±	±	NUM
aiua-8110	62	12	sd	sd	NOUN
aiua-8110	62	13	(	(	PUNCT
aiua-8110	62	14	median	median	NOUN
aiua-8110	62	15	)	)	PUNCT
aiua-8110	62	16	plt	plt	NOUN
aiua-8110	62	17	/	/	SYM
aiua-8110	62	18	lymphocyte	lymphocyte	NOUN
aiua-8110	62	19	128.91	128.91	NUM
aiua-8110	62	20	±	±	NUM
aiua-8110	62	21	95.19	95.19	NUM
aiua-8110	62	22	(	(	PUNCT
aiua-8110	62	23	110.4	110.4	NUM
aiua-8110	62	24	)	)	PUNCT
aiua-8110	62	25	125.45	125.45	NUM
aiua-8110	62	26	±	±	NUM
aiua-8110	62	27	63.3	63.3	NUM
aiua-8110	62	28	(	(	PUNCT
aiua-8110	62	29	110.8	110.8	NUM
aiua-8110	62	30	)	)	PUNCT
aiua-8110	62	31	0.9071	0.9071	PROPN
aiua-8110	62	32	neutrophil	neutrophil	ADJ
aiua-8110	62	33	/	/	SYM
aiua-8110	62	34	lymphocyte	lymphocyte	NOUN
aiua-8110	62	35	4.22	4.22	NUM
aiua-8110	62	36	±	±	NUM
aiua-8110	62	37	3.54	3.54	NUM
aiua-8110	62	38	(	(	PUNCT
aiua-8110	62	39	3.5	3.5	NUM
aiua-8110	62	40	)	)	PUNCT
aiua-8110	62	41	3.49	3.49	NUM
aiua-8110	62	42	±	±	NUM
aiua-8110	62	43	2.79	2.79	NUM
aiua-8110	62	44	(	(	PUNCT
aiua-8110	62	45	2.7	2.7	NUM
aiua-8110	62	46	)	)	PUNCT
aiua-8110	62	47	0.001	0.001	NUM
aiua-8110	62	48	*	*	NOUN
aiua-8110	62	49	,	,	PUNCT
aiua-8110	62	50	1	1	NUM
aiua-8110	62	51	mpv	mpv	PROPN
aiua-8110	62	52	8.05	8.05	NUM
aiua-8110	62	53	±	±	NUM
aiua-8110	62	54	1.46	1.46	NUM
aiua-8110	62	55	8.28	8.28	NUM
aiua-8110	62	56	±	±	NUM
aiua-8110	62	57	1.56	1.56	NUM
aiua-8110	62	58	0.2142	0.2142	NUM
aiua-8110	62	59	1	1	NUM
aiua-8110	62	60	mann	mann	PROPN
aiua-8110	62	61	whitney	whitney	PROPN
aiua-8110	62	62	u	u	PROPN
aiua-8110	62	63	test	test	NOUN
aiua-8110	62	64	;	;	PUNCT
aiua-8110	62	65	2	2	NUM
aiua-8110	62	66	student	student	NOUN
aiua-8110	62	67	t	t	PROPN
aiua-8110	62	68	test	test	NOUN
aiua-8110	62	69	;	;	PUNCT
aiua-8110	63	1	*	*	PUNCT
aiua-8110	63	2	p	p	X
aiua-8110	63	3	<	<	X
aiua-8110	63	4	0.05	0.05	NUM
aiua-8110	63	5	.	.	PUNCT
aiua-8110	63	6	table	table	NOUN
aiua-8110	63	7	2	2	NUM
aiua-8110	63	8	.	.	PUNCT
aiua-8110	63	9	evaluation	evaluation	NOUN
aiua-8110	63	10	of	of	ADP
aiua-8110	63	11	groups	group	NOUN
aiua-8110	63	12	in	in	ADP
aiua-8110	63	13	terms	term	NOUN
aiua-8110	63	14	of	of	ADP
aiua-8110	63	15	plt	plt	NOUN
aiua-8110	63	16	/	/	SYM
aiua-8110	63	17	lymphocyte	lymphocyte	ADJ
aiua-8110	63	18	,	,	PUNCT
aiua-8110	63	19	neutrophil	neutrophil	ADJ
aiua-8110	63	20	/	/	SYM
aiua-8110	63	21	lymphocyte	lymphocyte	ADJ
aiua-8110	63	22	ratio	ratio	NOUN
aiua-8110	63	23	and	and	CCONJ
aiua-8110	63	24	mpv	mpv	PROPN
aiua-8110	63	25	.	.	PUNCT
aiua-8110	64	1	pt1	pt1	PROPN
aiua-8110	64	2	(	(	PUNCT
aiua-8110	64	3	n	n	NOUN
aiua-8110	64	4	=	=	SYM
aiua-8110	64	5	60	60	NUM
aiua-8110	64	6	)	)	PUNCT
aiua-8110	64	7	pt2	pt2	NOUN
aiua-8110	64	8	(	(	PUNCT
aiua-8110	64	9	n	n	NOUN
aiua-8110	64	10	=	=	SYM
aiua-8110	64	11	43	43	NUM
aiua-8110	64	12	)	)	PUNCT
aiua-8110	64	13	pt3	pt3	NOUN
aiua-8110	64	14	(	(	PUNCT
aiua-8110	64	15	n	n	NOUN
aiua-8110	64	16	=	=	SYM
aiua-8110	64	17	5	5	NUM
aiua-8110	64	18	)	)	PUNCT
aiua-8110	64	19	p	p	NOUN
aiua-8110	64	20	mean	mean	NOUN
aiua-8110	64	21	±	±	NUM
aiua-8110	64	22	sd	sd	NOUN
aiua-8110	64	23	(	(	PUNCT
aiua-8110	64	24	median	median	PROPN
aiua-8110	64	25	)	)	PUNCT
aiua-8110	64	26	mean	mean	NOUN
aiua-8110	64	27	±	±	NUM
aiua-8110	64	28	sd	sd	NOUN
aiua-8110	64	29	(	(	PUNCT
aiua-8110	64	30	median	median	PROPN
aiua-8110	64	31	)	)	PUNCT
aiua-8110	64	32	mean	mean	NOUN
aiua-8110	64	33	±	±	NUM
aiua-8110	64	34	sd	sd	NOUN
aiua-8110	64	35	(	(	PUNCT
aiua-8110	64	36	median	median	NOUN
aiua-8110	64	37	)	)	PUNCT
aiua-8110	64	38	plt	plt	NOUN
aiua-8110	64	39	/	/	SYM
aiua-8110	64	40	lymphocyte	lymphocyte	NOUN
aiua-8110	64	41	115.57	115.57	NUM
aiua-8110	64	42	±	±	NOUN
aiua-8110	64	43	58.01	58.01	NUM
aiua-8110	64	44	(	(	PUNCT
aiua-8110	64	45	108.1	108.1	NUM
aiua-8110	64	46	)	)	PUNCT
aiua-8110	64	47	140	140	NUM
aiua-8110	64	48	±	±	NUM
aiua-8110	64	49	135.35	135.35	NUM
aiua-8110	64	50	(	(	PUNCT
aiua-8110	64	51	110.4	110.4	NUM
aiua-8110	64	52	)	)	PUNCT
aiua-8110	64	53	231.27	231.27	NUM
aiua-8110	64	54	±	±	NUM
aiua-8110	64	55	74.21	74.21	NUM
aiua-8110	64	56	(	(	PUNCT
aiua-8110	64	57	212.5	212.5	NUM
aiua-8110	64	58	)	)	PUNCT
aiua-8110	64	59	0006	0006	NUM
aiua-8110	64	60	*	*	PUNCT
aiua-8110	64	61	neutrophil	neutrophil	ADJ
aiua-8110	64	62	/	/	SYM
aiua-8110	64	63	lymphocyte	lymphocyte	NOUN
aiua-8110	64	64	3.83	3.83	NUM
aiua-8110	64	65	±	±	NUM
aiua-8110	64	66	2.58	2.58	NUM
aiua-8110	64	67	(	(	PUNCT
aiua-8110	64	68	3.4	3.4	NUM
aiua-8110	64	69	)	)	PUNCT
aiua-8110	64	70	4.62	4.62	NUM
aiua-8110	64	71	±	±	NUM
aiua-8110	64	72	4.94	4.94	NUM
aiua-8110	64	73	(	(	PUNCT
aiua-8110	64	74	3.5	3.5	NUM
aiua-8110	64	75	)	)	PUNCT
aiua-8110	64	76	5.78	5.78	NUM
aiua-8110	64	77	±	±	NUM
aiua-8110	64	78	1.87	1.87	NUM
aiua-8110	64	79	(	(	PUNCT
aiua-8110	64	80	6.3	6.3	NUM
aiua-8110	64	81	)	)	PUNCT
aiua-8110	64	82	0.108	0.108	NUM
aiua-8110	64	83	mpv	mpv	PROPN
aiua-8110	64	84	8.26	8.26	NUM
aiua-8110	64	85	±	±	NUM
aiua-8110	64	86	1.62	1.62	NUM
aiua-8110	64	87	(	(	PUNCT
aiua-8110	64	88	7.9	7.9	NUM
aiua-8110	64	89	)	)	PUNCT
aiua-8110	64	90	7.92	7.92	NUM
aiua-8110	64	91	±	±	NUM
aiua-8110	64	92	1.19	1.19	NUM
aiua-8110	64	93	(	(	PUNCT
aiua-8110	64	94	7.8	7.8	NUM
aiua-8110	64	95	)	)	PUNCT
aiua-8110	64	96	7.24	7.24	NUM
aiua-8110	64	97	±	±	NUM
aiua-8110	64	98	0.82	0.82	NUM
aiua-8110	64	99	(	(	PUNCT
aiua-8110	64	100	7.2	7.2	NUM
aiua-8110	64	101	)	)	PUNCT
aiua-8110	64	102	0.107	0.107	NUM
aiua-8110	64	103	kruskal	kruskal	PROPN
aiua-8110	64	104	wallis	wallis	PROPN
aiua-8110	64	105	test	test	NOUN
aiua-8110	64	106	;	;	PUNCT
aiua-8110	64	107	*	*	PUNCT
aiua-8110	64	108	p	p	X
aiua-8110	64	109	<	<	X
aiua-8110	64	110	0.05	0.05	NUM
aiua-8110	64	111	.	.	PUNCT
aiua-8110	65	1	note	note	NOUN
aiua-8110	65	2	:	:	PUNCT
aiua-8110	65	3	since	since	SCONJ
aiua-8110	65	4	the	the	DET
aiua-8110	65	5	number	number	NOUN
aiua-8110	65	6	of	of	ADP
aiua-8110	65	7	patients	patient	NOUN
aiua-8110	65	8	with	with	ADP
aiua-8110	65	9	pt3	pt3	NOUN
aiua-8110	65	10	was	be	AUX
aiua-8110	65	11	5	5	NUM
aiua-8110	65	12	,	,	PUNCT
aiua-8110	65	13	kruskal	kruskal	PROPN
aiua-8110	65	14	wallis	wallis	PROPN
aiua-8110	65	15	test	test	PROPN
aiua-8110	65	16	was	be	AUX
aiua-8110	65	17	used	use	VERB
aiua-8110	65	18	despite	despite	SCONJ
aiua-8110	65	19	the	the	DET
aiua-8110	65	20	normal	normal	ADJ
aiua-8110	65	21	distribution	distribution	NOUN
aiua-8110	65	22	of	of	ADP
aiua-8110	65	23	mpv	mpv	PROPN
aiua-8110	65	24	.	.	PROPN
aiua-8110	65	25	figure	figure	NOUN
aiua-8110	65	26	1	1	NUM
aiua-8110	65	27	.	.	PUNCT
aiua-8110	65	28	stone	stone	NOUN
aiua-8110	65	29	expulsion	expulsion	NOUN
aiua-8110	65	30	duration	duration	NOUN
aiua-8110	65	31	in	in	ADP
aiua-8110	65	32	the	the	DET
aiua-8110	65	33	groups	group	NOUN
aiua-8110	65	34	.	.	PUNCT
aiua-8110	66	1	under	under	ADP
aiua-8110	66	2	the	the	DET
aiua-8110	66	3	curve	curve	NOUN
aiua-8110	66	4	is	be	AUX
aiua-8110	66	5	0.612	0.612	NUM
aiua-8110	66	6	and	and	CCONJ
aiua-8110	66	7	the	the	DET
aiua-8110	66	8	standard	standard	ADJ
aiua-8110	66	9	deviation	deviation	NOUN
aiua-8110	66	10	is	be	AUX
aiua-8110	66	11	0.03	0.03	NUM
aiua-8110	66	12	.	.	PUNCT
aiua-8110	67	1	the	the	DET
aiua-8110	67	2	area	area	NOUN
aiua-8110	67	3	under	under	ADP
aiua-8110	67	4	the	the	DET
aiua-8110	67	5	roc	roc	PROPN
aiua-8110	67	6	curve	curve	NOUN
aiua-8110	67	7	was	be	AUX
aiua-8110	67	8	significantly	significantly	ADV
aiua-8110	67	9	higher	high	ADJ
aiua-8110	67	10	than	than	ADP
aiua-8110	67	11	0.5	0.5	NUM
aiua-8110	67	12	(	(	PUNCT
aiua-8110	67	13	p	p	NOUN
aiua-8110	67	14	=	=	NOUN
aiua-8110	67	15	0.001	0.001	NUM
aiua-8110	67	16	;	;	PUNCT
aiua-8110	67	17	p	p	X
aiua-8110	67	18	<	<	X
aiua-8110	67	19	0.05	0.05	NUM
aiua-8110	67	20	)	)	PUNCT
aiua-8110	67	21	.	.	PUNCT
aiua-8110	68	1	the	the	DET
aiua-8110	68	2	cut	cut	VERB
aiua-8110	68	3	-	-	PUNCT
aiua-8110	68	4	off	off	ADP
aiua-8110	68	5	point	point	NOUN
aiua-8110	68	6	for	for	ADP
aiua-8110	68	7	nlr	nlr	PROPN
aiua-8110	68	8	in	in	ADP
aiua-8110	68	9	the	the	DET
aiua-8110	68	10	diagnosis	diagnosis	NOUN
aiua-8110	68	11	of	of	ADP
aiua-8110	68	12	testicular	testicular	ADJ
aiua-8110	68	13	tumor	tumor	NOUN
aiua-8110	68	14	is	be	AUX
aiua-8110	68	15	>	>	X
aiua-8110	68	16	3.16	3.16	NUM
aiua-8110	68	17	.	.	PUNCT
aiua-8110	69	1	the	the	DET
aiua-8110	69	2	sensitivity	sensitivity	NOUN
aiua-8110	69	3	of	of	ADP
aiua-8110	69	4	this	this	DET
aiua-8110	69	5	value	value	NOUN
aiua-8110	69	6	was	be	AUX
aiua-8110	69	7	63.87	63.87	NUM
aiua-8110	69	8	%	%	NOUN
aiua-8110	69	9	and	and	CCONJ
aiua-8110	69	10	the	the	DET
aiua-8110	69	11	specificity	specificity	NOUN
aiua-8110	69	12	was	be	AUX
aiua-8110	69	13	63.16	63.16	NUM
aiua-8110	69	14	%	%	NOUN
aiua-8110	69	15	(	(	PUNCT
aiua-8110	69	16	figure	figure	NOUN
aiua-8110	69	17	2	2	NUM
aiua-8110	69	18	)	)	PUNCT
aiua-8110	69	19	.	.	PUNCT
aiua-8110	70	1	discussion	discussion	NOUN
aiua-8110	70	2	inflammation	inflammation	NOUN
aiua-8110	70	3	plays	play	VERB
aiua-8110	70	4	an	an	DET
aiua-8110	70	5	important	important	ADJ
aiua-8110	70	6	role	role	NOUN
aiua-8110	70	7	in	in	ADP
aiua-8110	70	8	tumor	tumor	NOUN
aiua-8110	70	9	development	development	NOUN
aiua-8110	70	10	and	and	CCONJ
aiua-8110	70	11	progression	progression	NOUN
aiua-8110	70	12	.	.	PUNCT
aiua-8110	71	1	the	the	DET
aiua-8110	71	2	relationship	relationship	NOUN
aiua-8110	71	3	between	between	ADP
aiua-8110	71	4	inflammation	inflammation	NOUN
aiua-8110	71	5	and	and	CCONJ
aiua-8110	71	6	cancer	cancer	NOUN
aiua-8110	71	7	has	have	AUX
aiua-8110	71	8	long	long	ADV
aiua-8110	71	9	been	be	AUX
aiua-8110	71	10	known	know	VERB
aiua-8110	71	11	.	.	PUNCT
aiua-8110	72	1	in	in	ADP
aiua-8110	72	2	1863	1863	NUM
aiua-8110	72	3	,	,	PUNCT
aiua-8110	72	4	virchow	virchow	NOUN
aiua-8110	72	5	put	put	VERB
aiua-8110	72	6	forward	forward	ADV
aiua-8110	72	7	the	the	DET
aiua-8110	72	8	hypothesis	hypothesis	NOUN
aiua-8110	72	9	that	that	PRON
aiua-8110	72	10	cancer	cancer	NOUN
aiua-8110	72	11	occurs	occur	VERB
aiua-8110	72	12	in	in	ADP
aiua-8110	72	13	the	the	DET
aiua-8110	72	14	areas	area	NOUN
aiua-8110	72	15	of	of	ADP
aiua-8110	72	16	chronic	chronic	ADJ
aiua-8110	72	17	inflammation	inflammation	NOUN
aiua-8110	72	18	,	,	PUNCT
aiua-8110	72	19	and	and	CCONJ
aiua-8110	72	20	that	that	SCONJ
aiua-8110	72	21	some	some	DET
aiua-8110	72	22	irritants	irritant	NOUN
aiua-8110	72	23	increase	increase	VERB
aiua-8110	72	24	cell	cell	NOUN
aiua-8110	72	25	proliferation	proliferation	NOUN
aiua-8110	72	26	along	along	ADP
aiua-8110	72	27	with	with	ADP
aiua-8110	72	28	inflammation	inflammation	NOUN
aiua-8110	72	29	leading	lead	VERB
aiua-8110	72	30	to	to	ADP
aiua-8110	72	31	tissue	tissue	NOUN
aiua-8110	72	32	injury	injury	NOUN
aiua-8110	72	33	(	(	PUNCT
aiua-8110	72	34	11	11	NUM
aiua-8110	72	35	)	)	PUNCT
aiua-8110	72	36	.	.	PUNCT
aiua-8110	73	1	although	although	SCONJ
aiua-8110	73	2	the	the	DET
aiua-8110	73	3	effect	effect	NOUN
aiua-8110	73	4	of	of	ADP
aiua-8110	73	5	this	this	DET
aiua-8110	73	6	proliferation	proliferation	NOUN
aiua-8110	73	7	is	be	AUX
aiua-8110	73	8	clear	clear	ADJ
aiua-8110	73	9	,	,	PUNCT
aiua-8110	73	10	cells	cell	NOUN
aiua-8110	73	11	alone	alone	ADV
aiua-8110	73	12	do	do	AUX
aiua-8110	73	13	not	not	PART
aiua-8110	73	14	cause	cause	VERB
aiua-8110	73	15	cancer	cancer	NOUN
aiua-8110	73	16	.	.	PUNCT
aiua-8110	74	1	continuous	continuous	ADJ
aiua-8110	74	2	cell	cell	NOUN
aiua-8110	74	3	proliferation	proliferation	NOUN
aiua-8110	74	4	,	,	PUNCT
aiua-8110	74	5	inflammatory	inflammatory	ADJ
aiua-8110	74	6	cells	cell	NOUN
aiua-8110	74	7	,	,	PUNCT
aiua-8110	74	8	growth	growth	NOUN
aiua-8110	74	9	factors	factor	NOUN
aiua-8110	74	10	,	,	PUNCT
aiua-8110	74	11	activated	activate	VERB
aiua-8110	74	12	stroma	stroma	NOUN
aiua-8110	74	13	and	and	CCONJ
aiua-8110	74	14	dna	dna	NOUN
aiua-8110	74	15	-	-	PUNCT
aiua-8110	74	16	damage	damage	NOUN
aiua-8110	74	17	enhancing	enhance	VERB
aiua-8110	74	18	agents	agent	NOUN
aiua-8110	74	19	increase	increase	VERB
aiua-8110	74	20	or	or	CCONJ
aiua-8110	74	21	promote	promote	VERB
aiua-8110	74	22	neoplastic	neoplastic	ADJ
aiua-8110	74	23	risk	risk	NOUN
aiua-8110	74	24	.	.	PUNCT
aiua-8110	75	1	neutrophils	neutrophil	NOUN
aiua-8110	75	2	mediate	mediate	VERB
aiua-8110	75	3	inflammation	inflammation	NOUN
aiua-8110	75	4	through	through	ADP
aiua-8110	75	5	various	various	ADJ
aiua-8110	75	6	biochemical	biochemical	ADJ
aiua-8110	75	7	mechanisms	mechanism	NOUN
aiua-8110	75	8	such	such	ADJ
aiua-8110	75	9	as	as	ADP
aiua-8110	75	10	release	release	NOUN
aiua-8110	75	11	of	of	ADP
aiua-8110	75	12	arachidonic	arachidonic	ADJ
aiua-8110	75	13	acid	acid	NOUN
aiua-8110	75	14	metabolites	metabolite	NOUN
aiua-8110	75	15	and	and	CCONJ
aiua-8110	75	16	platelet	platelet	NOUN
aiua-8110	75	17	aggravating	aggravating	ADJ
aiua-8110	75	18	factors	factor	NOUN
aiua-8110	75	19	(	(	PUNCT
aiua-8110	75	20	12	12	NUM
aiua-8110	75	21	)	)	PUNCT
aiua-8110	75	22	.	.	PUNCT
aiua-8110	76	1	neutrophilia	neutrophilia	PROPN
aiua-8110	76	2	could	could	AUX
aiua-8110	76	3	represent	represent	VERB
aiua-8110	76	4	a	a	DET
aiua-8110	76	5	consequence	consequence	NOUN
aiua-8110	76	6	of	of	ADP
aiua-8110	76	7	ectopic	ectopic	ADJ
aiua-8110	76	8	production	production	NOUN
aiua-8110	76	9	of	of	ADP
aiua-8110	76	10	myeloid	myeloid	ADJ
aiua-8110	76	11	growth	growth	NOUN
aiua-8110	76	12	factors	factor	NOUN
aiua-8110	76	13	as	as	ADP
aiua-8110	76	14	part	part	NOUN
aiua-8110	76	15	of	of	ADP
aiua-8110	76	16	a	a	DET
aiua-8110	76	17	paraneoplastic	paraneoplastic	ADJ
aiua-8110	76	18	syndrome	syndrome	NOUN
aiua-8110	76	19	(	(	PUNCT
aiua-8110	76	20	13	13	NUM
aiua-8110	76	21	)	)	PUNCT
aiua-8110	76	22	or	or	CCONJ
aiua-8110	76	23	,	,	PUNCT
aiua-8110	76	24	more	more	ADV
aiua-8110	76	25	likely	likely	ADJ
aiua-8110	76	26	,	,	PUNCT
aiua-8110	76	27	a	a	DET
aiua-8110	76	28	nonspecific	nonspecific	ADJ
aiua-8110	76	29	response	response	NOUN
aiua-8110	76	30	to	to	ADP
aiua-8110	76	31	cancer	cancer	NOUN
aiua-8110	76	32	-	-	PUNCT
aiua-8110	76	33	related	relate	VERB
aiua-8110	76	34	inflammation	inflammation	NOUN
aiua-8110	76	35	secondary	secondary	ADJ
aiua-8110	76	36	to	to	ADP
aiua-8110	76	37	tissue	tissue	NOUN
aiua-8110	76	38	destruction	destruction	NOUN
aiua-8110	76	39	and	and	CCONJ
aiua-8110	76	40	cytokine	cytokine	NOUN
aiua-8110	76	41	releases	release	NOUN
aiua-8110	76	42	.	.	PUNCT
aiua-8110	77	1	lymphopenia	lymphopenia	NOUN
aiua-8110	77	2	is	be	AUX
aiua-8110	77	3	associated	associate	VERB
aiua-8110	77	4	with	with	ADP
aiua-8110	77	5	cortisol	cortisol	NOUN
aiua-8110	77	6	induced	induce	VERB
aiua-8110	77	7	stress	stress	NOUN
aiua-8110	77	8	response	response	NOUN
aiua-8110	77	9	(	(	PUNCT
aiua-8110	77	10	12	12	NUM
aiua-8110	77	11	)	)	PUNCT
aiua-8110	77	12	.	.	PUNCT
aiua-8110	78	1	high	high	PROPN
aiua-8110	78	2	nlr	nlr	PROPN
aiua-8110	78	3	occurring	occur	VERB
aiua-8110	78	4	as	as	ADP
aiua-8110	78	5	a	a	DET
aiua-8110	78	6	result	result	NOUN
aiua-8110	78	7	of	of	ADP
aiua-8110	78	8	the	the	DET
aiua-8110	78	9	added	add	VERB
aiua-8110	78	10	effect	effect	NOUN
aiua-8110	78	11	of	of	ADP
aiua-8110	78	12	increased	increase	VERB
aiua-8110	78	13	neu	neu	NOUN
aiua-8110	78	14	response	response	NOUN
aiua-8110	78	15	to	to	ADP
aiua-8110	78	16	lym	lym	NOUN
aiua-8110	78	17	suppression	suppression	NOUN
aiua-8110	78	18	can	can	AUX
aiua-8110	78	19	support	support	VERB
aiua-8110	78	20	the	the	DET
aiua-8110	78	21	development	development	NOUN
aiua-8110	78	22	of	of	ADP
aiua-8110	78	23	cancer	cancer	NOUN
aiua-8110	78	24	by	by	ADP
aiua-8110	78	25	inhibiting	inhibit	VERB
aiua-8110	78	26	the	the	DET
aiua-8110	78	27	antitumor	antitumor	PROPN
aiua-8110	78	28	immune	immune	ADJ
aiua-8110	78	29	response	response	NOUN
aiua-8110	78	30	(	(	PUNCT
aiua-8110	78	31	14	14	NUM
aiua-8110	78	32	)	)	PUNCT
aiua-8110	78	33	.	.	PUNCT
aiua-8110	79	1	experimental	experimental	ADJ
aiua-8110	79	2	data	datum	NOUN
aiua-8110	79	3	have	have	AUX
aiua-8110	79	4	shown	show	VERB
aiua-8110	79	5	that	that	SCONJ
aiua-8110	79	6	active	active	ADJ
aiua-8110	79	7	neutrophils	neutrophil	NOUN
aiua-8110	79	8	can	can	AUX
aiua-8110	79	9	stimulate	stimulate	VERB
aiua-8110	79	10	tumor	tumor	NOUN
aiua-8110	79	11	growth	growth	NOUN
aiua-8110	79	12	directly	directly	ADV
aiua-8110	79	13	and	and	CCONJ
aiua-8110	79	14	indirectly	indirectly	ADV
aiua-8110	79	15	(	(	PUNCT
aiua-8110	79	16	15	15	NUM
aiua-8110	79	17	)	)	PUNCT
aiua-8110	79	18	.	.	PUNCT
aiua-8110	80	1	nlr	nlr	PROPN
aiua-8110	80	2	and	and	CCONJ
aiua-8110	80	3	platelet	platelet	ADJ
aiua-8110	80	4	/	/	SYM
aiua-8110	80	5	lymphocyte	lymphocyte	ADJ
aiua-8110	80	6	ratio	ratio	NOUN
aiua-8110	80	7	(	(	PUNCT
aiua-8110	80	8	plr	plr	NOUN
aiua-8110	80	9	)	)	PUNCT
aiua-8110	80	10	have	have	AUX
aiua-8110	80	11	also	also	ADV
aiua-8110	80	12	been	be	AUX
aiua-8110	80	13	shown	show	VERB
aiua-8110	80	14	to	to	PART
aiua-8110	80	15	be	be	AUX
aiua-8110	80	16	reliable	reliable	ADJ
aiua-8110	80	17	markers	marker	NOUN
aiua-8110	80	18	of	of	ADP
aiua-8110	80	19	systemic	systemic	ADJ
aiua-8110	80	20	inflammation	inflammation	NOUN
aiua-8110	80	21	by	by	ADP
aiua-8110	80	22	many	many	ADJ
aiua-8110	80	23	studies	study	NOUN
aiua-8110	80	24	(	(	PUNCT
aiua-8110	80	25	16	16	NUM
aiua-8110	80	26	)	)	PUNCT
aiua-8110	80	27	.	.	PUNCT
aiua-8110	81	1	according	accord	VERB
aiua-8110	81	2	to	to	ADP
aiua-8110	81	3	the	the	DET
aiua-8110	81	4	type	type	NOUN
aiua-8110	81	5	of	of	ADP
aiua-8110	81	6	malignancy	malignancy	NOUN
aiua-8110	81	7	,	,	PUNCT
aiua-8110	81	8	inflammatory	inflammatory	ADJ
aiua-8110	81	9	and	and	CCONJ
aiua-8110	81	10	immune	immune	ADJ
aiua-8110	81	11	responses	response	NOUN
aiua-8110	81	12	to	to	ADP
aiua-8110	81	13	systemic	systemic	ADJ
aiua-8110	81	14	tumor	tumor	NOUN
aiua-8110	81	15	cells	cell	NOUN
aiua-8110	81	16	and	and	CCONJ
aiua-8110	81	17	secreted	secrete	VERB
aiua-8110	81	18	peptides	peptide	NOUN
aiua-8110	81	19	can	can	AUX
aiua-8110	81	20	vary	vary	VERB
aiua-8110	81	21	.	.	PUNCT
aiua-8110	82	1	today	today	NOUN
aiua-8110	82	2	,	,	PUNCT
aiua-8110	82	3	systemic	systemic	ADJ
aiua-8110	82	4	inflammatory	inflammatory	ADJ
aiua-8110	82	5	response	response	NOUN
aiua-8110	82	6	indicators	indicator	NOUN
aiua-8110	82	7	such	such	ADJ
aiua-8110	82	8	as	as	ADP
aiua-8110	82	9	cytokine	cytokine	NOUN
aiua-8110	82	10	,	,	PUNCT
aiua-8110	82	11	crp	crp	PROPN
aiua-8110	82	12	,	,	PUNCT
aiua-8110	82	13	albumin	albumin	NOUN
aiua-8110	82	14	,	,	PUNCT
aiua-8110	82	15	serum	serum	NOUN
aiua-8110	82	16	amyloid	amyloid	NOUN
aiua-8110	82	17	a	a	PRON
aiua-8110	82	18	and	and	CCONJ
aiua-8110	82	19	leukocytes	leukocyte	NOUN
aiua-8110	82	20	have	have	AUX
aiua-8110	82	21	gained	gain	VERB
aiua-8110	82	22	importance	importance	NOUN
aiua-8110	82	23	in	in	ADP
aiua-8110	82	24	the	the	DET
aiua-8110	82	25	patients	patient	NOUN
aiua-8110	82	26	with	with	ADP
aiua-8110	82	27	malignancy	malignancy	NOUN
aiua-8110	82	28	and	and	CCONJ
aiua-8110	82	29	it	it	PRON
aiua-8110	82	30	has	have	AUX
aiua-8110	82	31	been	be	AUX
aiua-8110	82	32	thought	think	VERB
aiua-8110	82	33	that	that	SCONJ
aiua-8110	82	34	they	they	PRON
aiua-8110	82	35	can	can	AUX
aiua-8110	82	36	be	be	AUX
aiua-8110	82	37	independent	independent	ADJ
aiua-8110	82	38	prognostic	prognostic	ADJ
aiua-8110	82	39	factors	factor	NOUN
aiua-8110	82	40	(	(	PUNCT
aiua-8110	82	41	17	17	NUM
aiua-8110	82	42	)	)	PUNCT
aiua-8110	82	43	.	.	PUNCT
aiua-8110	83	1	the	the	DET
aiua-8110	83	2	immune	immune	ADJ
aiua-8110	83	3	system	system	NOUN
aiua-8110	83	4	has	have	VERB
aiua-8110	83	5	a	a	DET
aiua-8110	83	6	positive	positive	ADJ
aiua-8110	83	7	and	and	CCONJ
aiua-8110	83	8	negative	negative	ADJ
aiua-8110	83	9	effect	effect	NOUN
aiua-8110	83	10	on	on	ADP
aiua-8110	83	11	cancer	cancer	NOUN
aiua-8110	83	12	development	development	NOUN
aiua-8110	83	13	and	and	CCONJ
aiua-8110	83	14	progression	progression	NOUN
aiua-8110	83	15	.	.	PUNCT
aiua-8110	84	1	it	it	PRON
aiua-8110	84	2	can	can	AUX
aiua-8110	84	3	eliminate	eliminate	VERB
aiua-8110	84	4	tumor	tumor	NOUN
aiua-8110	84	5	cells	cell	NOUN
aiua-8110	84	6	or	or	CCONJ
aiua-8110	84	7	increase	increase	VERB
aiua-8110	84	8	the	the	DET
aiua-8110	84	9	metastatic	metastatic	ADJ
aiua-8110	84	10	ability	ability	NOUN
aiua-8110	84	11	and	and	CCONJ
aiua-8110	84	12	invasion	invasion	NOUN
aiua-8110	84	13	capacities	capacity	NOUN
aiua-8110	84	14	of	of	ADP
aiua-8110	84	15	active	active	ADJ
aiua-8110	84	16	malignant	malignant	ADJ
aiua-8110	84	17	cells	cell	NOUN
aiua-8110	84	18	,	,	PUNCT
aiua-8110	84	19	leading	lead	VERB
aiua-8110	84	20	to	to	ADP
aiua-8110	84	21	tumor	tumor	NOUN
aiua-8110	84	22	progression	progression	NOUN
aiua-8110	84	23	.	.	PUNCT
aiua-8110	85	1	the	the	DET
aiua-8110	85	2	excess	excess	NOUN
aiua-8110	85	3	of	of	ADP
aiua-8110	85	4	circulating	circulate	VERB
aiua-8110	85	5	neus	neus	NOUN
aiua-8110	85	6	is	be	AUX
aiua-8110	85	7	thought	think	VERB
aiua-8110	85	8	to	to	PART
aiua-8110	85	9	play	play	VERB
aiua-8110	85	10	an	an	DET
aiua-8110	85	11	important	important	ADJ
aiua-8110	85	12	role	role	NOUN
aiua-8110	85	13	in	in	ADP
aiua-8110	85	14	tumor	tumor	NOUN
aiua-8110	85	15	progression	progression	NOUN
aiua-8110	85	16	and	and	CCONJ
aiua-8110	85	17	angiogenesis	angiogenesis	NOUN
aiua-8110	85	18	.	.	PUNCT
aiua-8110	86	1	therefore	therefore	ADV
aiua-8110	86	2	,	,	PUNCT
aiua-8110	86	3	increased	increase	VERB
aiua-8110	86	4	number	number	NOUN
aiua-8110	86	5	of	of	ADP
aiua-8110	86	6	neus	neus	NOUN
aiua-8110	86	7	should	should	AUX
aiua-8110	86	8	be	be	AUX
aiua-8110	86	9	associated	associate	VERB
aiua-8110	86	10	with	with	ADP
aiua-8110	86	11	poor	poor	ADJ
aiua-8110	86	12	prognosis	prognosis	NOUN
aiua-8110	86	13	(	(	PUNCT
aiua-8110	86	14	18	18	NUM
aiua-8110	86	15	)	)	PUNCT
aiua-8110	86	16	.	.	PUNCT
aiua-8110	87	1	mpv	mpv	PROPN
aiua-8110	87	2	represents	represent	VERB
aiua-8110	87	3	the	the	DET
aiua-8110	87	4	mean	mean	ADJ
aiua-8110	87	5	platelet	platelet	NOUN
aiua-8110	87	6	size	size	NOUN
aiua-8110	87	7	in	in	ADP
aiua-8110	87	8	the	the	DET
aiua-8110	87	9	blood	blood	NOUN
aiua-8110	87	10	.	.	PUNCT
aiua-8110	88	1	it	it	PRON
aiua-8110	88	2	can	can	AUX
aiua-8110	88	3	be	be	AUX
aiua-8110	88	4	altered	alter	VERB
aiua-8110	88	5	in	in	ADP
aiua-8110	88	6	various	various	ADJ
aiua-8110	88	7	diseases	disease	NOUN
aiua-8110	88	8	such	such	ADJ
aiua-8110	88	9	as	as	ADP
aiua-8110	88	10	cancer	cancer	NOUN
aiua-8110	88	11	,	,	PUNCT
aiua-8110	88	12	thrombosis	thrombosis	NOUN
aiua-8110	88	13	,	,	PUNCT
aiua-8110	88	14	sepsis	sepsis	NOUN
aiua-8110	88	15	,	,	PUNCT
aiua-8110	88	16	respiratory	respiratory	ADJ
aiua-8110	88	17	distress	distress	NOUN
aiua-8110	88	18	syndrome	syndrome	NOUN
aiua-8110	88	19	,	,	PUNCT
aiua-8110	88	20	and	and	CCONJ
aiua-8110	88	21	acute	acute	ADJ
aiua-8110	88	22	appendicitis	appendicitis	NOUN
aiua-8110	88	23	(	(	PUNCT
aiua-8110	88	24	19	19	NUM
aiua-8110	88	25	)	)	PUNCT
aiua-8110	88	26	.	.	PUNCT
aiua-8110	89	1	plts	plt	NOUN
aiua-8110	89	2	are	be	AUX
aiua-8110	89	3	frequently	frequently	ADV
aiua-8110	89	4	observed	observe	VERB
aiua-8110	89	5	in	in	ADP
aiua-8110	89	6	the	the	DET
aiua-8110	89	7	cancer	cancer	NOUN
aiua-8110	89	8	microenvironment	microenvironment	NOUN
aiua-8110	89	9	and	and	CCONJ
aiua-8110	89	10	are	be	AUX
aiua-8110	89	11	thought	think	VERB
aiua-8110	89	12	to	to	PART
aiua-8110	89	13	stimulate	stimulate	VERB
aiua-8110	89	14	proliferation	proliferation	NOUN
aiua-8110	89	15	and	and	CCONJ
aiua-8110	89	16	transformation	transformation	NOUN
aiua-8110	89	17	of	of	ADP
aiua-8110	89	18	cancer	cancer	NOUN
aiua-8110	89	19	cells	cell	NOUN
aiua-8110	89	20	by	by	ADP
aiua-8110	89	21	platelet	platelet	NOUN
aiua-8110	89	22	derived	derive	VERB
aiua-8110	89	23	growth	growth	NOUN
aiua-8110	89	24	factor	factor	NOUN
aiua-8110	89	25	(	(	PUNCT
aiua-8110	89	26	pdgf	pdgf	NOUN
aiua-8110	89	27	)	)	PUNCT
aiua-8110	89	28	release	release	NOUN
aiua-8110	89	29	(	(	PUNCT
aiua-8110	89	30	20	20	NUM
aiua-8110	89	31	)	)	PUNCT
aiua-8110	89	32	.	.	PUNCT
aiua-8110	90	1	in	in	ADP
aiua-8110	90	2	the	the	DET
aiua-8110	90	3	study	study	NOUN
aiua-8110	90	4	of	of	ADP
aiua-8110	90	5	russell	russell	PROPN
aiua-8110	90	6	et	et	PROPN
aiua-8110	90	7	al	al	PROPN
aiua-8110	90	8	.	.	PROPN
aiua-8110	90	9	,	,	PUNCT
aiua-8110	90	10	it	it	PRON
aiua-8110	90	11	was	be	AUX
aiua-8110	90	12	reported	report	VERB
aiua-8110	90	13	that	that	SCONJ
aiua-8110	90	14	increased	increase	VERB
aiua-8110	90	15	pdgf	pdgf	ADJ
aiua-8110	90	16	alpha	alpha	NOUN
aiua-8110	90	17	receptor	receptor	NOUN
aiua-8110	90	18	expression	expression	NOUN
aiua-8110	90	19	was	be	AUX
aiua-8110	90	20	associated	associate	VERB
aiua-8110	90	21	with	with	ADP
aiua-8110	90	22	bone	bone	NOUN
aiua-8110	90	23	metastasis	metastasis	NOUN
aiua-8110	90	24	in	in	ADP
aiua-8110	90	25	castration	castration	NOUN
aiua-8110	90	26	-	-	PUNCT
aiua-8110	90	27	resistant	resistant	ADJ
aiua-8110	90	28	pca	pca	NOUN
aiua-8110	90	29	(	(	PUNCT
aiua-8110	90	30	21	21	NUM
aiua-8110	90	31	)	)	PUNCT
aiua-8110	90	32	.	.	PUNCT
aiua-8110	91	1	even	even	ADV
aiua-8110	91	2	in	in	ADP
aiua-8110	91	3	the	the	DET
aiua-8110	91	4	current	current	ADJ
aiua-8110	91	5	literature	literature	NOUN
aiua-8110	91	6	,	,	PUNCT
aiua-8110	91	7	anti	anti	ADJ
aiua-8110	91	8	-	-	ADJ
aiua-8110	91	9	platelet	platelet	ADJ
aiua-8110	91	10	therapy	therapy	NOUN
aiua-8110	91	11	has	have	AUX
aiua-8110	91	12	been	be	AUX
aiua-8110	91	13	reported	report	VERB
aiua-8110	91	14	to	to	PART
aiua-8110	91	15	have	have	VERB
aiua-8110	91	16	a	a	DET
aiua-8110	91	17	role	role	NOUN
aiua-8110	91	18	in	in	ADP
aiua-8110	91	19	pca	pca	PROPN
aiua-8110	91	20	adjuvant	adjuvant	NOUN
aiua-8110	91	21	therapy	therapy	NOUN
aiua-8110	91	22	(	(	PUNCT
aiua-8110	91	23	22	22	NUM
aiua-8110	91	24	)	)	PUNCT
aiua-8110	91	25	.	.	PUNCT
aiua-8110	92	1	mpv	mpv	PROPN
aiua-8110	92	2	measurement	measurement	PROPN
aiua-8110	92	3	is	be	AUX
aiua-8110	92	4	a	a	DET
aiua-8110	92	5	useful	useful	ADJ
aiua-8110	92	6	method	method	NOUN
aiua-8110	92	7	in	in	ADP
aiua-8110	92	8	determining	determine	VERB
aiua-8110	92	9	the	the	DET
aiua-8110	92	10	presence	presence	NOUN
aiua-8110	92	11	of	of	ADP
aiua-8110	92	12	these	these	DET
aiua-8110	92	13	activated	activate	VERB
aiua-8110	92	14	plts	plt	NOUN
aiua-8110	92	15	(	(	PUNCT
aiua-8110	92	16	9	9	NUM
aiua-8110	92	17	)	)	PUNCT
aiua-8110	92	18	.	.	PUNCT
aiua-8110	93	1	a	a	DET
aiua-8110	93	2	high	high	ADJ
aiua-8110	93	3	mpv	mpv	PROPN
aiua-8110	93	4	means	mean	VERB
aiua-8110	93	5	that	that	SCONJ
aiua-8110	93	6	your	your	PRON
aiua-8110	93	7	platelets	platelet	NOUN
aiua-8110	93	8	are	be	AUX
aiua-8110	93	9	larger	large	ADJ
aiua-8110	93	10	than	than	ADP
aiua-8110	93	11	average	average	ADJ
aiua-8110	93	12	.	.	PUNCT
aiua-8110	94	1	this	this	PRON
aiua-8110	94	2	is	be	AUX
aiua-8110	94	3	sometimes	sometimes	ADV
aiua-8110	94	4	a	a	DET
aiua-8110	94	5	sign	sign	NOUN
aiua-8110	94	6	that	that	SCONJ
aiua-8110	94	7	you	you	PRON
aiua-8110	94	8	're	be	AUX
aiua-8110	94	9	producing	produce	VERB
aiua-8110	94	10	too	too	ADV
aiua-8110	94	11	many	many	ADJ
aiua-8110	94	12	platelets	platelet	NOUN
aiua-8110	94	13	.	.	PUNCT
aiua-8110	95	1	platelets	platelet	NOUN
aiua-8110	95	2	are	be	AUX
aiua-8110	95	3	produced	produce	VERB
aiua-8110	95	4	in	in	ADP
aiua-8110	95	5	the	the	DET
aiua-8110	95	6	bone	bone	NOUN
aiua-8110	95	7	marrow	marrow	NOUN
aiua-8110	95	8	and	and	CCONJ
aiua-8110	95	9	released	release	VERB
aiua-8110	95	10	into	into	ADP
aiua-8110	95	11	the	the	DET
aiua-8110	95	12	bloodstream	bloodstream	NOUN
aiua-8110	95	13	.	.	PUNCT
aiua-8110	96	1	larger	large	ADJ
aiua-8110	96	2	platelets	platelet	NOUN
aiua-8110	96	3	are	be	AUX
aiua-8110	96	4	usually	usually	ADV
aiua-8110	96	5	young	young	ADJ
aiua-8110	96	6	and	and	CCONJ
aiua-8110	96	7	more	more	ADV
aiua-8110	96	8	recently	recently	ADV
aiua-8110	96	9	released	release	VERB
aiua-8110	96	10	from	from	ADP
aiua-8110	96	11	the	the	DET
aiua-8110	96	12	bone	bone	NOUN
aiua-8110	96	13	marrow	marrow	NOUN
aiua-8110	96	14	.	.	PUNCT
aiua-8110	97	1	smaller	small	ADJ
aiua-8110	97	2	platelets	platelet	NOUN
aiua-8110	97	3	are	be	AUX
aiua-8110	97	4	more	more	ADV
aiua-8110	97	5	likely	likely	ADJ
aiua-8110	97	6	to	to	PART
aiua-8110	97	7	have	have	AUX
aiua-8110	97	8	been	be	AUX
aiua-8110	97	9	in	in	ADP
aiua-8110	97	10	circulation	circulation	NOUN
aiua-8110	97	11	for	for	ADP
aiua-8110	97	12	a	a	DET
aiua-8110	97	13	few	few	ADJ
aiua-8110	97	14	days	day	NOUN
aiua-8110	97	15	.	.	PUNCT
aiua-8110	98	1	when	when	SCONJ
aiua-8110	98	2	someone	someone	PRON
aiua-8110	98	3	has	have	VERB
aiua-8110	98	4	a	a	DET
aiua-8110	98	5	low	low	ADJ
aiua-8110	98	6	platelet	platelet	NOUN
aiua-8110	98	7	count	count	NOUN
aiua-8110	98	8	and	and	CCONJ
aiua-8110	98	9	a	a	DET
aiua-8110	98	10	high	high	ADJ
aiua-8110	98	11	mpv	mpv	PROPN
aiua-8110	98	12	level	level	NOUN
aiua-8110	98	13	,	,	PUNCT
aiua-8110	98	14	it	it	PRON
aiua-8110	98	15	suggests	suggest	VERB
aiua-8110	98	16	that	that	SCONJ
aiua-8110	98	17	the	the	DET
aiua-8110	98	18	bone	bone	NOUN
aiua-8110	98	19	marrow	marrow	NOUN
aiua-8110	98	20	is	be	AUX
aiua-8110	98	21	rapidly	rapidly	ADV
aiua-8110	98	22	producing	produce	VERB
aiua-8110	98	23	platelets	platelet	NOUN
aiua-8110	98	24	.	.	PUNCT
aiua-8110	99	1	this	this	PRON
aiua-8110	99	2	may	may	AUX
aiua-8110	99	3	be	be	AUX
aiua-8110	99	4	because	because	SCONJ
aiua-8110	99	5	older	old	ADJ
aiua-8110	99	6	platelets	platelet	NOUN
aiua-8110	99	7	are	be	AUX
aiua-8110	99	8	being	be	AUX
aiua-8110	99	9	destroyed	destroy	VERB
aiua-8110	99	10	,	,	PUNCT
aiua-8110	99	11	so	so	CCONJ
aiua-8110	99	12	the	the	DET
aiua-8110	99	13	bone	bone	NOUN
aiua-8110	99	14	marrow	marrow	NOUN
aiua-8110	99	15	is	be	AUX
aiua-8110	99	16	trying	try	VERB
aiua-8110	99	17	to	to	PART
aiua-8110	99	18	compensate	compensate	VERB
aiua-8110	99	19	.	.	PUNCT
aiua-8110	100	1	increased	increase	VERB
aiua-8110	100	2	mpv	mpv	PROPN
aiua-8110	100	3	is	be	AUX
aiua-8110	100	4	associated	associate	VERB
aiua-8110	100	5	with	with	ADP
aiua-8110	100	6	platelet	platelet	NOUN
aiua-8110	100	7	activation	activation	NOUN
aiua-8110	100	8	,	,	PUNCT
aiua-8110	100	9	which	which	PRON
aiua-8110	100	10	can	can	AUX
aiua-8110	100	11	happen	happen	VERB
aiua-8110	100	12	when	when	SCONJ
aiua-8110	100	13	platelets	platelet	NOUN
aiua-8110	100	14	encounter	encounter	VERB
aiua-8110	100	15	tumor	tumor	NOUN
aiua-8110	100	16	byproducts	byproduct	NOUN
aiua-8110	100	17	.	.	PUNCT
aiua-8110	101	1	still	still	ADV
aiua-8110	101	2	,	,	PUNCT
aiua-8110	101	3	a	a	DET
aiua-8110	101	4	high	high	ADJ
aiua-8110	101	5	mpv	mpv	PROPN
aiua-8110	101	6	does	do	AUX
aiua-8110	101	7	n't	not	PART
aiua-8110	101	8	mean	mean	VERB
aiua-8110	101	9	you	you	PRON
aiua-8110	101	10	have	have	VERB
aiua-8110	101	11	cancer	cancer	NOUN
aiua-8110	101	12	.	.	PUNCT
aiua-8110	102	1	the	the	DET
aiua-8110	102	2	diagnostic	diagnostic	ADJ
aiua-8110	102	3	role	role	NOUN
aiua-8110	102	4	of	of	ADP
aiua-8110	102	5	mean	mean	ADJ
aiua-8110	102	6	platelet	platelet	NOUN
aiua-8110	102	7	volume	volume	NOUN
aiua-8110	102	8	(	(	PUNCT
aiua-8110	102	9	mpv	mpv	PROPN
aiua-8110	102	10	)	)	PUNCT
aiua-8110	102	11	is	be	AUX
aiua-8110	102	12	reported	report	VERB
aiua-8110	102	13	in	in	ADP
aiua-8110	102	14	various	various	ADJ
aiua-8110	102	15	malignant	malignant	ADJ
aiua-8110	102	16	tumors	tumor	NOUN
aiua-8110	102	17	such	such	ADJ
aiua-8110	102	18	as	as	ADP
aiua-8110	102	19	ovary	ovary	ADJ
aiua-8110	102	20	(	(	PUNCT
aiua-8110	102	21	23	23	NUM
aiua-8110	102	22	)	)	PUNCT
aiua-8110	102	23	,	,	PUNCT
aiua-8110	102	24	pancreas	pancrea	NOUN
aiua-8110	102	25	(	(	PUNCT
aiua-8110	102	26	24	24	NUM
aiua-8110	102	27	)	)	PUNCT
aiua-8110	102	28	,	,	PUNCT
aiua-8110	102	29	and	and	CCONJ
aiua-8110	102	30	colon	colon	NOUN
aiua-8110	102	31	(	(	PUNCT
aiua-8110	102	32	25	25	NUM
aiua-8110	102	33	)	)	PUNCT
aiua-8110	102	34	cancers	cancer	NOUN
aiua-8110	102	35	,	,	PUNCT
aiua-8110	102	36	the	the	DET
aiua-8110	102	37	diagnostic	diagnostic	ADJ
aiua-8110	102	38	and	and	CCONJ
aiua-8110	102	39	prognostic	prognostic	ADJ
aiua-8110	102	40	role	role	NOUN
aiua-8110	102	41	of	of	ADP
aiua-8110	102	42	mpv	mpv	PROPN
aiua-8110	102	43	can	can	AUX
aiua-8110	102	44	not	not	PART
aiua-8110	102	45	be	be	AUX
aiua-8110	102	46	precisely	precisely	ADV
aiua-8110	102	47	demonstrated	demonstrate	VERB
aiua-8110	102	48	for	for	ADP
aiua-8110	102	49	testicular	testicular	ADJ
aiua-8110	102	50	tumors	tumor	NOUN
aiua-8110	102	51	.	.	PUNCT
aiua-8110	103	1	in	in	ADP
aiua-8110	103	2	a	a	DET
aiua-8110	103	3	study	study	NOUN
aiua-8110	103	4	conducted	conduct	VERB
aiua-8110	103	5	by	by	ADP
aiua-8110	103	6	gokcen	gokcen	PROPN
aiua-8110	103	7	k	k	PROPN
aiua-8110	103	8	et	et	PROPN
aiua-8110	103	9	al	al	PROPN
aiua-8110	103	10	.	.	PROPN
aiua-8110	103	11	,	,	PUNCT
aiua-8110	103	12	36	36	NUM
aiua-8110	103	13	patients	patient	NOUN
aiua-8110	103	14	with	with	ADP
aiua-8110	103	15	testicular	testicular	ADJ
aiua-8110	103	16	tumors	tumor	NOUN
aiua-8110	103	17	were	be	AUX
aiua-8110	103	18	investigated	investigate	VERB
aiua-8110	103	19	.	.	PUNCT
aiua-8110	104	1	wbc	wbc	PROPN
aiua-8110	104	2	,	,	PUNCT
aiua-8110	104	3	neu	neu	PROPN
aiua-8110	104	4	,	,	PUNCT
aiua-8110	104	5	plr	plr	NOUN
aiua-8110	104	6	,	,	PUNCT
aiua-8110	104	7	and	and	CCONJ
aiua-8110	104	8	nlr	nlr	PROPN
aiua-8110	104	9	values	value	NOUN
aiua-8110	104	10	were	be	AUX
aiua-8110	104	11	significantly	significantly	ADV
aiua-8110	104	12	higher	high	ADJ
aiua-8110	104	13	in	in	ADP
aiua-8110	104	14	testicular	testicular	ADJ
aiua-8110	104	15	tumors	tumor	NOUN
aiua-8110	104	16	however	however	ADV
aiua-8110	104	17	mpv	mpv	PROPN
aiua-8110	104	18	was	be	AUX
aiua-8110	104	19	significantly	significantly	ADV
aiua-8110	104	20	lower	low	ADJ
aiua-8110	104	21	than	than	ADP
aiua-8110	104	22	the	the	DET
aiua-8110	104	23	control	control	NOUN
aiua-8110	104	24	group	group	NOUN
aiua-8110	104	25	p	p	X
aiua-8110	104	26	<	<	X
aiua-8110	104	27	0.05	0.05	NUM
aiua-8110	104	28	)	)	PUNCT
aiua-8110	104	29	.	.	PUNCT
aiua-8110	105	1	also	also	ADV
aiua-8110	105	2	differences	difference	NOUN
aiua-8110	105	3	between	between	ADP
aiua-8110	105	4	hematological	hematological	ADJ
aiua-8110	105	5	parameters	parameter	NOUN
aiua-8110	105	6	of	of	ADP
aiua-8110	105	7	patients	patient	NOUN
aiua-8110	105	8	with	with	ADP
aiua-8110	105	9	testicular	testicular	ADJ
aiua-8110	105	10	cancer	cancer	NOUN
aiua-8110	105	11	according	accord	VERB
aiua-8110	105	12	to	to	ADP
aiua-8110	105	13	the	the	DET
aiua-8110	105	14	stages	stage	NOUN
aiua-8110	105	15	were	be	AUX
aiua-8110	105	16	examined	examine	VERB
aiua-8110	105	17	,	,	PUNCT
aiua-8110	105	18	and	and	CCONJ
aiua-8110	105	19	differences	difference	NOUN
aiua-8110	105	20	were	be	AUX
aiua-8110	105	21	observed	observe	VERB
aiua-8110	105	22	between	between	ADP
aiua-8110	105	23	mean	mean	ADJ
aiua-8110	105	24	corpuscular	corpuscular	NOUN
aiua-8110	105	25	volume	volume	NOUN
aiua-8110	105	26	(	(	PUNCT
aiua-8110	105	27	mcv	mcv	PROPN
aiua-8110	105	28	)	)	PUNCT
aiua-8110	105	29	,	,	PUNCT
aiua-8110	105	30	mean	mean	VERB
aiua-8110	105	31	corpuscular	corpuscular	ADJ
aiua-8110	105	32	hemoglobin	hemoglobin	NOUN
aiua-8110	105	33	(	(	PUNCT
aiua-8110	105	34	mch	mch	PROPN
aiua-8110	105	35	)	)	PUNCT
aiua-8110	105	36	and	and	CCONJ
aiua-8110	105	37	mean	mean	VERB
aiua-8110	105	38	platlet	platlet	NOUN
aiua-8110	105	39	volume	volume	NOUN
aiua-8110	105	40	(	(	PUNCT
aiua-8110	105	41	mpv	mpv	PROPN
aiua-8110	105	42	)	)	PUNCT
aiua-8110	106	1	(	(	PUNCT
aiua-8110	106	2	p	p	X
aiua-8110	106	3	<	<	X
aiua-8110	106	4	0.05	0.05	NUM
aiua-8110	106	5	)	)	PUNCT
aiua-8110	106	6	.	.	PUNCT
aiua-8110	107	1	mcv	mcv	PROPN
aiua-8110	107	2	was	be	AUX
aiua-8110	107	3	significantly	significantly	ADV
aiua-8110	107	4	higher	high	ADJ
aiua-8110	107	5	in	in	ADP
aiua-8110	107	6	stage	stage	NOUN
aiua-8110	107	7	1	1	NUM
aiua-8110	107	8	compared	compare	VERB
aiua-8110	107	9	99archivio	99archivio	NUM
aiua-8110	107	10	italiano	italiano	PROPN
aiua-8110	107	11	di	di	X
aiua-8110	107	12	urologia	urologia	PROPN
aiua-8110	107	13	e	e	PROPN
aiua-8110	107	14	andrologia	andrologia	NOUN
aiua-8110	107	15	2019	2019	NUM
aiua-8110	107	16	;	;	PUNCT
aiua-8110	107	17	91	91	NUM
aiua-8110	107	18	,	,	PUNCT
aiua-8110	107	19	2	2	NUM
aiua-8110	107	20	increased	increase	VERB
aiua-8110	107	21	neutrophil	neutrophil	ADJ
aiua-8110	107	22	/	/	SYM
aiua-8110	107	23	lymphocyte	lymphocyte	ADJ
aiua-8110	107	24	ratio	ratio	NOUN
aiua-8110	107	25	in	in	ADP
aiua-8110	107	26	testicular	testicular	ADJ
aiua-8110	107	27	cancer	cancer	NOUN
aiua-8110	107	28	figure	figure	NOUN
aiua-8110	107	29	2	2	NUM
aiua-8110	107	30	.	.	PUNCT
aiua-8110	107	31	roc	roc	PROPN
aiua-8110	107	32	curve	curve	NOUN
aiua-8110	107	33	for	for	ADP
aiua-8110	107	34	nlr	nlr	PROPN
aiua-8110	107	35	in	in	ADP
aiua-8110	107	36	the	the	DET
aiua-8110	107	37	diagnosis	diagnosis	NOUN
aiua-8110	107	38	of	of	ADP
aiua-8110	107	39	testicular	testicular	ADJ
aiua-8110	107	40	tumor	tumor	NOUN
aiua-8110	107	41	.	.	PUNCT
aiua-8110	108	1	cut	cut	VERB
aiua-8110	108	2	off	off	ADP
aiua-8110	108	3	point	point	NOUN
aiua-8110	108	4	determination	determination	NOUN
aiua-8110	108	5	for	for	ADP
aiua-8110	108	6	nlr	nlr	PROPN
aiua-8110	108	7	in	in	ADP
aiua-8110	108	8	the	the	DET
aiua-8110	108	9	diagnosis	diagnosis	NOUN
aiua-8110	108	10	of	of	ADP
aiua-8110	108	11	testicular	testicular	ADJ
aiua-8110	108	12	tumors	tumor	NOUN
aiua-8110	108	13	.	.	PUNCT
aiua-8110	109	1	archivio	archivio	NOUN
aiua-8110	109	2	italiano	italiano	PROPN
aiua-8110	109	3	di	di	X
aiua-8110	109	4	urologia	urologia	PROPN
aiua-8110	109	5	e	e	PROPN
aiua-8110	109	6	andrologia	andrologia	NOUN
aiua-8110	109	7	2019	2019	NUM
aiua-8110	109	8	;	;	PUNCT
aiua-8110	109	9	91	91	NUM
aiua-8110	109	10	,	,	PUNCT
aiua-8110	109	11	2	2	NUM
aiua-8110	109	12	a.	a.	NOUN
aiua-8110	109	13	şahin	şahin	PROPN
aiua-8110	109	14	,	,	PUNCT
aiua-8110	109	15	t.	t.	PROPN
aiua-8110	109	16	toprak	toprak	PROPN
aiua-8110	109	17	,	,	PUNCT
aiua-8110	109	18	m.	m.	PROPN
aiua-8110	109	19	ali	ali	PROPN
aiua-8110	109	20	kutluhan	kutluhan	PROPN
aiua-8110	109	21	,	,	PUNCT
aiua-8110	109	22	yasin	yasin	PROPN
aiua-8110	109	23	vural	vural	PROPN
aiua-8110	109	24	,	,	PUNCT
aiua-8110	109	25	a.	a.	NOUN
aiua-8110	109	26	ürkmez	ürkmez	NOUN
aiua-8110	109	27	,	,	PUNCT
aiua-8110	109	28	a.	a.	PROPN
aiua-8110	109	29	verit	verit	PROPN
aiua-8110	109	30	100	100	NUM
aiua-8110	109	31	to	to	PART
aiua-8110	109	32	stage	stage	VERB
aiua-8110	109	33	2	2	NUM
aiua-8110	109	34	or	or	CCONJ
aiua-8110	109	35	3	3	NUM
aiua-8110	109	36	tumour	tumour	NOUN
aiua-8110	109	37	(	(	PUNCT
aiua-8110	109	38	p	p	NOUN
aiua-8110	109	39	=	=	NOUN
aiua-8110	109	40	0.035	0.035	NUM
aiua-8110	109	41	and	and	CCONJ
aiua-8110	109	42	p	p	NOUN
aiua-8110	109	43	=	=	PUNCT
aiua-8110	109	44	0.025	0.025	NUM
aiua-8110	109	45	,	,	PUNCT
aiua-8110	109	46	respectively	respectively	ADV
aiua-8110	109	47	)	)	PUNCT
aiua-8110	109	48	.	.	PUNCT
aiua-8110	110	1	mch	mch	PROPN
aiua-8110	110	2	was	be	AUX
aiua-8110	110	3	significantly	significantly	ADV
aiua-8110	110	4	higher	high	ADJ
aiua-8110	110	5	in	in	ADP
aiua-8110	110	6	stage	stage	NOUN
aiua-8110	110	7	1	1	NUM
aiua-8110	110	8	compared	compare	VERB
aiua-8110	110	9	to	to	ADP
aiua-8110	110	10	stage	stage	NOUN
aiua-8110	110	11	3	3	NUM
aiua-8110	110	12	(	(	PUNCT
aiua-8110	110	13	p	p	X
aiua-8110	110	14	=	=	NOUN
aiua-8110	110	15	0.022	0.022	NUM
aiua-8110	110	16	)	)	PUNCT
aiua-8110	110	17	.	.	PUNCT
aiua-8110	111	1	mpv	mpv	PROPN
aiua-8110	111	2	was	be	AUX
aiua-8110	111	3	significantly	significantly	ADV
aiua-8110	111	4	lower	low	ADJ
aiua-8110	111	5	in	in	ADP
aiua-8110	111	6	stage	stage	NOUN
aiua-8110	111	7	1	1	NUM
aiua-8110	111	8	compared	compare	VERB
aiua-8110	111	9	to	to	ADP
aiua-8110	111	10	stage	stage	NOUN
aiua-8110	111	11	3	3	NUM
aiua-8110	111	12	(	(	PUNCT
aiua-8110	111	13	p	p	X
aiua-8110	111	14	=	=	NOUN
aiua-8110	111	15	0.016	0.016	NUM
aiua-8110	111	16	)	)	PUNCT
aiua-8110	111	17	(	(	PUNCT
aiua-8110	111	18	26	26	NUM
aiua-8110	111	19	)	)	PUNCT
aiua-8110	111	20	.	.	PUNCT
aiua-8110	112	1	in	in	ADP
aiua-8110	112	2	our	our	PRON
aiua-8110	112	3	study	study	NOUN
aiua-8110	112	4	,	,	PUNCT
aiua-8110	112	5	the	the	DET
aiua-8110	112	6	neutrophil	neutrophil	ADJ
aiua-8110	112	7	/	/	SYM
aiua-8110	112	8	lymphocyte	lymphocyte	ADJ
aiua-8110	112	9	ratio	ratio	NOUN
aiua-8110	112	10	of	of	ADP
aiua-8110	112	11	the	the	DET
aiua-8110	112	12	tumor	tumor	NOUN
aiua-8110	112	13	group	group	NOUN
aiua-8110	112	14	was	be	AUX
aiua-8110	112	15	significantly	significantly	ADV
aiua-8110	112	16	higher	high	ADJ
aiua-8110	112	17	than	than	ADP
aiua-8110	112	18	the	the	DET
aiua-8110	112	19	varicocele	varicocele	NOUN
aiua-8110	112	20	group	group	NOUN
aiua-8110	112	21	(	(	PUNCT
aiua-8110	112	22	p	p	X
aiua-8110	112	23	=	=	NOUN
aiua-8110	112	24	0.001	0.001	NUM
aiua-8110	112	25	;	;	PUNCT
aiua-8110	112	26	p	p	X
aiua-8110	112	27	<	<	X
aiua-8110	112	28	0.05	0.05	NUM
aiua-8110	112	29	)	)	PUNCT
aiua-8110	112	30	,	,	PUNCT
aiua-8110	112	31	but	but	CCONJ
aiua-8110	112	32	there	there	PRON
aiua-8110	112	33	was	be	VERB
aiua-8110	112	34	no	no	DET
aiua-8110	112	35	statistically	statistically	ADV
aiua-8110	112	36	significant	significant	ADJ
aiua-8110	112	37	difference	difference	NOUN
aiua-8110	112	38	between	between	ADP
aiua-8110	112	39	the	the	DET
aiua-8110	112	40	groups	group	NOUN
aiua-8110	112	41	in	in	ADP
aiua-8110	112	42	terms	term	NOUN
aiua-8110	112	43	of	of	ADP
aiua-8110	112	44	plt	plt	NOUN
aiua-8110	112	45	/	/	SYM
aiua-8110	112	46	lymphocyte	lymphocyte	NOUN
aiua-8110	112	47	ratio	ratio	NOUN
aiua-8110	112	48	and	and	CCONJ
aiua-8110	112	49	mpv	mpv	PROPN
aiua-8110	112	50	levels	level	NOUN
aiua-8110	112	51	(	(	PUNCT
aiua-8110	112	52	p	p	X
aiua-8110	112	53	>	>	X
aiua-8110	112	54	0.05	0.05	NUM
aiua-8110	112	55	)	)	PUNCT
aiua-8110	112	56	.	.	PUNCT
aiua-8110	113	1	on	on	ADP
aiua-8110	113	2	the	the	DET
aiua-8110	113	3	other	other	ADJ
aiua-8110	113	4	hand	hand	NOUN
aiua-8110	113	5	we	we	PRON
aiua-8110	113	6	found	find	VERB
aiua-8110	113	7	that	that	SCONJ
aiua-8110	113	8	there	there	PRON
aiua-8110	113	9	was	be	VERB
aiua-8110	113	10	no	no	DET
aiua-8110	113	11	statistically	statistically	ADV
aiua-8110	113	12	significant	significant	ADJ
aiua-8110	113	13	difference	difference	NOUN
aiua-8110	113	14	between	between	ADP
aiua-8110	113	15	the	the	DET
aiua-8110	113	16	tumor	tumor	NOUN
aiua-8110	113	17	stages	stage	NOUN
aiua-8110	113	18	in	in	ADP
aiua-8110	113	19	terms	term	NOUN
aiua-8110	113	20	of	of	ADP
aiua-8110	113	21	neutrophil	neutrophil	ADJ
aiua-8110	113	22	/	/	SYM
aiua-8110	113	23	lymphocyte	lymphocyte	ADJ
aiua-8110	113	24	ratio	ratio	NOUN
aiua-8110	113	25	and	and	CCONJ
aiua-8110	113	26	mpv	mpv	PROPN
aiua-8110	113	27	levels	level	NOUN
aiua-8110	113	28	(	(	PUNCT
aiua-8110	113	29	p	p	X
aiua-8110	113	30	>	>	X
aiua-8110	113	31	0.05	0.05	NUM
aiua-8110	113	32	)	)	PUNCT
aiua-8110	113	33	.	.	PUNCT
aiua-8110	114	1	in	in	ADP
aiua-8110	114	2	contrast	contrast	NOUN
aiua-8110	114	3	,	,	PUNCT
aiua-8110	114	4	there	there	PRON
aiua-8110	114	5	was	be	VERB
aiua-8110	114	6	a	a	DET
aiua-8110	114	7	statistically	statistically	ADV
aiua-8110	114	8	significant	significant	ADJ
aiua-8110	114	9	difference	difference	NOUN
aiua-8110	114	10	in	in	ADP
aiua-8110	114	11	terms	term	NOUN
aiua-8110	114	12	of	of	ADP
aiua-8110	114	13	plt	plt	NOUN
aiua-8110	114	14	/	/	SYM
aiua-8110	114	15	lymphocyte	lymphocyte	ADJ
aiua-8110	114	16	ratios	ratio	NOUN
aiua-8110	114	17	(	(	PUNCT
aiua-8110	114	18	p	p	X
aiua-8110	114	19	:	:	PUNCT
aiua-8110	114	20	0.006	0.006	NUM
aiua-8110	114	21	;	;	PUNCT
aiua-8110	114	22	p	p	X
aiua-8110	114	23	<	<	X
aiua-8110	114	24	0.05	0.05	NUM
aiua-8110	114	25	)	)	PUNCT
aiua-8110	114	26	.	.	PUNCT
aiua-8110	115	1	as	as	ADP
aiua-8110	115	2	a	a	DET
aiua-8110	115	3	result	result	NOUN
aiua-8110	115	4	of	of	ADP
aiua-8110	115	5	paired	pair	VERB
aiua-8110	115	6	comparisons	comparison	NOUN
aiua-8110	115	7	plt	plt	NOUN
aiua-8110	115	8	/	/	SYM
aiua-8110	115	9	lymphocyte	lymphocyte	NOUN
aiua-8110	115	10	ratio	ratio	NOUN
aiua-8110	115	11	of	of	ADP
aiua-8110	115	12	pt3	pt3	NOUN
aiua-8110	115	13	group	group	NOUN
aiua-8110	115	14	was	be	AUX
aiua-8110	115	15	significantly	significantly	ADV
aiua-8110	115	16	higher	high	ADJ
aiua-8110	115	17	than	than	ADP
aiua-8110	115	18	pt1	pt1	PROPN
aiua-8110	115	19	and	and	CCONJ
aiua-8110	115	20	pt2	pt2	PROPN
aiua-8110	115	21	(	(	PUNCT
aiua-8110	115	22	p1	p1	PROPN
aiua-8110	115	23	:	:	PUNCT
aiua-8110	115	24	0.002	0.002	NUM
aiua-8110	115	25	;	;	PUNCT
aiua-8110	115	26	p2	p2	NOUN
aiua-8110	115	27	:	:	PUNCT
aiua-8110	115	28	0.003	0.003	NUM
aiua-8110	115	29	;	;	PUNCT
aiua-8110	115	30	p	p	X
aiua-8110	115	31	<	<	X
aiua-8110	115	32	0.05	0.05	NUM
aiua-8110	115	33	)	)	PUNCT
aiua-8110	115	34	.	.	PUNCT
aiua-8110	116	1	there	there	PRON
aiua-8110	116	2	was	be	VERB
aiua-8110	116	3	no	no	DET
aiua-8110	116	4	significant	significant	ADJ
aiua-8110	116	5	difference	difference	NOUN
aiua-8110	116	6	between	between	ADP
aiua-8110	116	7	pt1	pt1	PROPN
aiua-8110	116	8	and	and	CCONJ
aiua-8110	116	9	pt2	pt2	NOUN
aiua-8110	116	10	stages	stage	NOUN
aiua-8110	116	11	(	(	PUNCT
aiua-8110	116	12	p	p	X
aiua-8110	116	13	>	>	X
aiua-8110	116	14	0.05	0.05	NUM
aiua-8110	116	15	)	)	PUNCT
aiua-8110	116	16	.	.	PUNCT
aiua-8110	117	1	limited	limited	ADJ
aiua-8110	117	2	numbers	number	NOUN
aiua-8110	117	3	of	of	ADP
aiua-8110	117	4	reports	report	NOUN
aiua-8110	117	5	are	be	AUX
aiua-8110	117	6	available	available	ADJ
aiua-8110	117	7	on	on	ADP
aiua-8110	117	8	immune	immune	ADJ
aiua-8110	117	9	resistance	resistance	NOUN
aiua-8110	117	10	in	in	ADP
aiua-8110	117	11	patients	patient	NOUN
aiua-8110	117	12	with	with	ADP
aiua-8110	117	13	testicular	testicular	ADJ
aiua-8110	117	14	cancer	cancer	NOUN
aiua-8110	117	15	.	.	PUNCT
aiua-8110	118	1	considerable	considerable	ADJ
aiua-8110	118	2	evidence	evidence	NOUN
aiua-8110	118	3	supports	support	VERB
aiua-8110	118	4	the	the	DET
aiua-8110	118	5	view	view	NOUN
aiua-8110	118	6	that	that	SCONJ
aiua-8110	118	7	the	the	DET
aiua-8110	118	8	biological	biological	ADJ
aiua-8110	118	9	behavior	behavior	NOUN
aiua-8110	118	10	of	of	ADP
aiua-8110	118	11	tumors	tumor	NOUN
aiua-8110	118	12	and	and	CCONJ
aiua-8110	118	13	in	in	ADP
aiua-8110	118	14	particular	particular	ADJ
aiua-8110	118	15	,	,	PUNCT
aiua-8110	118	16	their	their	PRON
aiua-8110	118	17	capacity	capacity	NOUN
aiua-8110	118	18	to	to	PART
aiua-8110	118	19	metastasize	metastasize	VERB
aiua-8110	118	20	are	be	AUX
aiua-8110	118	21	in	in	ADP
aiua-8110	118	22	part	part	NOUN
aiua-8110	118	23	determined	determine	VERB
aiua-8110	118	24	by	by	ADP
aiua-8110	118	25	immunological	immunological	ADJ
aiua-8110	118	26	factors	factor	NOUN
aiua-8110	118	27	requiring	require	VERB
aiua-8110	118	28	participation	participation	NOUN
aiua-8110	118	29	of	of	ADP
aiua-8110	118	30	t	t	PROPN
aiua-8110	118	31	lymphocytes	lymphocyte	NOUN
aiua-8110	118	32	,	,	PUNCT
aiua-8110	118	33	b	b	NOUN
aiua-8110	118	34	lymphocytes	lymphocyte	NOUN
aiua-8110	118	35	,	,	PUNCT
aiua-8110	118	36	macrophages	macrophage	NOUN
aiua-8110	118	37	and	and	CCONJ
aiua-8110	118	38	natural	natural	ADJ
aiua-8110	118	39	killer	killer	NOUN
aiua-8110	118	40	cells	cell	NOUN
aiua-8110	118	41	.	.	PUNCT
aiua-8110	119	1	immunological	immunological	ADJ
aiua-8110	119	2	reactivity	reactivity	NOUN
aiua-8110	119	3	has	have	AUX
aiua-8110	119	4	been	be	AUX
aiua-8110	119	5	analyzed	analyze	VERB
aiua-8110	119	6	in	in	ADP
aiua-8110	119	7	a	a	DET
aiua-8110	119	8	wide	wide	ADJ
aiua-8110	119	9	spectrum	spectrum	NOUN
aiua-8110	119	10	of	of	ADP
aiua-8110	119	11	solid	solid	ADJ
aiua-8110	119	12	tumors	tumor	NOUN
aiua-8110	119	13	and	and	CCONJ
aiua-8110	119	14	a	a	DET
aiua-8110	119	15	vast	vast	ADJ
aiua-8110	119	16	literature	literature	NOUN
aiua-8110	119	17	indicates	indicate	VERB
aiua-8110	119	18	a	a	DET
aiua-8110	119	19	correlation	correlation	NOUN
aiua-8110	119	20	between	between	ADP
aiua-8110	119	21	depressed	depressed	ADJ
aiua-8110	119	22	cell	cell	NOUN
aiua-8110	119	23	-	-	PUNCT
aiua-8110	119	24	mediated	mediate	VERB
aiua-8110	119	25	immunity	immunity	NOUN
aiua-8110	119	26	and	and	CCONJ
aiua-8110	119	27	the	the	DET
aiua-8110	119	28	stage	stage	NOUN
aiua-8110	119	29	of	of	ADP
aiua-8110	119	30	the	the	DET
aiua-8110	119	31	disease	disease	NOUN
aiua-8110	119	32	.	.	PUNCT
aiua-8110	120	1	on	on	ADP
aiua-8110	120	2	the	the	DET
aiua-8110	120	3	contrary	contrary	NOUN
aiua-8110	120	4	,	,	PUNCT
aiua-8110	120	5	there	there	PRON
aiua-8110	120	6	is	be	VERB
aiua-8110	120	7	little	little	ADJ
aiua-8110	120	8	evidence	evidence	NOUN
aiua-8110	120	9	about	about	ADP
aiua-8110	120	10	the	the	DET
aiua-8110	120	11	role	role	NOUN
aiua-8110	120	12	of	of	ADP
aiua-8110	120	13	immunological	immunological	ADJ
aiua-8110	120	14	factors	factor	NOUN
aiua-8110	120	15	in	in	ADP
aiua-8110	120	16	the	the	DET
aiua-8110	120	17	development	development	NOUN
aiua-8110	120	18	and	and	CCONJ
aiua-8110	120	19	spread	spread	VERB
aiua-8110	120	20	of	of	ADP
aiua-8110	120	21	testicular	testicular	ADJ
aiua-8110	120	22	tumors	tumor	NOUN
aiua-8110	120	23	.	.	PUNCT
aiua-8110	121	1	conclusions	conclusion	NOUN
aiua-8110	121	2	in	in	ADP
aiua-8110	121	3	this	this	DET
aiua-8110	121	4	study	study	NOUN
aiua-8110	121	5	,	,	PUNCT
aiua-8110	121	6	there	there	PRON
aiua-8110	121	7	was	be	VERB
aiua-8110	121	8	only	only	ADV
aiua-8110	121	9	statistically	statistically	ADV
aiua-8110	121	10	significant	significant	ADJ
aiua-8110	121	11	increase	increase	NOUN
aiua-8110	121	12	in	in	ADP
aiua-8110	121	13	nlr	nlr	PROPN
aiua-8110	121	14	values	value	NOUN
aiua-8110	121	15	in	in	ADP
aiua-8110	121	16	the	the	DET
aiua-8110	121	17	testicular	testicular	ADJ
aiua-8110	121	18	tumor	tumor	NOUN
aiua-8110	121	19	group	group	NOUN
aiua-8110	121	20	compared	compare	VERB
aiua-8110	121	21	to	to	ADP
aiua-8110	121	22	the	the	DET
aiua-8110	121	23	varicocele	varicocele	PROPN
aiua-8110	121	24	group	group	NOUN
aiua-8110	121	25	.	.	PUNCT
aiua-8110	122	1	there	there	PRON
aiua-8110	122	2	was	be	VERB
aiua-8110	122	3	no	no	DET
aiua-8110	122	4	statistically	statistically	ADV
aiua-8110	122	5	significant	significant	ADJ
aiua-8110	122	6	result	result	NOUN
aiua-8110	122	7	for	for	ADP
aiua-8110	122	8	mpv	mpv	PROPN
aiua-8110	122	9	and	and	CCONJ
aiua-8110	122	10	plr	plr	PROPN
aiua-8110	122	11	.	.	PUNCT
aiua-8110	123	1	in	in	ADP
aiua-8110	123	2	the	the	DET
aiua-8110	123	3	evaluation	evaluation	NOUN
aiua-8110	123	4	of	of	ADP
aiua-8110	123	5	patients	patient	NOUN
aiua-8110	123	6	with	with	ADP
aiua-8110	123	7	testicular	testicular	ADJ
aiua-8110	123	8	tumors	tumor	NOUN
aiua-8110	123	9	according	accord	VERB
aiua-8110	123	10	to	to	ADP
aiua-8110	123	11	their	their	PRON
aiua-8110	123	12	stages	stage	NOUN
aiua-8110	123	13	,	,	PUNCT
aiua-8110	123	14	the	the	DET
aiua-8110	123	15	plt	plt	NOUN
aiua-8110	123	16	/	/	SYM
aiua-8110	123	17	lymphocyte	lymphocyte	NOUN
aiua-8110	123	18	ratio	ratio	NOUN
aiua-8110	123	19	of	of	ADP
aiua-8110	123	20	the	the	DET
aiua-8110	123	21	pt3	pt3	NOUN
aiua-8110	123	22	group	group	NOUN
aiua-8110	123	23	was	be	AUX
aiua-8110	123	24	found	find	VERB
aiua-8110	123	25	to	to	PART
aiua-8110	123	26	be	be	AUX
aiua-8110	123	27	significantly	significantly	ADV
aiua-8110	123	28	higher	high	ADJ
aiua-8110	123	29	than	than	ADP
aiua-8110	123	30	the	the	DET
aiua-8110	123	31	pt1	pt1	PROPN
aiua-8110	123	32	and	and	CCONJ
aiua-8110	123	33	pt2	pt2	NOUN
aiua-8110	123	34	stages	stage	NOUN
aiua-8110	123	35	.	.	PUNCT
aiua-8110	124	1	although	although	SCONJ
aiua-8110	124	2	there	there	PRON
aiua-8110	124	3	are	be	VERB
aiua-8110	124	4	many	many	ADJ
aiua-8110	124	5	studies	study	NOUN
aiua-8110	124	6	on	on	ADP
aiua-8110	124	7	hematological	hematological	ADJ
aiua-8110	124	8	parameters	parameter	NOUN
aiua-8110	124	9	related	relate	VERB
aiua-8110	124	10	to	to	ADP
aiua-8110	124	11	other	other	ADJ
aiua-8110	124	12	cancers	cancer	NOUN
aiua-8110	124	13	,	,	PUNCT
aiua-8110	124	14	there	there	PRON
aiua-8110	124	15	is	be	VERB
aiua-8110	124	16	limited	limited	ADJ
aiua-8110	124	17	data	datum	NOUN
aiua-8110	124	18	for	for	ADP
aiua-8110	124	19	testicular	testicular	ADJ
aiua-8110	124	20	tumors	tumor	NOUN
aiua-8110	124	21	in	in	ADP
aiua-8110	124	22	the	the	DET
aiua-8110	124	23	literature	literature	NOUN
aiua-8110	124	24	.	.	PUNCT
aiua-8110	125	1	the	the	DET
aiua-8110	125	2	limitations	limitation	NOUN
aiua-8110	125	3	of	of	ADP
aiua-8110	125	4	our	our	PRON
aiua-8110	125	5	study	study	NOUN
aiua-8110	125	6	were	be	AUX
aiua-8110	125	7	that	that	SCONJ
aiua-8110	125	8	it	it	PRON
aiua-8110	125	9	was	be	AUX
aiua-8110	125	10	a	a	DET
aiua-8110	125	11	retrospective	retrospective	ADJ
aiua-8110	125	12	one	one	NOUN
aiua-8110	125	13	with	with	ADP
aiua-8110	125	14	limited	limited	ADJ
aiua-8110	125	15	study	study	NOUN
aiua-8110	125	16	group	group	NOUN
aiua-8110	125	17	and	and	CCONJ
aiua-8110	125	18	had	have	VERB
aiua-8110	125	19	not	not	PART
aiua-8110	125	20	a	a	DET
aiua-8110	125	21	prognostic	prognostic	ADJ
aiua-8110	125	22	predictive	predictive	ADJ
aiua-8110	125	23	design	design	NOUN
aiua-8110	125	24	.	.	PUNCT
aiua-8110	126	1	larger	large	ADJ
aiua-8110	126	2	,	,	PUNCT
aiua-8110	126	3	randomized	randomize	VERB
aiua-8110	126	4	controlled	control	VERB
aiua-8110	126	5	studies	study	NOUN
aiua-8110	126	6	are	be	AUX
aiua-8110	126	7	needed	need	VERB
aiua-8110	126	8	at	at	ADP
aiua-8110	126	9	this	this	DET
aiua-8110	126	10	field	field	NOUN
aiua-8110	126	11	.	.	PUNCT
aiua-8110	127	1	references	reference	NOUN
aiua-8110	127	2	1	1	NUM
aiua-8110	127	3	.	.	PUNCT
aiua-8110	127	4	borghesi	borghesi	PROPN
aiua-8110	127	5	m	m	PROPN
aiua-8110	127	6	,	,	PUNCT
aiua-8110	127	7	brunocilla	brunocilla	PROPN
aiua-8110	127	8	e	e	NOUN
aiua-8110	127	9	,	,	PUNCT
aiua-8110	127	10	schiavina	schiavina	ADJ
aiua-8110	127	11	r	r	NOUN
aiua-8110	127	12	,	,	PUNCT
aiua-8110	127	13	et	et	PROPN
aiua-8110	127	14	al	al	PROPN
aiua-8110	127	15	.	.	PUNCT
aiua-8110	128	1	role	role	NOUN
aiua-8110	128	2	of	of	ADP
aiua-8110	128	3	testis	testis	NOUN
aiua-8110	128	4	sparing	spare	VERB
aiua-8110	128	5	surgery	surgery	NOUN
aiua-8110	128	6	in	in	ADP
aiua-8110	128	7	the	the	DET
aiua-8110	128	8	conservative	conservative	ADJ
aiua-8110	128	9	management	management	NOUN
aiua-8110	128	10	of	of	ADP
aiua-8110	128	11	small	small	ADJ
aiua-8110	128	12	testicular	testicular	ADJ
aiua-8110	128	13	masses	masse	NOUN
aiua-8110	128	14	:	:	PUNCT
aiua-8110	128	15	oncological	oncological	ADJ
aiua-8110	128	16	and	and	CCONJ
aiua-8110	128	17	functional	functional	ADJ
aiua-8110	128	18	perspectives	perspective	NOUN
aiua-8110	128	19	.	.	PUNCT
aiua-8110	129	1	actas	actas	VERB
aiua-8110	129	2	urol	urol	PROPN
aiua-8110	129	3	esp	esp	PROPN
aiua-8110	129	4	.	.	PUNCT
aiua-8110	130	1	2015	2015	NUM
aiua-8110	130	2	;	;	PUNCT
aiua-8110	130	3	39:57	39:57	NUM
aiua-8110	130	4	-	-	SYM
aiua-8110	130	5	62	62	NUM
aiua-8110	130	6	.	.	PUNCT
aiua-8110	131	1	2	2	NUM
aiua-8110	131	2	.	.	X
aiua-8110	131	3	gregory	gregory	PROPN
aiua-8110	131	4	ad	ad	PROPN
aiua-8110	131	5	,	,	PUNCT
aiua-8110	131	6	houghton	houghton	PROPN
aiua-8110	131	7	am	am	NOUN
aiua-8110	131	8	.	.	PUNCT
aiua-8110	132	1	tumor	tumor	NOUN
aiua-8110	132	2	associated	associate	VERB
aiua-8110	132	3	neutrophils	neutrophil	NOUN
aiua-8110	132	4	:	:	PUNCT
aiua-8110	132	5	new	new	ADJ
aiua-8110	132	6	targets	target	NOUN
aiua-8110	132	7	for	for	ADP
aiua-8110	132	8	cancer	cancer	NOUN
aiua-8110	132	9	therapy	therapy	NOUN
aiua-8110	132	10	.	.	PUNCT
aiua-8110	133	1	cancer	cancer	NOUN
aiua-8110	133	2	res	re	NOUN
aiua-8110	133	3	.	.	PUNCT
aiua-8110	133	4	2011	2011	NUM
aiua-8110	133	5	;	;	PUNCT
aiua-8110	133	6	71:24116	71:24116	X
aiua-8110	133	7	.	.	X
aiua-8110	134	1	3	3	X
aiua-8110	134	2	.	.	X
aiua-8110	134	3	grivennikov	grivennikov	PROPN
aiua-8110	134	4	si	si	PROPN
aiua-8110	134	5	,	,	PUNCT
aiua-8110	134	6	greten	greten	ADJ
aiua-8110	134	7	fr	fr	PROPN
aiua-8110	134	8	,	,	PUNCT
aiua-8110	134	9	karin	karin	PROPN
aiua-8110	134	10	m.	m.	PROPN
aiua-8110	134	11	immunity	immunity	NOUN
aiua-8110	134	12	,	,	PUNCT
aiua-8110	134	13	inflammation	inflammation	NOUN
aiua-8110	134	14	,	,	PUNCT
aiua-8110	134	15	and	and	CCONJ
aiua-8110	134	16	cancer	cancer	NOUN
aiua-8110	134	17	.	.	PUNCT
aiua-8110	135	1	cell	cell	NOUN
aiua-8110	135	2	2010	2010	NUM
aiua-8110	135	3	;	;	PUNCT
aiua-8110	135	4	140:88399	140:88399	NUM
aiua-8110	135	5	.	.	PUNCT
aiua-8110	136	1	4	4	NUM
aiua-8110	136	2	.	.	X
aiua-8110	136	3	duan	duan	PROPN
aiua-8110	136	4	h	h	PROPN
aiua-8110	136	5	,	,	PUNCT
aiua-8110	136	6	zhang	zhang	PROPN
aiua-8110	136	7	x	x	PROPN
aiua-8110	136	8	,	,	PUNCT
aiua-8110	136	9	wang	wang	PROPN
aiua-8110	136	10	fx	fx	PROPN
aiua-8110	136	11	,	,	PUNCT
aiua-8110	136	12	et	et	PROPN
aiua-8110	136	13	al	al	PROPN
aiua-8110	136	14	.	.	PUNCT
aiua-8110	136	15	prognostic	prognostic	ADJ
aiua-8110	136	16	role	role	NOUN
aiua-8110	136	17	of	of	ADP
aiua-8110	136	18	neutrophil	neutrophil	ADJ
aiua-8110	136	19	lymphocyte	lymphocyte	ADJ
aiua-8110	136	20	ratio	ratio	NOUN
aiua-8110	136	21	in	in	ADP
aiua-8110	136	22	operable	operable	ADJ
aiua-8110	136	23	esophageal	esophageal	ADJ
aiua-8110	136	24	squamous	squamous	ADJ
aiua-8110	136	25	cell	cell	NOUN
aiua-8110	136	26	carcinoma	carcinoma	NOUN
aiua-8110	136	27	.	.	PUNCT
aiua-8110	137	1	world	world	PROPN
aiua-8110	137	2	j	j	PROPN
aiua-8110	137	3	gastroenterol	gastroenterol	PROPN
aiua-8110	137	4	.	.	PUNCT
aiua-8110	138	1	2015	2015	NUM
aiua-8110	138	2	;	;	PUNCT
aiua-8110	138	3	21:55917	21:55917	X
aiua-8110	138	4	.	.	NOUN
aiua-8110	139	1	5	5	NUM
aiua-8110	139	2	.	.	X
aiua-8110	139	3	viers	vier	NOUN
aiua-8110	139	4	br	br	PROPN
aiua-8110	139	5	,	,	PUNCT
aiua-8110	139	6	boorjian	boorjian	PROPN
aiua-8110	139	7	sa	sa	PROPN
aiua-8110	139	8	,	,	PUNCT
aiua-8110	139	9	frank	frank	PROPN
aiua-8110	139	10	i	i	PROPN
aiua-8110	139	11	,	,	PUNCT
aiua-8110	139	12	et	et	PROPN
aiua-8110	139	13	al	al	PROPN
aiua-8110	139	14	.	.	PUNCT
aiua-8110	140	1	pretreatment	pretreatment	NOUN
aiua-8110	140	2	neutrophil	neutrophil	NOUN
aiua-8110	140	3	to	to	ADP
aiua-8110	140	4	lymphocyte	lymphocyte	ADJ
aiua-8110	140	5	ratio	ratio	NOUN
aiua-8110	140	6	is	be	AUX
aiua-8110	140	7	associated	associate	VERB
aiua-8110	140	8	with	with	ADP
aiua-8110	140	9	advanced	advanced	ADJ
aiua-8110	140	10	pathologic	pathologic	ADJ
aiua-8110	140	11	tumor	tumor	NOUN
aiua-8110	140	12	stage	stage	NOUN
aiua-8110	140	13	and	and	CCONJ
aiua-8110	140	14	increased	increase	VERB
aiua-8110	140	15	cancer	cancer	NOUN
aiua-8110	140	16	specific	specific	ADJ
aiua-8110	140	17	mortality	mortality	NOUN
aiua-8110	140	18	among	among	ADP
aiua-8110	140	19	patients	patient	NOUN
aiua-8110	140	20	with	with	ADP
aiua-8110	140	21	urothelial	urothelial	ADJ
aiua-8110	140	22	carcinoma	carcinoma	NOUN
aiua-8110	140	23	of	of	ADP
aiua-8110	140	24	the	the	DET
aiua-8110	140	25	bladder	bladder	NOUN
aiua-8110	140	26	undergoing	undergo	VERB
aiua-8110	140	27	radical	radical	ADJ
aiua-8110	140	28	cystectomy	cystectomy	NOUN
aiua-8110	140	29	.	.	PUNCT
aiua-8110	141	1	eur	eur	PROPN
aiua-8110	141	2	urol	urol	PROPN
aiua-8110	141	3	.	.	PUNCT
aiua-8110	142	1	2014	2014	NUM
aiua-8110	142	2	;	;	PUNCT
aiua-8110	143	1	66:115764	66:115764	NUM
aiua-8110	143	2	.	.	PUNCT
aiua-8110	144	1	6	6	X
aiua-8110	144	2	.	.	X
aiua-8110	144	3	templeton	templeton	PROPN
aiua-8110	144	4	aj	aj	PROPN
aiua-8110	144	5	,	,	PUNCT
aiua-8110	144	6	mcnamara	mcnamara	PROPN
aiua-8110	144	7	mg	mg	PROPN
aiua-8110	144	8	,	,	PUNCT
aiua-8110	144	9	šeruga	šeruga	PROPN
aiua-8110	144	10	b	b	PROPN
aiua-8110	144	11	,	,	PUNCT
aiua-8110	144	12	et	et	PROPN
aiua-8110	144	13	al	al	PROPN
aiua-8110	144	14	.	.	PUNCT
aiua-8110	145	1	prognostic	prognostic	ADJ
aiua-8110	145	2	role	role	NOUN
aiua-8110	145	3	of	of	ADP
aiua-8110	145	4	neutrophil	neutrophil	NOUN
aiua-8110	145	5	to	to	ADP
aiua-8110	145	6	lymphocyte	lymphocyte	ADJ
aiua-8110	145	7	ratio	ratio	NOUN
aiua-8110	145	8	in	in	ADP
aiua-8110	145	9	solid	solid	ADJ
aiua-8110	145	10	tumors	tumor	NOUN
aiua-8110	145	11	:	:	PUNCT
aiua-8110	145	12	a	a	DET
aiua-8110	145	13	systematic	systematic	ADJ
aiua-8110	145	14	review	review	NOUN
aiua-8110	145	15	and	and	CCONJ
aiua-8110	145	16	metaanalysis	metaanalysis	NOUN
aiua-8110	145	17	.	.	PUNCT
aiua-8110	146	1	j	j	PROPN
aiua-8110	146	2	natl	natl	PROPN
aiua-8110	146	3	cancer	cancer	PROPN
aiua-8110	146	4	inst	inst	PROPN
aiua-8110	146	5	.	.	PUNCT
aiua-8110	146	6	2014	2014	NUM
aiua-8110	146	7	;	;	PUNCT
aiua-8110	146	8	106	106	NUM
aiua-8110	146	9	:	:	PUNCT
aiua-8110	146	10	dju124	dju124	NOUN
aiua-8110	146	11	.	.	PUNCT
aiua-8110	147	1	7	7	X
aiua-8110	147	2	.	.	X
aiua-8110	147	3	lee	lee	PROPN
aiua-8110	147	4	js	js	PROPN
aiua-8110	147	5	,	,	PUNCT
aiua-8110	147	6	kim	kim	PROPN
aiua-8110	147	7	ny	ny	PROPN
aiua-8110	147	8	,	,	PUNCT
aiua-8110	147	9	na	na	PROPN
aiua-8110	147	10	sh	sh	PROPN
aiua-8110	147	11	,	,	PUNCT
aiua-8110	147	12	et	et	PROPN
aiua-8110	147	13	al	al	PROPN
aiua-8110	147	14	.	.	PROPN
aiua-8110	148	1	reference	reference	NOUN
aiua-8110	148	2	values	value	NOUN
aiua-8110	148	3	of	of	ADP
aiua-8110	148	4	neutrophil	neutrophil	ADJ
aiua-8110	148	5	-	-	PUNCT
aiua-8110	148	6	lymphocyte	lymphocyte	NOUN
aiua-8110	148	7	ratio	ratio	NOUN
aiua-8110	148	8	,	,	PUNCT
aiua-8110	148	9	lymphocyte	lymphocyte	ADJ
aiua-8110	148	10	-	-	PUNCT
aiua-8110	148	11	monocyte	monocyte	NOUN
aiua-8110	148	12	ratio	ratio	NOUN
aiua-8110	148	13	,	,	PUNCT
aiua-8110	148	14	platelet	platelet	ADJ
aiua-8110	148	15	-	-	PUNCT
aiua-8110	148	16	lymphocyte	lymphocyte	ADJ
aiua-8110	148	17	ratio	ratio	NOUN
aiua-8110	148	18	,	,	PUNCT
aiua-8110	148	19	and	and	CCONJ
aiua-8110	148	20	mean	mean	VERB
aiua-8110	148	21	platelet	platelet	NOUN
aiua-8110	148	22	volume	volume	NOUN
aiua-8110	148	23	in	in	ADP
aiua-8110	148	24	healthy	healthy	ADJ
aiua-8110	148	25	adults	adult	NOUN
aiua-8110	148	26	in	in	ADP
aiua-8110	148	27	south	south	PROPN
aiua-8110	148	28	korea	korea	PROPN
aiua-8110	148	29	.	.	PUNCT
aiua-8110	149	1	medicine	medicine	NOUN
aiua-8110	149	2	(	(	PUNCT
aiua-8110	149	3	baltimore	baltimore	PROPN
aiua-8110	149	4	)	)	PUNCT
aiua-8110	149	5	2018	2018	NUM
aiua-8110	149	6	;	;	PUNCT
aiua-8110	149	7	97	97	NUM
aiua-8110	149	8	:	:	PUNCT
aiua-8110	149	9	e11138	e11138	NUM
aiua-8110	149	10	.	.	NOUN
aiua-8110	149	11	8	8	NUM
aiua-8110	149	12	.	.	X
aiua-8110	149	13	goubran	goubran	PROPN
aiua-8110	149	14	ha	ha	INTJ
aiua-8110	149	15	,	,	PUNCT
aiua-8110	149	16	stakiw	stakiw	PROPN
aiua-8110	149	17	j	j	PROPN
aiua-8110	149	18	,	,	PUNCT
aiua-8110	149	19	radosevic	radosevic	PROPN
aiua-8110	149	20	m	m	PROPN
aiua-8110	149	21	,	,	PUNCT
aiua-8110	149	22	et	et	PROPN
aiua-8110	149	23	al	al	PROPN
aiua-8110	149	24	.	.	PUNCT
aiua-8110	150	1	platelet	platelet	NOUN
aiua-8110	150	2	-	-	PUNCT
aiua-8110	150	3	cancerinteractions	cancerinteraction	NOUN
aiua-8110	150	4	.	.	PUNCT
aiua-8110	151	1	semin	semin	PROPN
aiua-8110	151	2	thrombhemost	thrombhemost	PROPN
aiua-8110	151	3	.	.	PUNCT
aiua-8110	152	1	2014	2014	NUM
aiua-8110	152	2	;	;	PUNCT
aiua-8110	152	3	40:296	40:296	NUM
aiua-8110	152	4	-	-	SYM
aiua-8110	152	5	305	305	NUM
aiua-8110	152	6	.	.	PUNCT
aiua-8110	153	1	9	9	NUM
aiua-8110	153	2	.	.	X
aiua-8110	153	3	yun	yun	PROPN
aiua-8110	153	4	zy	zy	PROPN
aiua-8110	153	5	,	,	PUNCT
aiua-8110	153	6	zhang	zhang	PROPN
aiua-8110	153	7	x	x	PROPN
aiua-8110	153	8	,	,	PUNCT
aiua-8110	153	9	liu	liu	PROPN
aiua-8110	153	10	zp	zp	PROPN
aiua-8110	153	11	,	,	PUNCT
aiua-8110	153	12	et	et	PROPN
aiua-8110	153	13	al	al	PROPN
aiua-8110	153	14	.	.	PROPN
aiua-8110	153	15	association	association	PROPN
aiua-8110	153	16	of	of	ADP
aiua-8110	153	17	decreased	decrease	VERB
aiua-8110	153	18	mean	mean	ADJ
aiua-8110	153	19	platelet	platelet	NOUN
aiua-8110	153	20	volume	volume	NOUN
aiua-8110	153	21	with	with	ADP
aiua-8110	153	22	renal	renal	ADJ
aiua-8110	153	23	cell	cell	NOUN
aiua-8110	153	24	carcinoma	carcinoma	NOUN
aiua-8110	153	25	.	.	PUNCT
aiua-8110	154	1	int	int	PROPN
aiua-8110	155	1	j	j	PROPN
aiua-8110	155	2	clin	clin	PROPN
aiua-8110	155	3	oncol	oncol	PROPN
aiua-8110	155	4	.	.	PUNCT
aiua-8110	156	1	2017	2017	NUM
aiua-8110	156	2	;	;	PUNCT
aiua-8110	156	3	22;1076	22;1076	NUM
aiua-8110	156	4	-	-	SYM
aiua-8110	156	5	1080	1080	NUM
aiua-8110	156	6	.	.	PUNCT
aiua-8110	157	1	10	10	NUM
aiua-8110	157	2	.	.	PUNCT
aiua-8110	157	3	gasparyan	gasparyan	PROPN
aiua-8110	157	4	ay	ay	PROPN
aiua-8110	157	5	,	,	PUNCT
aiua-8110	157	6	ayvazyan	ayvazyan	PROPN
aiua-8110	157	7	l	l	PROPN
aiua-8110	157	8	,	,	PUNCT
aiua-8110	157	9	mikhailidis	mikhailidis	ADJ
aiua-8110	157	10	dp	dp	NOUN
aiua-8110	157	11	,	,	PUNCT
aiua-8110	157	12	et	et	PROPN
aiua-8110	157	13	al.meanplateletvolume	al.meanplateletvolume	VERB
aiua-8110	157	14	:	:	PUNCT
aiua-8110	157	15	a	a	DET
aiua-8110	157	16	link	link	NOUN
aiua-8110	157	17	between	between	ADP
aiua-8110	157	18	thrombosis	thrombosis	NOUN
aiua-8110	157	19	and	and	CCONJ
aiua-8110	157	20	inflammation	inflammation	NOUN
aiua-8110	157	21	.	.	PUNCT
aiua-8110	158	1	curr	curr	PROPN
aiua-8110	158	2	pharm	pharm	PROPN
aiua-8110	158	3	des	des	PROPN
aiua-8110	158	4	.	.	PROPN
aiua-8110	158	5	2011	2011	NUM
aiua-8110	158	6	;	;	PUNCT
aiua-8110	158	7	17:47	17:47	NUM
aiua-8110	158	8	-	-	SYM
aiua-8110	158	9	58	58	NUM
aiua-8110	158	10	.	.	PUNCT
aiua-8110	159	1	11	11	NUM
aiua-8110	159	2	.	.	PUNCT
aiua-8110	160	1	balkwill	balkwill	PROPN
aiua-8110	160	2	f	f	PROPN
aiua-8110	160	3	,	,	PUNCT
aiua-8110	160	4	mantovani	mantovani	PROPN
aiua-8110	160	5	a.	a.	NOUN
aiua-8110	160	6	inflammation	inflammation	NOUN
aiua-8110	160	7	and	and	CCONJ
aiua-8110	160	8	cancer	cancer	NOUN
aiua-8110	160	9	:	:	PUNCT
aiua-8110	160	10	back	back	ADV
aiua-8110	160	11	to	to	ADP
aiua-8110	160	12	virchow	virchow	NOUN
aiua-8110	160	13	?	?	PUNCT
aiua-8110	161	1	lancet	lancet	PROPN
aiua-8110	161	2	.	.	PUNCT
aiua-8110	162	1	2001	2001	NUM
aiua-8110	162	2	;	;	PUNCT
aiua-8110	163	1	357:539	357:539	X
aiua-8110	163	2	-	-	SYM
aiua-8110	163	3	545	545	NUM
aiua-8110	163	4	.	.	PUNCT
aiua-8110	163	5	12	12	NUM
aiua-8110	163	6	.	.	PUNCT
aiua-8110	163	7	tamhane	tamhane	NOUN
aiua-8110	163	8	uu	uu	PROPN
aiua-8110	163	9	,	,	PUNCT
aiua-8110	163	10	aneja	aneja	PROPN
aiua-8110	163	11	s	s	PROPN
aiua-8110	163	12	,	,	PUNCT
aiua-8110	163	13	montgomery	montgomery	PROPN
aiua-8110	163	14	d	d	PROPN
aiua-8110	163	15	,	,	PUNCT
aiua-8110	163	16	et	et	PROPN
aiua-8110	163	17	al	al	PROPN
aiua-8110	163	18	.	.	PROPN
aiua-8110	163	19	association	association	PROPN
aiua-8110	163	20	between	between	ADP
aiua-8110	163	21	admission	admission	NOUN
aiua-8110	163	22	neutrophil	neutrophil	ADJ
aiua-8110	163	23	to	to	ADP
aiua-8110	163	24	lymphocyte	lymphocyte	ADJ
aiua-8110	163	25	ratio	ratio	NOUN
aiua-8110	163	26	and	and	CCONJ
aiua-8110	163	27	outcomes	outcome	NOUN
aiua-8110	163	28	in	in	ADP
aiua-8110	163	29	patients	patient	NOUN
aiua-8110	163	30	with	with	ADP
aiua-8110	163	31	acute	acute	ADJ
aiua-8110	163	32	coronary	coronary	ADJ
aiua-8110	163	33	syndrome	syndrome	NOUN
aiua-8110	163	34	.	.	PUNCT
aiua-8110	164	1	am	be	AUX
aiua-8110	164	2	j	j	PROPN
aiua-8110	164	3	cardiol	cardiol	NOUN
aiua-8110	164	4	.	.	PUNCT
aiua-8110	165	1	2008	2008	NUM
aiua-8110	165	2	;	;	PUNCT
aiua-8110	165	3	102:653	102:653	NUM
aiua-8110	165	4	-	-	SYM
aiua-8110	165	5	7	7	NUM
aiua-8110	165	6	.	.	NOUN
aiua-8110	165	7	13	13	NUM
aiua-8110	165	8	.	.	PUNCT
aiua-8110	166	1	vassilatou	vassilatou	PROPN
aiua-8110	166	2	e	e	NOUN
aiua-8110	166	3	,	,	PUNCT
aiua-8110	166	4	fisfis	fisfi	VERB
aiua-8110	166	5	m	m	PROPN
aiua-8110	166	6	,	,	PUNCT
aiua-8110	166	7	morphopoulos	morphopoulo	NOUN
aiua-8110	166	8	g	g	PROPN
aiua-8110	166	9	,	,	PUNCT
aiua-8110	166	10	et	et	PROPN
aiua-8110	166	11	al	al	PROPN
aiua-8110	166	12	.	.	PROPN
aiua-8110	166	13	papillary	papillary	PROPN
aiua-8110	166	14	thyroid	thyroid	NOUN
aiua-8110	166	15	carcinoma	carcinoma	NOUN
aiua-8110	166	16	producing	produce	VERB
aiua-8110	166	17	granulocyte	granulocyte	ADJ
aiua-8110	166	18	-	-	PUNCT
aiua-8110	166	19	macrophage	macrophage	ADJ
aiua-8110	166	20	colony	colony	NOUN
aiua-8110	166	21	-	-	PUNCT
aiua-8110	166	22	stimulating	stimulate	VERB
aiua-8110	166	23	factor	factor	NOUN
aiua-8110	166	24	is	be	AUX
aiua-8110	166	25	associated	associate	VERB
aiua-8110	166	26	with	with	ADP
aiua-8110	166	27	neutrophilia	neutrophilia	PROPN
aiua-8110	166	28	and	and	CCONJ
aiua-8110	166	29	eosinophilia	eosinophilia	PROPN
aiua-8110	166	30	.	.	PUNCT
aiua-8110	167	1	hormones	hormone	NOUN
aiua-8110	167	2	(	(	PUNCT
aiua-8110	167	3	athens	athens	PROPN
aiua-8110	167	4	)	)	PUNCT
aiua-8110	167	5	.	.	PUNCT
aiua-8110	168	1	2006	2006	NUM
aiua-8110	168	2	;	;	PUNCT
aiua-8110	168	3	5:303	5:303	NUM
aiua-8110	168	4	-	-	SYM
aiua-8110	168	5	9	9	NUM
aiua-8110	168	6	.	.	NOUN
aiua-8110	168	7	14	14	NUM
aiua-8110	168	8	.	.	PUNCT
aiua-8110	169	1	schaider	schaider	PROPN
aiua-8110	169	2	h	h	NOUN
aiua-8110	169	3	,	,	PUNCT
aiua-8110	169	4	oka	oka	PROPN
aiua-8110	169	5	m	m	PROPN
aiua-8110	169	6	,	,	PUNCT
aiua-8110	169	7	bogenrieder	bogenrieder	PROPN
aiua-8110	169	8	t	t	PROPN
aiua-8110	169	9	,	,	PUNCT
aiua-8110	169	10	et	et	PROPN
aiua-8110	169	11	al	al	PROPN
aiua-8110	169	12	.	.	PROPN
aiua-8110	169	13	differential	differential	ADJ
aiua-8110	169	14	response	response	NOUN
aiua-8110	169	15	of	of	ADP
aiua-8110	169	16	primary	primary	ADJ
aiua-8110	169	17	and	and	CCONJ
aiua-8110	169	18	metastatic	metastatic	ADJ
aiua-8110	169	19	melanomas	melanoma	NOUN
aiua-8110	169	20	to	to	ADP
aiua-8110	169	21	neutrophils	neutrophil	NOUN
aiua-8110	169	22	attracted	attract	VERB
aiua-8110	169	23	by	by	ADP
aiua-8110	169	24	il	il	PROPN
aiua-8110	169	25	8	8	NUM
aiua-8110	169	26	.	.	PUNCT
aiua-8110	170	1	int	int	PROPN
aiua-8110	170	2	j	j	PROPN
aiua-8110	170	3	cancer	cancer	NOUN
aiua-8110	170	4	.	.	PUNCT
aiua-8110	171	1	2003	2003	NUM
aiua-8110	171	2	;	;	PUNCT
aiua-8110	171	3	103:33543	103:33543	NUM
aiua-8110	171	4	15	15	NUM
aiua-8110	171	5	.	.	PUNCT
aiua-8110	172	1	fridlender	fridlender	PROPN
aiua-8110	172	2	zg	zg	PROPN
aiua-8110	172	3	,	,	PUNCT
aiua-8110	172	4	sun	sun	PROPN
aiua-8110	172	5	j	j	PROPN
aiua-8110	172	6	,	,	PUNCT
aiua-8110	172	7	kim	kim	PROPN
aiua-8110	172	8	s	s	PROPN
aiua-8110	172	9	et	et	PROPN
aiua-8110	172	10	al	al	PROPN
aiua-8110	172	11	.	.	PROPN
aiua-8110	172	12	polarization	polarization	NOUN
aiua-8110	172	13	of	of	ADP
aiua-8110	172	14	tumor	tumor	NOUN
aiua-8110	172	15	-	-	PUNCT
aiua-8110	172	16	associated	associate	VERB
aiua-8110	172	17	neutrophil	neutrophil	ADJ
aiua-8110	172	18	phenotype	phenotype	NOUN
aiua-8110	172	19	by	by	ADP
aiua-8110	172	20	tgf	tgf	PROPN
aiua-8110	172	21	-	-	PUNCT
aiua-8110	172	22	beta	beta	NOUN
aiua-8110	172	23	:	:	PUNCT
aiua-8110	172	24	“	"	PUNCT
aiua-8110	172	25	n1”versus	n1”versus	ADJ
aiua-8110	172	26	“	"	PUNCT
aiua-8110	172	27	n2	n2	ADJ
aiua-8110	172	28	”	"	PUNCT
aiua-8110	172	29	tan	tan	PROPN
aiua-8110	172	30	.	.	PUNCT
aiua-8110	173	1	cancer	cancer	NOUN
aiua-8110	173	2	cell	cell	NOUN
aiua-8110	173	3	.	.	PUNCT
aiua-8110	174	1	2009	2009	NUM
aiua-8110	174	2	;	;	PUNCT
aiua-8110	174	3	16:183	16:183	NUM
aiua-8110	174	4	-	-	SYM
aiua-8110	174	5	94	94	NUM
aiua-8110	174	6	.	.	PUNCT
aiua-8110	175	1	16	16	NUM
aiua-8110	175	2	.	.	PUNCT
aiua-8110	176	1	guthrie	guthrie	PROPN
aiua-8110	176	2	gj	gj	PROPN
aiua-8110	176	3	,	,	PUNCT
aiua-8110	176	4	charles	charles	PROPN
aiua-8110	176	5	ka	ka	PROPN
aiua-8110	176	6	,	,	PUNCT
aiua-8110	176	7	roxburgh	roxburgh	PROPN
aiua-8110	176	8	cs	cs	PROPN
aiua-8110	176	9	,	,	PUNCT
aiua-8110	176	10	et	et	PROPN
aiua-8110	176	11	al	al	PROPN
aiua-8110	176	12	.	.	PUNCT
aiua-8110	177	1	the	the	DET
aiua-8110	177	2	systemic	systemic	ADJ
aiua-8110	177	3	inflammation	inflammation	NOUN
aiua-8110	177	4	-	-	PUNCT
aiua-8110	177	5	based	base	VERB
aiua-8110	177	6	neutrophil	neutrophil	ADJ
aiua-8110	177	7	lymphocyte	lymphocyte	ADJ
aiua-8110	177	8	ratio	ratio	NOUN
aiua-8110	177	9	:	:	PUNCT
aiua-8110	177	10	experience	experience	NOUN
aiua-8110	177	11	in	in	ADP
aiua-8110	177	12	patients	patient	NOUN
aiua-8110	177	13	with	with	ADP
aiua-8110	177	14	cancer	cancer	NOUN
aiua-8110	177	15	.	.	PUNCT
aiua-8110	178	1	crit	crit	PROPN
aiua-8110	178	2	rev	rev	VERB
aiua-8110	178	3	oncol	oncol	ADJ
aiua-8110	178	4	hematol	hematol	NOUN
aiua-8110	178	5	.	.	PUNCT
aiua-8110	179	1	2013	2013	NUM
aiua-8110	179	2	;	;	PUNCT
aiua-8110	179	3	88:218	88:218	NUM
aiua-8110	179	4	-	-	SYM
aiua-8110	179	5	30	30	NUM
aiua-8110	179	6	.	.	PUNCT
aiua-8110	180	1	17	17	NUM
aiua-8110	180	2	.	.	PUNCT
aiua-8110	181	1	moore	moore	PROPN
aiua-8110	181	2	mm	mm	PROPN
aiua-8110	181	3	,	,	PUNCT
aiua-8110	181	4	chua	chua	PROPN
aiua-8110	181	5	w	w	PROPN
aiua-8110	181	6	,	,	PUNCT
aiua-8110	181	7	charles	charles	PROPN
aiua-8110	181	8	ka	ka	PROPN
aiua-8110	181	9	,	,	PUNCT
aiua-8110	181	10	clarke	clarke	PROPN
aiua-8110	181	11	sj	sj	PROPN
aiua-8110	181	12	.	.	PROPN
aiua-8110	181	13	inflammation	inflammation	NOUN
aiua-8110	181	14	and	and	CCONJ
aiua-8110	181	15	cancer	cancer	NOUN
aiua-8110	181	16	:	:	PUNCT
aiua-8110	181	17	causes	cause	NOUN
aiua-8110	181	18	and	and	CCONJ
aiua-8110	181	19	consequences	consequence	NOUN
aiua-8110	181	20	.	.	PUNCT
aiua-8110	182	1	clin	clin	PROPN
aiua-8110	182	2	pharmacol	pharmacol	PROPN
aiua-8110	182	3	ther	ther	ADV
aiua-8110	182	4	.	.	PUNCT
aiua-8110	183	1	2010	2010	NUM
aiua-8110	183	2	;	;	PUNCT
aiua-8110	183	3	87:5048	87:5048	NUM
aiua-8110	183	4	.	.	PROPN
aiua-8110	183	5	18	18	NUM
aiua-8110	183	6	.	.	PUNCT
aiua-8110	184	1	kusumanto	kusumanto	ADP
aiua-8110	184	2	yh	yh	PROPN
aiua-8110	184	3	,	,	PUNCT
aiua-8110	184	4	dam	dam	PROPN
aiua-8110	184	5	wa	wa	PROPN
aiua-8110	184	6	,	,	PUNCT
aiua-8110	184	7	hospers	hospers	PROPN
aiua-8110	184	8	ga	ga	PROPN
aiua-8110	184	9	,	,	PUNCT
aiua-8110	184	10	et	et	PROPN
aiua-8110	184	11	al	al	PROPN
aiua-8110	184	12	.	.	PUNCT
aiua-8110	185	1	platelets	platelet	NOUN
aiua-8110	185	2	and	and	CCONJ
aiua-8110	185	3	granulocytes	granulocyte	NOUN
aiua-8110	185	4	,	,	PUNCT
aiua-8110	185	5	in	in	ADP
aiua-8110	185	6	particular	particular	ADJ
aiua-8110	185	7	the	the	DET
aiua-8110	185	8	neutrophils	neutrophil	NOUN
aiua-8110	185	9	,	,	PUNCT
aiua-8110	185	10	form	form	VERB
aiua-8110	185	11	important	important	ADJ
aiua-8110	185	12	compartments	compartment	NOUN
aiua-8110	185	13	for	for	ADP
aiua-8110	185	14	circulating	circulate	VERB
aiua-8110	185	15	vascular	vascular	ADJ
aiua-8110	185	16	endothelial	endothelial	ADJ
aiua-8110	185	17	growth	growth	NOUN
aiua-8110	185	18	factor	factor	NOUN
aiua-8110	185	19	.	.	PUNCT
aiua-8110	186	1	angiogenesis	angiogenesis	NOUN
aiua-8110	186	2	.	.	PUNCT
aiua-8110	187	1	2003	2003	NUM
aiua-8110	187	2	;	;	PUNCT
aiua-8110	188	1	6:2837	6:2837	NUM
aiua-8110	188	2	.	.	PUNCT
aiua-8110	189	1	19	19	NUM
aiua-8110	189	2	.	.	X
aiua-8110	189	3	albayrak	albayrak	PROPN
aiua-8110	189	4	y	y	PROPN
aiua-8110	189	5	,	,	PUNCT
aiua-8110	189	6	albayrak	albayrak	VERB
aiua-8110	189	7	a	a	PRON
aiua-8110	189	8	,	,	PUNCT
aiua-8110	189	9	albayrak	albayrak	PROPN
aiua-8110	189	10	f	f	PROPN
aiua-8110	189	11	,	,	PUNCT
aiua-8110	189	12	et	et	PROPN
aiua-8110	189	13	al	al	PROPN
aiua-8110	189	14	.	.	PROPN
aiua-8110	190	1	mean	mean	ADJ
aiua-8110	190	2	platelet	platelet	NOUN
aiua-8110	190	3	volume	volume	NOUN
aiua-8110	190	4	:	:	PUNCT
aiua-8110	190	5	a	a	DET
aiua-8110	190	6	new	new	ADJ
aiua-8110	190	7	predictor	predictor	NOUN
aiua-8110	190	8	in	in	ADP
aiua-8110	190	9	confirming	confirm	VERB
aiua-8110	190	10	acute	acute	ADJ
aiua-8110	190	11	appendicitis	appendicitis	NOUN
aiua-8110	190	12	diagnosis	diagnosis	NOUN
aiua-8110	190	13	.	.	PUNCT
aiua-8110	191	1	clin	clin	PROPN
aiua-8110	191	2	appl	appl	PROPN
aiua-8110	191	3	thromb	thromb	PROPN
aiua-8110	191	4	hemost	hemost	PROPN
aiua-8110	191	5	.	.	PUNCT
aiua-8110	192	1	2011	2011	NUM
aiua-8110	192	2	;	;	PUNCT
aiua-8110	192	3	17:362	17:362	NUM
aiua-8110	192	4	-	-	SYM
aiua-8110	192	5	6	6	NUM
aiua-8110	192	6	.	.	NOUN
aiua-8110	192	7	20	20	NUM
aiua-8110	192	8	.	.	PUNCT
aiua-8110	193	1	ustach	ustach	PROPN
aiua-8110	193	2	cv	cv	PROPN
aiua-8110	193	3	,	,	PUNCT
aiua-8110	193	4	taube	taube	VERB
aiua-8110	193	5	me	i	PRON
aiua-8110	193	6	,	,	PUNCT
aiua-8110	193	7	hurst	hurst	PROPN
aiua-8110	193	8	nj	nj	PROPN
aiua-8110	193	9	,	,	PUNCT
aiua-8110	193	10	et	et	PROPN
aiua-8110	193	11	al	al	PROPN
aiua-8110	193	12	.	.	PUNCT
aiua-8110	194	1	a	a	DET
aiua-8110	194	2	potential	potential	ADJ
aiua-8110	194	3	oncogenic	oncogenic	ADJ
aiua-8110	194	4	activity	activity	NOUN
aiua-8110	194	5	of	of	ADP
aiua-8110	194	6	platelet	platelet	NOUN
aiua-8110	194	7	-	-	PUNCT
aiua-8110	194	8	derived	derive	VERB
aiua-8110	194	9	growth	growth	NOUN
aiua-8110	194	10	factor	factor	NOUN
aiua-8110	194	11	d	d	NOUN
aiua-8110	194	12	in	in	ADP
aiua-8110	194	13	prostate	prostate	NOUN
aiua-8110	194	14	cancer	cancer	NOUN
aiua-8110	194	15	progression	progression	NOUN
aiua-8110	194	16	.	.	PUNCT
aiua-8110	195	1	cancer	cancer	NOUN
aiua-8110	195	2	res	re	NOUN
aiua-8110	195	3	.	.	PUNCT
aiua-8110	195	4	2004	2004	NUM
aiua-8110	195	5	;	;	PUNCT
aiua-8110	195	6	64:1722	64:1722	NOUN
aiua-8110	195	7	-	-	SYM
aiua-8110	195	8	9	9	NUM
aiua-8110	195	9	.	.	NOUN
aiua-8110	195	10	21	21	NUM
aiua-8110	195	11	.	.	PUNCT
aiua-8110	196	1	russell	russell	PROPN
aiua-8110	196	2	mr	mr	PROPN
aiua-8110	196	3	,	,	PUNCT
aiua-8110	196	4	liu	liu	PROPN
aiua-8110	196	5	q	q	PROPN
aiua-8110	196	6	,	,	PUNCT
aiua-8110	196	7	fatatis	fatatis	PROPN
aiua-8110	196	8	a.	a.	NOUN
aiua-8110	196	9	targetingthe	targetingthe	PROPN
aiua-8110	196	10	{	{	PUNCT
aiua-8110	196	11	alpha	alpha	NOUN
aiua-8110	196	12	}	}	PUNCT
aiua-8110	196	13	receptor	receptor	NOUN
aiua-8110	196	14	for	for	ADP
aiua-8110	196	15	platelet	platelet	NOUN
aiua-8110	196	16	-	-	PUNCT
aiua-8110	196	17	derived	derive	VERB
aiua-8110	196	18	growth	growth	NOUN
aiua-8110	196	19	factor	factor	NOUN
aiua-8110	196	20	as	as	ADP
aiua-8110	196	21	a	a	DET
aiua-8110	196	22	primary	primary	ADJ
aiua-8110	196	23	or	or	CCONJ
aiua-8110	196	24	combination	combination	NOUN
aiua-8110	196	25	therapy	therapy	NOUN
aiua-8110	196	26	in	in	ADP
aiua-8110	196	27	a	a	DET
aiua-8110	196	28	preclinical	preclinical	ADJ
aiua-8110	196	29	model	model	NOUN
aiua-8110	196	30	of	of	ADP
aiua-8110	196	31	prostate	prostate	NOUN
aiua-8110	196	32	cancer	cancer	NOUN
aiua-8110	196	33	skeletal	skeletal	ADJ
aiua-8110	196	34	metastasis	metastasis	NOUN
aiua-8110	196	35	.	.	PUNCT
aiua-8110	197	1	clin	clin	PROPN
aiua-8110	197	2	cancer	cancer	NOUN
aiua-8110	197	3	res	re	NOUN
aiua-8110	197	4	.	.	PUNCT
aiua-8110	198	1	2010	2010	NUM
aiua-8110	198	2	;	;	PUNCT
aiua-8110	198	3	16:5002	16:5002	NUM
aiua-8110	198	4	-	-	SYM
aiua-8110	198	5	10	10	NUM
aiua-8110	198	6	.	.	PUNCT
aiua-8110	199	1	22	22	NUM
aiua-8110	199	2	.	.	PUNCT
aiua-8110	200	1	mezouar	mezouar	PROPN
aiua-8110	200	2	s	s	PROPN
aiua-8110	200	3	,	,	PUNCT
aiua-8110	200	4	frere	frere	PROPN
aiua-8110	200	5	c	c	AUX
aiua-8110	200	6	,	,	PUNCT
aiua-8110	200	7	darbousset	darbousset	NOUN
aiua-8110	200	8	r	r	NOUN
aiua-8110	200	9	,	,	PUNCT
aiua-8110	200	10	et	et	PROPN
aiua-8110	200	11	al	al	PROPN
aiua-8110	200	12	.	.	PUNCT
aiua-8110	201	1	role	role	NOUN
aiua-8110	201	2	of	of	ADP
aiua-8110	201	3	platelets	platelet	NOUN
aiua-8110	201	4	in	in	ADP
aiua-8110	201	5	cancerandcancer	cancerandcancer	NOUN
aiua-8110	201	6	-	-	PUNCT
aiua-8110	201	7	associated	associate	VERB
aiua-8110	201	8	thrombosis	thrombosis	NOUN
aiua-8110	201	9	:	:	PUNCT
aiua-8110	201	10	experimental	experimental	ADJ
aiua-8110	201	11	and	and	CCONJ
aiua-8110	201	12	clinical	clinical	ADJ
aiua-8110	201	13	evidences	evidence	NOUN
aiua-8110	201	14	.	.	PUNCT
aiua-8110	202	1	thromb	thromb	NOUN
aiua-8110	202	2	res	re	NOUN
aiua-8110	202	3	.	.	PROPN
aiua-8110	202	4	2016	2016	NUM
aiua-8110	202	5	;	;	PUNCT
aiua-8110	202	6	139	139	NUM
aiua-8110	202	7	:	:	SYM
aiua-8110	202	8	65	65	NUM
aiua-8110	202	9	-	-	SYM
aiua-8110	202	10	76	76	NUM
aiua-8110	202	11	.	.	PUNCT
aiua-8110	203	1	23	23	NUM
aiua-8110	203	2	.	.	PUNCT
aiua-8110	204	1	kemal	kemal	PROPN
aiua-8110	204	2	y	y	PROPN
aiua-8110	204	3	,	,	PUNCT
aiua-8110	204	4	demirag	demirag	VERB
aiua-8110	204	5	g	g	PROPN
aiua-8110	204	6	,	,	PUNCT
aiua-8110	204	7	ekiz	ekiz	PROPN
aiua-8110	204	8	k	k	PROPN
aiua-8110	204	9	,	,	PUNCT
aiua-8110	204	10	et	et	PROPN
aiua-8110	204	11	al	al	PROPN
aiua-8110	204	12	.	.	PROPN
aiua-8110	205	1	mean	mean	ADJ
aiua-8110	205	2	platelet	platelet	NOUN
aiua-8110	205	3	volume	volume	NOUN
aiua-8110	205	4	could	could	AUX
aiua-8110	205	5	be	be	AUX
aiua-8110	205	6	a	a	DET
aiua-8110	205	7	useful	useful	ADJ
aiua-8110	205	8	biomarker	biomarker	NOUN
aiua-8110	205	9	for	for	ADP
aiua-8110	205	10	monitoring	monitor	VERB
aiua-8110	205	11	epithelial	epithelial	ADJ
aiua-8110	205	12	ovarian	ovarian	ADJ
aiua-8110	205	13	cancer	cancer	NOUN
aiua-8110	205	14	.	.	PUNCT
aiua-8110	206	1	j	j	PROPN
aiua-8110	206	2	obstet	obstet	PROPN
aiua-8110	206	3	gynaecol	gynaecol	PROPN
aiua-8110	206	4	.	.	PROPN
aiua-8110	206	5	2014	2014	NUM
aiua-8110	206	6	;	;	PUNCT
aiua-8110	206	7	34:515	34:515	NOUN
aiua-8110	206	8	-	-	SYM
aiua-8110	206	9	8	8	NUM
aiua-8110	206	10	.	.	NUM
aiua-8110	206	11	24	24	NUM
aiua-8110	206	12	.	.	PUNCT
aiua-8110	207	1	karaman	karaman	PROPN
aiua-8110	207	2	k	k	PROPN
aiua-8110	207	3	,	,	PUNCT
aiua-8110	207	4	bostanci	bostanci	PROPN
aiua-8110	207	5	eb	eb	PROPN
aiua-8110	207	6	,	,	PUNCT
aiua-8110	207	7	aksoy	aksoy	NOUN
aiua-8110	207	8	e	e	NOUN
aiua-8110	207	9	,	,	PUNCT
aiua-8110	207	10	et	et	PROPN
aiua-8110	207	11	al	al	PROPN
aiua-8110	207	12	.	.	PUNCT
aiua-8110	208	1	the	the	DET
aiua-8110	208	2	predictive	predictive	ADJ
aiua-8110	208	3	value	value	NOUN
aiua-8110	208	4	of	of	ADP
aiua-8110	208	5	mean	mean	ADJ
aiua-8110	208	6	platelet	platelet	NOUN
aiua-8110	208	7	volume	volume	NOUN
aiua-8110	208	8	in	in	ADP
aiua-8110	208	9	differential	differential	ADJ
aiua-8110	208	10	diagnosis	diagnosis	NOUN
aiua-8110	208	11	of	of	ADP
aiua-8110	208	12	non	non	ADJ
aiua-8110	208	13	functional	functional	ADJ
aiua-8110	208	14	pancreatic	pancreatic	ADJ
aiua-8110	208	15	neuroendocrine	neuroendocrine	NOUN
aiua-8110	208	16	tumors	tumor	NOUN
aiua-8110	208	17	from	from	ADP
aiua-8110	208	18	pancreatic	pancreatic	ADJ
aiua-8110	208	19	adenocarcinomas	adenocarcinoma	NOUN
aiua-8110	208	20	.	.	PUNCT
aiua-8110	209	1	eur	eur	PROPN
aiua-8110	209	2	j	j	PROPN
aiua-8110	209	3	intern	intern	NOUN
aiua-8110	209	4	med	me	VERB
aiua-8110	209	5	.	.	PUNCT
aiua-8110	210	1	2011	2011	NUM
aiua-8110	210	2	;	;	PUNCT
aiua-8110	210	3	22	22	NUM
aiua-8110	210	4	:	:	PUNCT
aiua-8110	210	5	e95	e95	PROPN
aiua-8110	210	6	-	-	SYM
aiua-8110	210	7	8	8	NUM
aiua-8110	210	8	.	.	X
aiua-8110	211	1	25	25	NUM
aiua-8110	211	2	.	.	PUNCT
aiua-8110	212	1	kilincalp	kilincalp	PROPN
aiua-8110	212	2	s	s	PROPN
aiua-8110	212	3	,	,	PUNCT
aiua-8110	212	4	çoban	çoban	PROPN
aiua-8110	212	5	s	s	PROPN
aiua-8110	212	6	,	,	PUNCT
aiua-8110	212	7	akinci	akinci	PROPN
aiua-8110	212	8	h	h	PROPN
aiua-8110	212	9	,	,	PUNCT
aiua-8110	212	10	et	et	PROPN
aiua-8110	212	11	al	al	PROPN
aiua-8110	212	12	.	.	PUNCT
aiua-8110	213	1	neutrophil	neutrophil	ADJ
aiua-8110	213	2	/	/	SYM
aiua-8110	213	3	lymphocyte	lymphocyte	ADJ
aiua-8110	213	4	ratio	ratio	NOUN
aiua-8110	213	5	,	,	PUNCT
aiua-8110	213	6	platelet	platelet	NOUN
aiua-8110	213	7	/	/	SYM
aiua-8110	213	8	lymphocyte	lymphocyte	ADJ
aiua-8110	213	9	ratio	ratio	NOUN
aiua-8110	213	10	,	,	PUNCT
aiua-8110	213	11	and	and	CCONJ
aiua-8110	213	12	mean	mean	VERB
aiua-8110	213	13	platelet	platelet	NOUN
aiua-8110	213	14	volume	volume	NOUN
aiua-8110	213	15	as	as	ADP
aiua-8110	213	16	potential	potential	ADJ
aiua-8110	213	17	biomarkers	biomarker	NOUN
aiua-8110	213	18	for	for	ADP
aiua-8110	213	19	early	early	ADJ
aiua-8110	213	20	detection	detection	NOUN
aiua-8110	213	21	and	and	CCONJ
aiua-8110	213	22	monitoring	monitoring	NOUN
aiua-8110	213	23	of	of	ADP
aiua-8110	213	24	colorectal	colorectal	ADJ
aiua-8110	213	25	adenocarcinoma	adenocarcinoma	NOUN
aiua-8110	213	26	.	.	PUNCT
aiua-8110	214	1	eur	eur	PROPN
aiua-8110	214	2	j	j	PROPN
aiua-8110	214	3	cancer	cancer	NOUN
aiua-8110	214	4	prev	prev	X
aiua-8110	214	5	2015	2015	NUM
aiua-8110	214	6	;	;	PUNCT
aiua-8110	214	7	24:328	24:328	NUM
aiua-8110	214	8	-	-	SYM
aiua-8110	214	9	3	3	NUM
aiua-8110	214	10	.	.	NOUN
aiua-8110	214	11	26	26	NUM
aiua-8110	214	12	.	.	PUNCT
aiua-8110	215	1	gokcen	gokcen	PROPN
aiua-8110	216	1	k	k	NOUN
aiua-8110	216	2	,	,	PUNCT
aiua-8110	216	3	dundar	dundar	VERB
aiua-8110	216	4	g	g	PROPN
aiua-8110	216	5	,	,	PUNCT
aiua-8110	216	6	gulbahar	gulbahar	PROPN
aiua-8110	216	7	h	h	NOUN
aiua-8110	216	8	,	,	PUNCT
aiua-8110	216	9	et	et	PROPN
aiua-8110	216	10	al	al	PROPN
aiua-8110	216	11	.	.	PROPN
aiua-8110	216	12	can	can	AUX
aiua-8110	216	13	routine	routine	VERB
aiua-8110	216	14	peripheral	peripheral	ADJ
aiua-8110	216	15	blood	blood	NOUN
aiua-8110	216	16	counts	count	NOUN
aiua-8110	216	17	like	like	ADP
aiua-8110	216	18	neutrophil	neutrophil	NOUN
aiua-8110	216	19	to	to	ADP
aiua-8110	216	20	lymphocyte	lymphocyte	ADJ
aiua-8110	216	21	ratio	ratio	NOUN
aiua-8110	216	22	be	be	AUX
aiua-8110	216	23	beneficial	beneficial	ADJ
aiua-8110	216	24	in	in	ADP
aiua-8110	216	25	prediagnosis	prediagnosis	NOUN
aiua-8110	216	26	of	of	ADP
aiua-8110	216	27	testicular	testicular	ADJ
aiua-8110	216	28	cancer	cancer	NOUN
aiua-8110	216	29	and	and	CCONJ
aiua-8110	216	30	its	its	PRON
aiua-8110	216	31	stages	stage	NOUN
aiua-8110	216	32	?	?	PUNCT
aiua-8110	217	1	j	j	PROPN
aiua-8110	217	2	res	res	PROPN
aiua-8110	217	3	med	med	PROPN
aiua-8110	217	4	sci	sci	PROPN
aiua-8110	217	5	.	.	PROPN
aiua-8110	217	6	2018	2018	NUM
aiua-8110	217	7	;	;	PUNCT
aiua-8110	217	8	23:64	23:64	NUM
aiua-8110	217	9	.	.	PUNCT
aiua-8110	218	1	101archivio	101archivio	NUM
aiua-8110	218	2	italiano	italiano	NOUN
aiua-8110	218	3	di	di	X
aiua-8110	218	4	urologia	urologia	PROPN
aiua-8110	218	5	e	e	PROPN
aiua-8110	218	6	andrologia	andrologia	NOUN
aiua-8110	218	7	2019	2019	NUM
aiua-8110	218	8	;	;	PUNCT
aiua-8110	218	9	91	91	NUM
aiua-8110	218	10	,	,	PUNCT
aiua-8110	218	11	2	2	NUM
aiua-8110	218	12	increased	increase	VERB
aiua-8110	218	13	neutrophil	neutrophil	ADJ
aiua-8110	218	14	/	/	SYM
aiua-8110	218	15	lymphocyte	lymphocyte	ADJ
aiua-8110	218	16	ratio	ratio	NOUN
aiua-8110	218	17	in	in	ADP
aiua-8110	218	18	testicular	testicular	ADJ
aiua-8110	218	19	cancer	cancer	NOUN
aiua-8110	218	20	correspondence	correspondence	NOUN
aiua-8110	218	21	aytaç	aytaç	PROPN
aiua-8110	218	22	şahin	şahin	PROPN
aiua-8110	218	23	md	md	PROPN
aiua-8110	218	24	(	(	PUNCT
aiua-8110	218	25	corresponding	correspond	VERB
aiua-8110	218	26	author	author	NOUN
aiua-8110	218	27	)	)	PUNCT
aiua-8110	219	1	draytacsahin@gmail.com	draytacsahin@gmail.com	X
aiua-8110	219	2	tuncay	tuncay	NOUN
aiua-8110	219	3	toprak	toprak	NOUN
aiua-8110	219	4	,	,	PUNCT
aiua-8110	219	5	md	md	PROPN
aiua-8110	219	6	drtuncay55@hotmail.com	drtuncay55@hotmail.com	PROPN
aiua-8110	219	7	musab	musab	PROPN
aiua-8110	219	8	ali	ali	PROPN
aiua-8110	219	9	kutluhan	kutluhan	PROPN
aiua-8110	219	10	,	,	PUNCT
aiua-8110	219	11	md	md	PROPN
aiua-8110	219	12	dr.musab151@hotmail.com	dr.musab151@hotmail.com	PROPN
aiua-8110	219	13	yasin	yasin	PROPN
aiua-8110	219	14	vural	vural	PROPN
aiua-8110	219	15	,	,	PUNCT
aiua-8110	219	16	md	md	PROPN
aiua-8110	219	17	yasin_vural@windowslive.com	yasin_vural@windowslive.com	PROPN
aiua-8110	219	18	ahmet	ahmet	PROPN
aiua-8110	219	19	urkmez	urkmez	PROPN
aiua-8110	219	20	,	,	PUNCT
aiua-8110	219	21	md	md	PROPN
aiua-8110	219	22	ahmeturkmez@hotmail.com	ahmeturkmez@hotmail.com	PROPN
aiua-8110	219	23	ayhan	ayhan	PROPN
aiua-8110	219	24	verit	verit	PROPN
aiua-8110	219	25	,	,	PUNCT
aiua-8110	219	26	prof	prof	NOUN
aiua-8110	219	27	.	.	PUNCT
aiua-8110	220	1	veritayhan@yahoo.com	veritayhan@yahoo.com	PROPN
aiua-8110	221	1	urology	urology	NOUN
aiua-8110	221	2	clinic	clinic	NOUN
aiua-8110	221	3	sbu	sbu	NOUN
aiua-8110	221	4	fatih	fatih	PROPN
aiua-8110	221	5	sultan	sultan	PROPN
aiua-8110	221	6	mehmet	mehmet	PROPN
aiua-8110	221	7	training	training	PROPN
aiua-8110	221	8	and	and	CCONJ
aiua-8110	221	9	research	research	NOUN
aiua-8110	221	10	hospital	hospital	NOUN
aiua-8110	221	11	atasehir	atasehir	NOUN
aiua-8110	221	12	,	,	PUNCT
aiua-8110	221	13	i̇stanbul	i̇stanbul	PROPN
aiua-8110	221	14	34752	34752	NUM
aiua-8110	221	15	turkey	turkey	NOUN